首页 » 细胞株Cell Lines 96及完全培养基-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心http://www.biovector.net

细胞株Cell Lines 96及完全培养基-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心http://www.biovector.net

  • 价  格:¥19200
  • 货  号:NTCC-CV96
  • 产  地:北京
点击询问我要采购
 竭诚为您服务!
BioVector NTCC典型培养物保藏中心
联系人:Dr.Xu, Biovector NTCC Inc.点击这里给我发消息

电话:+86-010-53513060. 工作QQ:1843439339

邮件:Biovector@163.com

手机:18901268599

地址:北京

已注册
 

细胞株Cell Lines-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心


http://www.biovector.net


ID   WM3758

AC   CVCL_AP79

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.rockland-inc.com/Product.aspx?id=51328

CC   Part of: Wistar Institute melanoma cell line collection.

ST   Source(s): Wistar

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 12,14

ST   D16S539: 14

ST   D18S51: 14,15

ST   D19S433: 14,15

ST   D21S11: 28,29

ST   D2S1338: 17,23

ST   D3S1358: 14,17

ST   D5S818: 13

ST   D7S820: 9,10

ST   D8S1179: 11,12

ST   FGA: 22

ST   TH01: 6

ST   TPOX: 8,11

ST   vWA: 17,18

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AP78 ! WM3682

OI   CVCL_0B77 ! WM3702

SX   Male

CA   Cancer cell line

//

ID   WM3772F

AC   CVCL_0B81

SY   WM3772

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.rockland-inc.com/Product.aspx?id=51329

CC   Part of: Wistar Institute melanoma cell line collection.

CC   Derived from metastatic site: Lung.

ST   Source(s): Wistar

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 8,12

ST   D16S539: 13

ST   D18S51: 13,14

ST   D19S433: 13,14

ST   D21S11: 28,31

ST   D2S1338: 20,25

ST   D3S1358: 16

ST   D5S818: 11,13

ST   D7S820: 10,13

ST   D8S1179: 10,15

ST   FGA: 20

ST   TH01: 9.3

ST   TPOX: 8,9

ST   vWA: 15,16

DI   NCIt; C7712; Uveal melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_0B74 ! WM3618F

SX   Female

CA   Cancer cell line

//

ID   WM3792

AC   CVCL_0B82

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.rockland-inc.com/Product.aspx?id=51349

CC   Part of: Wistar Institute melanoma cell line collection.

ST   Source(s): Wistar

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 8,9

ST   D16S539: 11

ST   D18S51: 10,14

ST   D19S433: 14,15

ST   D21S11: 30,31.2

ST   D2S1338: 17,20

ST   D3S1358: 18

ST   D5S818: 13

ST   D7S820: 11,12

ST   D8S1179: 9,15

ST   FGA: 19,20

ST   TH01: 8

ST   TPOX: 8,10

ST   vWA: 17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Cancer cell line

//

ID   WM3854

AC   CVCL_6801

SY   WM-3854; WM 3854; WC00125

DR   Coriell; WC00125

DR   Cosmic; 2159435

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.rockland-inc.com/Product.aspx?id=51885

CC   Part of: Wistar Institute melanoma cell line collection.

CC   Discontinued: Coriell; WC00125; probable.

CC   Derived from metastatic site: Right lymph node.

ST   Source(s): Wistar

ST   Amelogenin: X

ST   CSF1PO: 12,13

ST   D13S317: 9,12

ST   D16S539: 12

ST   D18S51: 12,15

ST   D19S433: 13,15

ST   D21S11: 29,33.2

ST   D2S1338: 17,25

ST   D3S1358: 14,17

ST   D5S818: 12,13

ST   D7S820: 11,13

ST   D8S1179: 11,16

ST   FGA: 20,24

ST   TH01: 7

ST   TPOX: 8,11

ST   vWA: 17,19

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   WM3862

AC   CVCL_0B83

DR   Cosmic; 2159429

CC   Part of: Wistar Institute melanoma cell line collection.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Cancer cell line

//

ID   WM39

AC   CVCL_2240

SY   WM-39; WM 39; WC00077

DR   CLO; CLO_0009618

DR   ATCC; CRL-2811

DR   BioSample; SAMN03471795

DR   Coriell; WC00077

DR   Cosmic; 686399

DR   Cosmic; 1155549

DR   Cosmic; 1187580

DR   Cosmic; 2159437

DR   Cosmic; 2163807

DR   ESTDAB; ESTDAB-080

DR   GEO; GSM186486

DR   GEO; GSM186487

DR   GEO; GSM186488

DR   GEO; GSM555171

RX   PubMed=18632627;

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.rockland-inc.com/Product.aspx?id=51871

CC   Part of: Wistar Institute melanoma cell line collection.

CC   Omics: Transcriptome analysis.

CC   Discontinued: ATCC; CRL-2811; true.

CC   Discontinued: Coriell; WC00077; probable.

ST   Source(s): ATCC; ESTDAB; Wistar

ST   Amelogenin: X,Y (ATCC; ESTDAB)

ST   Amelogenin: X (Wistar)

ST   CSF1PO: 10,11

ST   D13S317: 10,12

ST   D16S539: 12

ST   D18S51: 12,16

ST   D19S433: 15,16

ST   D21S11: 30

ST   D2S1338: 17,19

ST   D3S1358: 18

ST   D5S818: 11

ST   D7S820: 14

ST   D8S1179: 13,15

ST   FGA: 20,22

ST   TH01: 8,9.3

ST   TPOX: 8,11

ST   vWA: 17,18

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   WM3912

AC   CVCL_C278

SY   WM-3912; WM 3912

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.rockland-inc.com/Product.aspx?id=51357

CC   Part of: Wistar Institute melanoma cell line collection.

CC   Derived from metastatic site: Neck.

ST   Source(s): Wistar

ST   Amelogenin: X,Y

ST   CSF1PO: 10

ST   D13S317: 11,12

ST   D16S539: 10,11

ST   D18S51: 13,19

ST   D19S433: 12

ST   D21S11: 29,31

ST   D2S1338: 17,19

ST   D3S1358: 14,16

ST   D5S818: 11

ST   D7S820: 7,8

ST   D8S1179: 13,14

ST   FGA: 21

ST   TH01: 7,9

ST   TPOX: 8

ST   vWA: 17,18

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   WM3918

AC   CVCL_C279

SY   WM-3918; WM 3918

DR   GEO; GSM952608

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.rockland-inc.com/Product.aspx?id=51355

CC   Part of: Wistar Institute melanoma cell line collection.

ST   Source(s): Wistar

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 11

ST   D16S539: 10,13

ST   D18S51: 13

ST   D19S433: 14,16

ST   D21S11: 28,30

ST   D2S1338: 19,24

ST   D3S1358: 17

ST   D5S818: 11,12

ST   D7S820: 12

ST   D8S1179: 13,16

ST   FGA: 21,24

ST   TH01: 6

ST   TPOX: 8

ST   vWA: 16,17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   WM3928

AC   CVCL_6802

SY   WM-3928; WM 3928; WM3928F; WC00115

DR   Coriell; WC00115

DR   GEO; GSM952609

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.rockland-inc.com/Product.aspx?id=51906

CC   Part of: Wistar Institute melanoma cell line collection.

CC   Discontinued: Coriell; WC00115; probable.

CC   Derived from metastatic site: Left inguinal lymph node.

ST   Source(s): Wistar

ST   Amelogenin: X,Y

ST   CSF1PO: 12,13

ST   D13S317: 8,9

ST   D16S539: 10

ST   D18S51: 14,19

ST   D19S433: 12,17

ST   D21S11: 28,30

ST   D2S1338: 17,24

ST   D3S1358: 14,15

ST   D5S818: 11,12

ST   D7S820: 10,11

ST   D8S1179: 10,13

ST   FGA: 21

ST   TH01: 7,8

ST   TPOX: 8,11

ST   vWA: 17,18

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   WM4002

AC   CVCL_L032

SY   WM-4002; WM 4002; WM4002F; WM-4002F; WM 4002F

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.rockland-inc.com/Product.aspx?id=51367

CC   Part of: Wistar Institute melanoma cell line collection.

ST   Source(s): Wistar

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 11

ST   D16S539: 13

ST   D18S51: 15,17

ST   D19S433: 14,14.2

ST   D21S11: 28,30

ST   D2S1338: 17,20

ST   D3S1358: 17

ST   D5S818: 10,13

ST   D7S820: 9

ST   D8S1179: 11,13

ST   FGA: 20,23

ST   TH01: 8,9.3

ST   TPOX: 11

ST   vWA: 17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   WM46

AC   CVCL_6803

SY   WM-46; WM 46; WC00069

DR   Coriell; WC00069

DR   Cosmic; 1155269

DR   Cosmic; 1155552

DR   Cosmic; 1187582

DR   Cosmic; 1303076

DR   GEO; GSM186489

DR   GEO; GSM186490

RX   PubMed=18632627;

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-metastatic-melanoma-cell-lines-the-primary-lesi

WW   http://www.rockland-inc.com/Product.aspx?id=51952

CC   Part of: Wistar Institute melanoma cell line collection.

CC   Omics: Transcriptome analysis.

CC   Discontinued: Coriell; WC00069; probable.

CC   Derived from metastatic site: Skin.

ST   Source(s): Wistar

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 11,13

ST   D16S539: 11,14

ST   D19S433: 13,14

ST   D21S11: 29,30

ST   D2S1338: 17,18

ST   D3S1358: 15,17

ST   D5S818: 12

ST   D7S820: 11

ST   D8S1179: 13,14

ST   FGA: 22,23,28

ST   TH01: 6

ST   TPOX: 11

ST   vWA: 17,19

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   WM47

AC   CVCL_C280

SY   WM-47; WM 47

DR   GEO; GSM186491

DR   GEO; GSM186492

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.rockland-inc.com/Product.aspx?id=51398

CC   Part of: Wistar Institute melanoma cell line collection.

ST   Source(s): Wistar

ST   Amelogenin: X,Y

ST   CSF1PO: 10

ST   D13S317: 10,12

ST   D16S539: 8,12

ST   D21S11: 28,29

ST   D5S818: 11

ST   D7S820: 8,11

ST   TH01: 9.3

ST   TPOX: 10,11

ST   vWA: 16,17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   WM51

AC   CVCL_6995

SY   WM-51; WM 51; WC00122

DR   Coriell; WC00122

DR   Cosmic; 1155276

DR   Cosmic; 1155562

DR   Cosmic; 1303077

DR   GEO; GSM186493

DR   GEO; GSM186494

RX   PubMed=18632627;

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.rockland-inc.com/Product.aspx?id=51551

CC   Part of: Wistar Institute melanoma cell line collection.

CC   Omics: Transcriptome analysis.

CC   Discontinued: Coriell; WC00122; probable.

ST   Source(s): Wistar

ST   Amelogenin: X

ST   CSF1PO: 9,14

ST   D13S317: 11,12

ST   D16S539: 11,12

ST   D18S51: 19

ST   D19S433: 15,16

ST   D21S11: 30

ST   D2S1338: 17

ST   D3S1358: 15,18

ST   D5S818: 12

ST   D7S820: 10,11

ST   D8S1179: 11,13

ST   FGA: 22,23,24

ST   TH01: 9.3

ST   TPOX: 8,11

ST   vWA: 16,18,19

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   WM740V

AC   CVCL_L030

SY   WM-740V; WM 740V; WML-740V

RX   PubMed=3856042;

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-vgp

CC   Part of: Wistar Institute melanoma cell line collection.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_C283 ! WM858

OI   CVCL_C284 ! WM873-1

OI   CVCL_C285 ! WM873-2

OI   CVCL_C286 ! WM873-3

SX   Female

CA   Cancer cell line

//

ID   WM75

AC   CVCL_7156

SY   WM-75; WM 75; WM75C

DR   BTO; BTO:0003711

DR   Cosmic; 686400

DR   Cosmic; 972272

DR   Cosmic; 1155551

DR   Cosmic; 2163809

DR   ESTDAB; ESTDAB-082

DR   GEO; GSM185200

DR   GEO; GSM185201

DR   GEO; GSM186495

DR   GEO; GSM186496

RX   PubMed=2068080;

RX   PubMed=3856042;

RX   PubMed=18632627;

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-vgp

WW   http://www.rockland-inc.com/Product.aspx?id=51434

CC   Part of: Wistar Institute melanoma cell line collection.

CC   Omics: Transcriptome analysis.

ST   Source(s): ESTDAB; Wistar

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 12

ST   D16S539: 12,13

ST   D21S11: 28,29

ST   D3S1358: 14

ST   D5S818: 11

ST   D7S820: 8,9

ST   FGA: 19,20

ST   TH01: 6

ST   TPOX: 9,11

ST   vWA: 17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_C277 ! WM373

SX   Male

CA   Cancer cell line

//

ID   WM793

AC   CVCL_8787

AS   CVCL_5414

SY   WM-793; WM 793; WM793B; WM-793B; WM 793B; WM793b; WC00062

DR   BTO; BTO:0004612

DR   CLO; CLO_0009619

DR   EFO; EFO_0002873

DR   ATCC; CRL-2806

DR   BioSample; SAMN03471791

DR   Coriell; WC00062

DR   CCLE; WM793_SKIN

DR   Cosmic; 686397

DR   Cosmic; 886836

DR   Cosmic; 928693

DR   Cosmic; 972274

DR   Cosmic; 1155266

DR   Cosmic; 1155545

DR   Cosmic; 1155567

DR   Cosmic; 1238114

DR   Cosmic; 1303078

DR   Cosmic; 2159433

DR   Cosmic; 2163810

DR   Cosmic-CLP; 1299081

DR   ESTDAB; ESTDAB-083

DR   GDSC; 1299081

DR   GEO; GSM185202

DR   GEO; GSM185203

DR   GEO; GSM185204

DR   GEO; GSM185205

DR   GEO; GSM188235

DR   GEO; GSM188265

DR   GEO; GSM188324

DR   GEO; GSM887738

DR   GEO; GSM888833

DR   GEO; GSM952587

DR   GEO; GSM1670581

DR   PRIDE; PXD004343

RX   PubMed=2068080;

RX   PubMed=8342600;

RX   PubMed=18632627;

RX   PubMed=22460905;

RX   PubMed=27087056;

RX   PubMed=27397505;

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-vgp

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: Wistar Institute melanoma cell line collection.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Discontinued: ATCC; CRL-2806; true.

CC   Discontinued: Coriell; WC00062; probable.

ST   Source(s): ATCC; Cosmic-CLP; ESTDAB; PubMed=27087056; Wistar

ST   Amelogenin: X,Y (ATCC; Cosmic-CLP; ESTDAB; PubMed=27087056)

ST   Amelogenin: X (Wistar)

ST   CSF1PO: 11

ST   D13S317: 8,14

ST   D16S539: 12

ST   D18S51: 11,14

ST   D19S433: 13,15

ST   D21S11: 28,29

ST   D2S1338: 17,24

ST   D3S1358: 14,16

ST   D5S818: 10,12

ST   D7S820: 10,12 (ATCC; Cosmic-CLP; PubMed=27087056; Wistar)

ST   D7S820: 10 (ESTDAB)

ST   D8S1179: 12,14

ST   FGA: 20,21

ST   TH01: 6,8

ST   TPOX: 8

ST   vWA: 17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   WM793-P1N1

AC   CVCL_A800

SY   793-P1-N1

DR   EFO; EFO_0002874

RX   PubMed=8160777;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_8787 ! WM793

SX   Male

CA   Cancer cell line

//

ID   WM793-P1N2

AC   CVCL_A801

SY   793-P1-N2

RX   PubMed=8160777;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_8787 ! WM793

SX   Male

CA   Cancer cell line

//

ID   WM793-P1N3

AC   CVCL_A802

SY   793-P1-N3

RX   PubMed=8160777;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_8787 ! WM793

SX   Male

CA   Cancer cell line

//

ID   WM793-P2N1

AC   CVCL_A803

SY   793-P2-N1

DR   EFO; EFO_0002875

RX   PubMed=8160777;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_8787 ! WM793

SX   Male

CA   Cancer cell line

//

ID   WM793-P2N2

AC   CVCL_A804

SY   793-P2-N2

RX   PubMed=8160777;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_8787 ! WM793

SX   Male

CA   Cancer cell line

//

ID   WM793-P2N3

AC   CVCL_A805

SY   793-P2-N3

RX   PubMed=8160777;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_8787 ! WM793

SX   Male

CA   Cancer cell line

//

ID   WM8

AC   CVCL_C281

SY   WM-8; WM 8

DR   Cosmic; 928683

DR   Cosmic; 1155543

DR   GEO; GSM185206

DR   GEO; GSM185207

DR   GEO; GSM952610

RX   PubMed=18632627;

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.rockland-inc.com/Product.aspx?id=51426

CC   Part of: Wistar Institute melanoma cell line collection.

CC   Omics: Transcriptome analysis.

ST   Source(s): Wistar

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 11,12

ST   D16S539: 9

ST   D18S51: 19,20

ST   D19S433: 12.2,15

ST   D21S11: 30

ST   D2S1338: 17,23

ST   D3S1358: 15,16

ST   D5S818: 12,13

ST   D7S820: 9,13

ST   D8S1179: 11,12,14

ST   FGA: 22

ST   TH01: 8

ST   TPOX: 8,11

ST   vWA: 16,19

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Cancer cell line

//

ID   WM852

AC   CVCL_6804

SY   WM-852; WM 852; WC00065; EST84

DR   Coriell; WC00065

DR   Cosmic; 886832

DR   Cosmic; 972282

DR   Cosmic; 1047657

DR   Cosmic; 1155275

DR   Cosmic; 1303079

DR   Cosmic; 2163811

DR   Cosmic; 2479249

DR   ESTDAB; ESTDAB-084

DR   GEO; GSM156017

DR   GEO; GSM952601

RX   PubMed=8342600;

RX   PubMed=17260012;

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-metastatic-melanoma-cell-lines-the-primary-lesi

WW   http://www.rockland-inc.com/Product.aspx?id=51888

CC   Part of: Wistar Institute melanoma cell line collection.

CC   Omics: Array-based CGH.

CC   Omics: Transcriptome analysis.

CC   Misspelling: 'VM852' in Cosmic 2479249.

CC   Discontinued: Coriell; WC00065; probable.

CC   Derived from metastatic site: Skin.

ST   Source(s): ESTDAB; Wistar

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 11,12

ST   D16S539: 13,14

ST   D18S51: 18

ST   D19S433: 13,14

ST   D21S11: 30

ST   D2S1338: 16,17

ST   D3S1358: 15,18

ST   D5S818: 13 (ESTDAB)

ST   D5S818: 12,13 (Wistar)

ST   D7S820: 8,10

ST   D8S1179: 12,13

ST   FGA: 21,26 (ESTDAB)

ST   FGA: 21 (Wistar)

ST   TH01: 6,7

ST   TPOX: 8

ST   vWA: 15,17 (ESTDAB)

ST   vWA: 14,15 (Wistar)

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   WM853-2

AC   CVCL_C282

SY   WM-853-2; WM 853-2

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-vgp

WW   http://www.rockland-inc.com/Product.aspx?id=51465

CC   Part of: Wistar Institute melanoma cell line collection.

ST   Source(s): Wistar

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 11,12

ST   D16S539: 10,13

ST   D18S51: 14

ST   D19S433: 14,15

ST   D21S11: 29,30

ST   D2S1338: 17,24

ST   D3S1358: 16,17

ST   D5S818: 11,13

ST   D7S820: 10,12

ST   D8S1179: 11

ST   FGA: 22

ST   TH01: 9,9.3

ST   TPOX: 8

ST   vWA: 16,17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   WM858

AC   CVCL_C283

SY   WM-858; WM 858; Wm858; WML-858

DR   Cosmic; 1155558

DR   GEO; GSM186497

DR   GEO; GSM186498

DR   GEO; GSM952588

RX   PubMed=3856042;

RX   PubMed=18632627;

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.rockland-inc.com/Product.aspx?id=51478

CC   Part of: Wistar Institute melanoma cell line collection.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Right axillary lymph node.

ST   Source(s): Wistar

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 11

ST   D16S539: 8,12

ST   D21S11: 29,32.2

ST   D5S818: 10,12

ST   D7S820: 9,10

ST   TH01: 6,8

ST   TPOX: 8

ST   vWA: 16,17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_L030 ! WM740V

OI   CVCL_C284 ! WM873-1

OI   CVCL_C285 ! WM873-2

OI   CVCL_C286 ! WM873-3

SX   Female

CA   Cancer cell line

//

ID   WM873-1

AC   CVCL_C284

SY   WM-873-1; WM 873-1; WML-873-1

RX   PubMed=3856042;

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.rockland-inc.com/Product.aspx?id=51462

CC   Part of: Wistar Institute melanoma cell line collection.

CC   Derived from metastatic site: Right axillary lymph node.

ST   Source(s): Wistar

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 11

ST   D16S539: 8,12

ST   D18S51: 14

ST   D19S433: 13,15

ST   D21S11: 29,32.2

ST   D2S1338: 22,23

ST   D3S1358: 17

ST   D5S818: 10,12

ST   D7S820: 9,10

ST   D8S1179: 12,13

ST   FGA: 20,23

ST   TH01: 6,8

ST   TPOX: 8

ST   vWA: 16,17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_L030 ! WM740V

OI   CVCL_C283 ! WM858

OI   CVCL_C285 ! WM873-2

OI   CVCL_C286 ! WM873-3

SX   Female

CA   Cancer cell line

//

ID   WM873-2

AC   CVCL_C285

SY   WM-873-2; WM 873-2; WML-873-2

RX   PubMed=3856042;

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.rockland-inc.com/Product.aspx?id=51505

CC   Part of: Wistar Institute melanoma cell line collection.

CC   Derived from metastatic site: Right axillary lymph node.

ST   Source(s): Wistar

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 11

ST   D16S539: 8

ST   D18S51: 14

ST   D19S433: 13,15

ST   D21S11: 29,32.2

ST   D2S1338: 22,23

ST   D3S1358: 17

ST   D5S818: 10,12

ST   D7S820: 9,10

ST   D8S1179: 12,13

ST   FGA: 20,23

ST   TH01: 6,8

ST   TPOX: 8

ST   vWA: 16,17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_L030 ! WM740V

OI   CVCL_C283 ! WM858

OI   CVCL_C284 ! WM873-1

OI   CVCL_C286 ! WM873-3

SX   Female

CA   Cancer cell line

//

ID   WM873-3

AC   CVCL_C286

SY   WM-873-3; WM 873-3; WML-873-3

RX   PubMed=3856042;

CC   Part of: Wistar Institute melanoma cell line collection.

CC   Derived from metastatic site: Right axillary lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_L030 ! WM740V

OI   CVCL_C283 ! WM858

OI   CVCL_C284 ! WM873-1

OI   CVCL_C285 ! WM873-2

SX   Female

CA   Cancer cell line

//

ID   WM88

AC   CVCL_6805

SY   WM-88; WM 88; WC00123

DR   CCLE; WM88_SKIN

DR   Coriell; WC00123

DR   Cosmic; 1155563

DR   Cosmic; 1303080

DR   Cosmic; 1669265

DR   GEO; GSM188065

DR   GEO; GSM188117

DR   GEO; GSM188190

DR   GEO; GSM188205

DR   GEO; GSM188212

DR   GEO; GSM188236

DR   GEO; GSM188266

DR   GEO; GSM188281

DR   GEO; GSM188290

DR   GEO; GSM188325

DR   GEO; GSM887739

DR   GEO; GSM888834

DR   GEO; GSM952589

DR   SKY/M-FISH/CGH; 4948

RX   PubMed=18632627;

RX   PubMed=22460905;

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.rockland-inc.com/Product.aspx?id=51919

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: Wistar Institute melanoma cell line collection.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Discontinued: Coriell; WC00123; probable.

ST   Source(s): Wistar

ST   Amelogenin: X,Y

ST   CSF1PO: 10

ST   D13S317: 10,13

ST   D16S539: 11,13

ST   D18S51: 15,19

ST   D19S433: 12,13

ST   D21S11: 29,30

ST   D2S1338: 19

ST   D3S1358: 15

ST   D5S818: 12,13

ST   D7S820: 8,10

ST   D8S1179: 13,15

ST   FGA: 20,21

ST   TH01: 9.3

ST   TPOX: 12

ST   vWA: 18

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   WM9

AC   CVCL_6806

SY   WM-9; WM 9; WC00056

DR   BTO; BTO:0003438

DR   Coriell; WC00056

DR   Cosmic; 686408

DR   GEO; GSM186499

DR   GEO; GSM186500

DR   GEO; GSM952590

RX   PubMed=2068080;

RX   PubMed=3020539;

RX   PubMed=8342600;

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-metastatic-melanoma-cell-lines-the-primary-lesi

WW   http://www.rockland-inc.com/Product.aspx?id=51939

CC   Part of: Wistar Institute melanoma cell line collection.

CC   Discontinued: Coriell; WC00056; probable.

CC   Derived from metastatic site: Left axillary lymph node.

ST   Source(s): Wistar

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 9

ST   D16S539: 11,14

ST   D18S51: 13

ST   D19S433: 12,15

ST   D21S11: 29

ST   D2S1338: 24,25

ST   D3S1358: 14,17

ST   D5S818: 9,11

ST   D7S820: 9,11

ST   D8S1179: 12,13

ST   FGA: 20,25

ST   TH01: 7,9

ST   TPOX: 8,11

ST   vWA: 17,19

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   WM902B

AC   CVCL_6807

SY   WM-902B; WM 902B; WM 902 B; WC00083

DR   BTO; BTO:0005780

DR   Coriell; WC00083

DR   Cosmic; 686398

DR   Cosmic; 972273

DR   Cosmic; 1155282

DR   Cosmic; 1155553

DR   Cosmic; 1187581

DR   Cosmic; 2163812

DR   ESTDAB; ESTDAB-085

DR   GDSC; 1240227

DR   GEO; GSM186501

DR   GEO; GSM186502

DR   GEO; GSM952591

RX   PubMed=2068080;

RX   PubMed=18632627;

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-vgp

WW   http://www.rockland-inc.com/Product.aspx?id=51955

CC   Part of: Wistar Institute melanoma cell line collection.

CC   Discontinued: Coriell; WC00083; probable.

CC   Discontinued: ESTDAB; ESTDAB-085; probable.

ST   Source(s): Wistar

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 12

ST   D16S539: 11,13

ST   D19S433: 12,13

ST   D21S11: 28,30

ST   D2S1338: 17,24

ST   D3S1358: 15

ST   D5S818: 12

ST   D7S820: 11

ST   D8S1179: 12,14

ST   FGA: 19

ST   TH01: 6,8

ST   TPOX: 8,9

ST   vWA: 15,16

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   WM98-1

AC   CVCL_L073

SY   WM-98-1; WM 98-1

DR   BTO; BTO:0003712

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-vgp

CC   Part of: Wistar Institute melanoma cell line collection.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   WM983A

AC   CVCL_6808

SY   WM-983A; WM 983A; WM983-A; WC00048

DR   Coriell; WC00048

DR   Cosmic; 686405

DR   Cosmic; 928685

DR   Cosmic; 1155272

DR   Cosmic; 1155565

DR   Cosmic; 1155569

DR   Cosmic; 1303081

DR   GEO; GSM185208

DR   GEO; GSM185209

DR   GEO; GSM186503

DR   GEO; GSM186504

RX   PubMed=2068080;

RX   PubMed=18632627;

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-vgp

WW   http://www.rockland-inc.com/Product.aspx?id=51987

CC   Part of: Wistar Institute melanoma cell line collection.

CC   Omics: Transcriptome analysis.

CC   Discontinued: Coriell; WC00048; probable.

ST   Source(s): Wistar

ST   Amelogenin: X,Y

ST   CSF1PO: 10,11

ST   D13S317: 11,12

ST   D16S539: 11,12

ST   D21S11: 29,32.2

ST   D5S818: 10,11

ST   D7S820: 10,11

ST   TH01: 6

ST   TPOX: 11

ST   vWA: 17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_6809 ! WM983B

OI   CVCL_A338 ! WM983C

SX   Male

CA   Cancer cell line

//

ID   WM983B

AC   CVCL_6809

SY   WM-983B; WM 983B; WM983-B; WM-983/B; WC00066

DR   BTO; BTO:0005042

DR   CCLE; WM983B_SKIN

DR   Coriell; WC00066

DR   Cosmic; 686406

DR   Cosmic; 1155557

DR   Cosmic; 1303082

DR   GEO; GSM887740

DR   GEO; GSM888835

DR   GEO; GSM952592

RX   PubMed=2068080;

RX   PubMed=18632627;

RX   PubMed=22460905;

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.rockland-inc.com/Product.aspx?id=51973

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: Wistar Institute melanoma cell line collection.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Discontinued: Coriell; WC00066; probable.

CC   Derived from metastatic site: Lymph node.

ST   Source(s): Wistar

ST   Amelogenin: X,Y

ST   CSF1PO: 11

ST   D13S317: 12

ST   D16S539: 11,12

ST   D18S51: 14

ST   D19S433: 10,14

ST   D21S11: 29,31.2

ST   D2S1338: 25,27

ST   D3S1358: 17

ST   D5S818: 11

ST   D7S820: 11

ST   D8S1179: 8,13

ST   FGA: 20,23

ST   TH01: 6

ST   TPOX: 11

ST   vWA: 17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_6808 ! WM983A

OI   CVCL_A338 ! WM983C

SX   Male

CA   Cancer cell line

//

ID   WM983B-BR

AC   CVCL_AP81

SY   WM983B BR; WM983BBR; WM983B-R

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.rockland-inc.com/Product.aspx?id=52006

CC   Part of: Wistar Institute melanoma cell line collection.

CC   Selected for resistance to: ChEBI; CHEBI:131882; SB-590885.

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_6809 ! WM983B

SX   Male

CA   Cancer cell line

//

ID   WM983C

AC   CVCL_A338

SY   WM-983C; WM 983C

DR   Cosmic; 1155556

DR   Cosmic; 1187585

DR   Cosmic; 1303083

DR   GEO; GSM188069

DR   GEO; GSM188121

DR   GEO; GSM188194

DR   GEO; GSM188209

DR   GEO; GSM188214

DR   GEO; GSM188237

DR   GEO; GSM188267

DR   GEO; GSM188285

DR   GEO; GSM188294

DR   GEO; GSM188326

DR   SKY/M-FISH/CGH; 4949

RX   PubMed=18632627;

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.rockland-inc.com/Product.aspx?id=51519

CC   Part of: Wistar Institute melanoma cell line collection.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Lymph node.

ST   Source(s): Wistar

ST   Amelogenin: X,Y

ST   CSF1PO: 11

ST   D13S317: 12

ST   D16S539: 11

ST   D18S51: 14

ST   D19S433: 10,14

ST   D21S11: 29,31.2

ST   D2S1338: 25,27

ST   D3S1358: 17

ST   D5S818: 11

ST   D7S820: 11

ST   D8S1179: 8,13

ST   FGA: 20,23

ST   TH01: 6

ST   TPOX: 11

ST   vWA: 17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_6808 ! WM983A

OI   CVCL_6809 ! WM983B

SX   Male

CA   Cancer cell line

//

ID   WM989

AC   CVCL_0B84

WW   http://www.wistar.org/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0

WW   http://www.rockland-inc.com/Product.aspx?id=51531

CC   Part of: Wistar Institute melanoma cell line collection.

ST   Source(s): Wistar

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 11,13

ST   D16S539: 13

ST   D18S51: 10,13

ST   D19S433: 13

ST   D21S11: 28

ST   D2S1338: 18,19

ST   D3S1358: 18

ST   D5S818: 12,15

ST   D7S820: 9,10

ST   D8S1179: 13,14

ST   FGA: 20

ST   TH01: 9

ST   TPOX: 8,10

ST   vWA: 14,15

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   WMM1175

AC   CVCL_W753

SY   WMM 1175

DR   Cosmic; 1102380

RX   PubMed=10338330;

RX   PubMed=11595726;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   WMM1215

AC   CVCL_W754

DR   Cosmic; 929201

RX   PubMed=10338330;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   WMP-1

AC   CVCL_C853

SY   WMP1

RX   PubMed=7606923;

CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).

CC   Breed/subspecies: WMP/PasDnJ.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Female

CA   Transformed cell line

//

ID   WMP-2

AC   CVCL_2241

SY   WMP2

DR   CLO; CLO_0009620

DR   DSMZ; ACC-453

RX   PubMed=7606923;

RX   PubMed=11124532;

RX   PubMed=16391817;

CC   Doubling time: ~30-40 hours (DSMZ).

CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).

CC   Breed/subspecies: WMP/PasDnJ.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Female

CA   Transformed cell line

//

ID   WMPa

AC   CVCL_T689

SY   WMPA; Wisconsin-Minnesota Pronephros, strain A

RX   PubMed=1087310;

RX   PubMed=1429360;

RX   PubMed=4545299;

CC   Group: Amphibian cell line.

OX   NCBI_TaxID=8404; ! Lithobates pipiens

CA   Spontaneously immortalized cell line

//

ID   WN-R

AC   CVCL_0I64

DR   CCLV; CCLV-RIE 0755

RX   PubMed=19941903;

OX   NCBI_TaxID=9902; ! Bison bonasus

CA   Finite cell line

//

ID   Wo Fel

AC   CVCL_3431

DR   CLO; CLO_0009621

DR   ATCC; CRL-1273

DI   NCIt; C34568; Ehlers-Danlos syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   Wo Jo

AC   CVCL_3432

DR   CLO; CLO_0009622

DR   ATCC; CRL-1247

DI   NCIt; C26837; Osteogenesis imperfecta

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   Wo Mec

AC   CVCL_U668

SY   WoMec; XP4BE

DR   ATCC; CRL-1162

RX   PubMed=225015;

CC   Discontinued: ATCC; CRL-1162; true.

DI   NCIt; C3452; Xeroderma pigmentosum

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   WO-E

AC   CVCL_0C30

RX   PubMed=7736387;

DI   NCIt; C5214; Breast adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   WOL-1

AC   CVCL_F848

RX   PubMed=10393935;

CC   Characteristics: IL7 dependent.

CC   Breed/subspecies: BALB/c.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Stromal cell line

//

ID   WON,C

AC   CVCL_E878

SY   WON, C

DR   dbMHC; 49068

DR   ECACC; 94082295

DR   IHW; IHW9195

DR   IMGT/HLA; 11736

WW   http://bioinformatics.hsanmartino.it/ecbr/cl195.html

CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   WON,I

AC   CVCL_E879

SY   WON, I; TER238; TER412

DR   dbMHC; 49069

DR   ECACC; 94082294

DR   IHW; IHW9194

DR   IMGT/HLA; 11735

RX   PubMed=8307784;

WW   http://bioinformatics.hsanmartino.it/ecbr/cl194.html

CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   WON,M

AC   CVCL_E880

SY   WON, M

DR   dbMHC; 49070

DR   ECACC; 94082293

DR   IHW; IHW9193

DR   IMGT/HLA; 11569

RX   PubMed=8307784;

WW   http://bioinformatics.hsanmartino.it/ecbr/cl193.html

CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   WON,PY

AC   CVCL_E881

SY   WON, PY

DR   dbMHC; 49071

DR   ECACC; 94082256

DR   IHW; IHW9156

DR   IMGT/HLA; 11699

RX   PubMed=8307784;

WW   http://bioinformatics.hsanmartino.it/ecbr/cl156.html

CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   WOO,EM

AC   CVCL_E882

SY   WOO, EM

DR   dbMHC; 49072

DR   ECACC; 94082221

DR   IHW; IHW9122

DR   IMGT/HLA; 11666

RX   PubMed=8307784;

WW   http://bioinformatics.hsanmartino.it/ecbr/cl122.html

CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   WOP

AC   CVCL_3433

DR   CLO; CLO_0009623

DR   CLDB; cl4970

DR   ICLC; ATL99011

CC   Breed/subspecies: NIH Swiss.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0594 ! NIH 3T3

SX   Male

CA   Transformed cell line

//

ID   WP

AC   CVCL_F820

SY   TER225

DR   IMGT/HLA; 11819

CC   Part of: International Histocompatibility Workshop cell lines.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   WPE-int

AC   CVCL_K282

DR   BTO; BTO:0006000

DR   ATCC; CRL-2888

DR   BioSample; SAMN03471697

RX   PubMed=16351690;

CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).

CC   Misspelling: 'WPE1-7-1' in BioSample SAMN03471697.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 13,14

ST   D13S317: 14

ST   D16S539: 9,11

ST   D5S818: 12,15

ST   D7S820: 10,11

ST   TH01: 8,9.3

ST   TPOX: 8,11

ST   vWA: 18

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3791 ! RWPE-1

SX   Male

CA   Transformed cell line

//

ID   WPE-stem

AC   CVCL_K283

DR   ATCC; CRL-2887

DR   BioSample; SAMN03471813

RX   PubMed=16351690;

CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).

ST   Source(s): ATCC

ST   Amelogenin: X,Y

ST   CSF1PO: 13

ST   D13S317: 8,14

ST   D16S539: 9,11

ST   D5S818: 12,15

ST   D7S820: 10,11

ST   TH01: 8

ST   TPOX: 8,11

ST   vWA: 14,18

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3791 ! RWPE-1

SX   Male

CA   Transformed cell line

//

ID   WPE1-NA22

AC   CVCL_3810

DR   CLO; CLO_0009624

DR   ATCC; CRL-2849

DR   BioSample; SAMN03471802

DR   GEO; GSM827392

RX   PubMed=11304724;

WW   http://capcelllines.ca/details.asp?id=116

CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).

CC   Transformant: ChEBI; CHEBI:50102; N-methyl-N-nitrosourea (NMU).

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 13

ST   D13S317: 14

ST   D16S539: 9,11

ST   D5S818: 12,15

ST   D7S820: 10,11

ST   TH01: 8,9.3

ST   TPOX: 8,11

ST   vWA: 18

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3791 ! RWPE-1

SX   Male

CA   Transformed cell line

//

ID   WPE1-NB11

AC   CVCL_3811

DR   CLO; CLO_0009625

DR   ATCC; CRL-2851

DR   GEO; GSM827394

RX   PubMed=11304724;

WW   http://capcelllines.ca/details.asp?id=127

CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).

CC   Transformant: ChEBI; CHEBI:50102; N-methyl-N-nitrosourea (NMU).

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 13

ST   D13S317: 14

ST   D16S539: 9,11

ST   D5S818: 12,15

ST   D7S820: 10,11

ST   TH01: 8,9.3

ST   TPOX: 8,11

ST   vWA: 18

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3791 ! RWPE-1

SX   Male

CA   Transformed cell line

//

ID   WPE1-NB14

AC   CVCL_3812

SY   WPE-1/NB14

DR   CLO; CLO_0009626

DR   ATCC; CRL-2850

DR   GEO; GSM827570

RX   PubMed=11304724;

WW   http://capcelllines.ca/details.asp?id=126

CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).

CC   Transformant: ChEBI; CHEBI:50102; N-methyl-N-nitrosourea (NMU).

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 13

ST   D13S317: 14

ST   D16S539: 9,11

ST   D5S818: 12,15

ST   D7S820: 10,11

ST   TH01: 8,9.3

ST   TPOX: 8,11

ST   vWA: 18

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3791 ! RWPE-1

SX   Male

CA   Transformed cell line

//

ID   WPE1-NB26

AC   CVCL_3813

DR   CLO; CLO_0009627

DR   ATCC; CRL-2852

DR   GEO; GSM648825

DR   GEO; GSM827395

RX   PubMed=11304724;

RX   PubMed=16471037;

WW   http://capcelllines.ca/details.asp?id=125

CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).

CC   Transformant: ChEBI; CHEBI:50102; N-methyl-N-nitrosourea (NMU).

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 13

ST   D13S317: 14

ST   D16S539: 9,11

ST   D5S818: 12,15

ST   D7S820: 10,11

ST   TH01: 8,9.3

ST   TPOX: 8,11

ST   vWA: 18

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3791 ! RWPE-1

SX   Male

CA   Transformed cell line

//

ID   WPE1-NB26-64

AC   CVCL_K284

DR   ATCC; CRL-2889

RX   PubMed=16471037;

CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).

CC   Transformant: ChEBI; CHEBI:50102; N-methyl-N-nitrosourea (NMU).

ST   Source(s): ATCC

ST   Amelogenin: X,Y

ST   CSF1PO: 13

ST   D13S317: 8,14

ST   D16S539: 9,11

ST   D5S818: 12,15

ST   D7S820: 10,11

ST   TH01: 8

ST   TPOX: 8,11

ST   vWA: 14,18

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3813 ! WPE1-NB26

SX   Male

CA   Transformed cell line

//

ID   WPE1-NB26-65

AC   CVCL_K285

DR   ATCC; CRL-2890

RX   PubMed=16471037;

CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).

CC   Transformant: ChEBI; CHEBI:50102; N-methyl-N-nitrosourea (NMU).

ST   Source(s): ATCC

ST   Amelogenin: X,Y

ST   CSF1PO: 13

ST   D13S317: 8,14

ST   D16S539: 9,11

ST   D5S818: 12,15

ST   D7S820: 10,11

ST   TH01: 8

ST   TPOX: 8,11

ST   vWA: 14,18

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3813 ! WPE1-NB26

SX   Male

CA   Transformed cell line

//

ID   WPF22

AC   CVCL_W044

RX   PubMed=24556363;

CC   Doubling time: 30.2 hours (PubMed=24556363).

CC   Breed/subspecies: Wuzhishan miniature pig.

OX   NCBI_TaxID=9823; ! Sus scrofa

SX   Male

CA   Finite cell line

//

ID   WPMY-1

AC   CVCL_3814

SY   WPMY1

DR   BTO; BTO:0003708

DR   CLO; CLO_0009628

DR   ATCC; CRL-2854

DR   BioSample; SAMN03471803

RX   PubMed=10383888;

WW   http://capcelllines.ca/details.asp?id=154

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pRSV-T].

ST   Source(s): ATCC

ST   Amelogenin: X,Y

ST   CSF1PO: 13

ST   D13S317: 8,14

ST   D16S539: 9

ST   D5S818: 12,15

ST   D7S820: 10,11

ST   TH01: 8,9.3

ST   TPOX: 8,11

ST   vWA: 14,18

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_3791 ! RWPE-1

SX   Male

CA   Transformed cell line

//

ID   WR Di-1

AC   CVCL_Z814

SY   WR-72-Di-1

DR   DGRC; 207

RX   DOI=10.1016/B978-012229460-0/50004-X;

CC   Group: Insect cell line.

OX   NCBI_TaxID=7250; ! Drosophila immigrans

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   WR Dv-1

AC   CVCL_Z815

SY   WR-75-Dv-1

DR   DGRC; 40

RX   DOI=10.1016/B978-012229460-0/50004-X;

CC   Group: Insect cell line.

OX   NCBI_TaxID=7244; ! Drosophila virilis

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   WR002

AC   CVCL_W060

SY   WR2

RX   PubMed=2502918;

RX   PubMed=3343350;

RX   PubMed=3488062;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C121564; Adenine phosphoribosyltransferase deficiency

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   WR004

AC   CVCL_W061

SY   WR4

RX   PubMed=2502918;

RX   PubMed=3343350;

RX   PubMed=3488062;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C121564; Adenine phosphoribosyltransferase deficiency

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   WR005

AC   CVCL_W062

SY   WR5

RX   PubMed=3343350;

RX   PubMed=3488062;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C121564; Adenine phosphoribosyltransferase deficiency

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   WR010

AC   CVCL_W063

SY   WR10

RX   PubMed=3343350;

RX   PubMed=3488062;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C121564; Adenine phosphoribosyltransferase deficiency

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   WR011

AC   CVCL_W064

SY   WR11

RX   PubMed=2502918;

RX   PubMed=3343350;

RX   PubMed=3488062;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C121564; Adenine phosphoribosyltransferase deficiency

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   WR012

AC   CVCL_W065

SY   WR12

RX   PubMed=2502918;

RX   PubMed=3343350;

RX   PubMed=3488062;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C121564; Adenine phosphoribosyltransferase deficiency

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   WR015

AC   CVCL_W066

SY   WR15

RX   PubMed=2502918;

RX   PubMed=3488062;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C121564; Adenine phosphoribosyltransferase deficiency

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   WR016

AC   CVCL_W067

SY   WR16

RX   PubMed=3488062;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C121564; Adenine phosphoribosyltransferase deficiency

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   WR017

AC   CVCL_W068

SY   WR17

RX   PubMed=3488062;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C121564; Adenine phosphoribosyltransferase deficiency

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   WR020

AC   CVCL_W069

SY   WR20

RX   PubMed=3343350;

RX   PubMed=3488062;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C121564; Adenine phosphoribosyltransferase deficiency

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   WR035

AC   CVCL_W070

SY   WR35

RX   PubMed=3488062;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C121564; Adenine phosphoribosyltransferase deficiency

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   WR036

AC   CVCL_W071

SY   WR36

RX   PubMed=3488062;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C121564; Adenine phosphoribosyltransferase deficiency

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   WR063

AC   CVCL_W072

SY   WR63

RX   PubMed=3343350;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C121564; Adenine phosphoribosyltransferase deficiency

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   WR064

AC   CVCL_W073

SY   WR64

RX   PubMed=3343350;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C121564; Adenine phosphoribosyltransferase deficiency

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   WR067

AC   CVCL_W074

SY   WR67

RX   PubMed=2502918;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C121564; Adenine phosphoribosyltransferase deficiency

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   WR077

AC   CVCL_W075

SY   WR77

RX   PubMed=2502918;

RX   PubMed=3343350;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C121564; Adenine phosphoribosyltransferase deficiency

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   WR081

AC   CVCL_W076

SY   WR81

RX   PubMed=2502918;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C121564; Adenine phosphoribosyltransferase deficiency

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   WR083

AC   CVCL_W077

SY   WR83

RX   PubMed=2502918;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C121564; Adenine phosphoribosyltransferase deficiency

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   WR19L

AC   CVCL_4338

SY   WR 19L; WR 19L.1

DR   CLO; CLO_0009629

DR   ATCC; TIB-52

DR   ECACC; 95050414

RX   PubMed=212198;

CC   Breed/subspecies: BALB/c.

DI   NCIt; C21602; Mouse lymphoma

OX   NCBI_TaxID=10090; ! Mus musculus

OI   CVCL_5415 ! WR19M.1

SX   Female

CA   Cancer cell line

//

ID   WR19M.1

AC   CVCL_5415

SY   WR 19M.1; WR 19M

DR   CLO; CLO_0009630

DR   ATCC; TIB-70

RX   PubMed=212198;

RX   PubMed=3792703;

CC   Breed/subspecies: BALB/c.

DI   NCIt; C21602; Mouse lymphoma

OX   NCBI_TaxID=10090; ! Mus musculus

OI   CVCL_4338 ! WR19L

SX   Female

CA   Cancer cell line

//

ID   WR21

AC   CVCL_3623

DR   CLO; CLO_0009631

DR   ATCC; CRL-2189

RX   PubMed=7803707;

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Cancer cell line

//

ID   WR216

AC   CVCL_5606

DR   CLO; CLO_0050975

DR   BioSample; SAMN03472279

DR   RCB; RCB0520

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 12,14

ST   D16S539: 9,12

ST   D5S818: 10,13

ST   D7S820: 8,12

ST   TH01: 6,9

ST   TPOX: 8,9

ST   vWA: 14

DI   NCIt; C121564; Adenine phosphoribosyltransferase deficiency

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   WRC

AC   CVCL_4339

DR   CLO; CLO_0009632

DR   CLDB; cl4729

DR   ECACC; 88031148

DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_3537 ! LLC-WRC 256

SX   Female

CA   Cancer cell line

//

ID   WRL 68

AC   CVCL_0581

AS   CVCL_D685

SY   WRL-68; WRL68

DR   BTO; BTO:0002584

DR   BTO; BTO:0005288

DR   CLO; CLO_0009633

DR   MCCL; MCC:0000487

DR   CLDB; cl4730

DR   ATCC; CL-48

DR   BioSample; SAMN03151767

DR   ChEMBL-Cells; CHEMBL3307993

DR   ChEMBL-Targets; CHEMBL612587

DR   ECACC; 89121403

DR   IZSLER; BS CL 173

RX   Patent=US3935066;

RX   PubMed=7522099;

RX   PubMed=20143388;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=20143388). Originally thought to be a hepatic fetal epithelial cell line.

CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).

CC   Misspelling: Occasionally 'CL-48' (based on the ATCC catalog number).

ST   Source(s): ATCC; ECACC

ST   Amelogenin: X

ST   CSF1PO: 9,10

ST   D13S317: 12,13.3 (ATCC)

ST   D13S317: 12,14 (ECACC)

ST   D16S539: 9,10

ST   D5S818: 11,12

ST   D7S820: 8,12

ST   TH01: 7

ST   TPOX: 8,12

ST   vWA: 16,18

DI   NCIt; C4029; Cervical adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0030 ! HeLa

SX   Female

CA   Cancer cell line

//

ID   WRLS1

AC   CVCL_4W86

RX   PubMed=23111106;

CC   Problematic cell line: Contaminated. Parent cell line (WRL-68) has been shown to be a HeLa derivative.

CC   Selected for resistance to: ChEBI; CHEBI:50924; Sorafenib (Nexavar).

CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).

DI   NCIt; C4029; Cervical adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0581 ! WRL 68

SX   Female

CA   Cancer cell line

//

ID   WRO

AC   CVCL_0582

AS   CVCL_1663

SY   WRO82-1; WRO 82-1; WRO-82; WRO82; UCLA RO 82-W-1; UCLA RO-82W-1; UCLA RO82W1; RO 82 W-1; RO82-W-1; RO82W-1; RO82

DR   BTO; BTO:0004772

DR   CLO; CLO_0008860

DR   MCCL; MCC:0000488

DR   CLDB; cl4167

DR   CLDB; cl4902

DR   ChEMBL-Cells; CHEMBL3308779

DR   ChEMBL-Targets; CHEMBL1075565

DR   Cosmic; 684194

DR   Cosmic; 685606

DR   Cosmic; 849971

DR   Cosmic; 886554

DR   Cosmic; 918181

DR   Cosmic; 928830

DR   Cosmic; 930083

DR   Cosmic; 931244

DR   Cosmic; 990535

DR   Cosmic; 1005459

DR   Cosmic; 1094762

DR   Cosmic; 1152113

DR   Cosmic; 1155332

DR   Cosmic; 1161614

DR   Cosmic; 1162842

DR   Cosmic; 1280051

DR   Cosmic; 1699415

DR   Cosmic; 2319849

DR   Cosmic-CLP; 930083

DR   ECACC; 92030502

DR   GDSC; 930083

DR   GEO; GSM827437

DR   GEO; GSM1670384

DR   Lonza; 1209

DR   ICLC; HTL98002

DR   TOKU-E; 4066

RX   PubMed=2570483;

RX   PubMed=17804723;

RX   PubMed=18713817;

RX   PubMed=23162534;

RX   PubMed=27397505;

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; ICLC

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 9

ST   D16S539: 12 (Cosmic-CLP)

ST   D16S539: 11,12 (ICLC)

ST   D21S11: 29

ST   D5S818: 12

ST   D7S820: 8,12

ST   TH01: 7,9.3

ST   TPOX: 8

ST   vWA: 16,19 (Cosmic-CLP)

ST   vWA: 16,21 (ICLC)

DI   NCIt; C8054; Thyroid gland follicular carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Ws-HMG

AC   CVCL_U700

DR   ATCC; CRL-1253

CC   Discontinued: ATCC; CRL-1253; true.

DI   NCIt; C3447; Werner syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   WS1

AC   CVCL_2766

DR   CLO; CLO_0009634

DR   CLDB; cl4732

DR   ATCC; CRL-1502

DR   BioSample; SAMN03471371

DR   BCRC; 60300

DR   ECACC; 88021104

DR   CLS; 300344/NA

RX   PubMed=721103;

CC   Discontinued: CLS; 300344; true.

ST   Source(s): ATCC; ECACC

ST   Amelogenin: X

ST   CSF1PO: 10,13

ST   D13S317: 12

ST   D16S539: 10,11

ST   D5S818: 13

ST   D7S820: 9,10

ST   TH01: 8,10

ST   TPOX: 8,9

ST   vWA: 17,18

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   WS1-CLS

AC   CVCL_6211

DR   CLS; 300378/p621_WS1-CLS

ST   Source(s): CLS

ST   Amelogenin: X,Y

ST   CSF1PO: 11

ST   D13S317: 11,12

ST   D16S539: 11,12

ST   D18S51: 12,17

ST   D21S11: 29,31.2

ST   D3S1358: 15,18

ST   D5S818: 12

ST   D7S820: 9,10

ST   D8S1179: 13

ST   FGA: 20,23

ST   Penta D: 9,13

ST   Penta E: 12,20

ST   TH01: 8,9.3

ST   TPOX: 8,11

ST   vWA: 16,17

DI   NCIt; C5585; Skin sarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   WS1TKB

AC   CVCL_J710

DR   CLO; CLO_0050654

DR   BioSample; SAMN03472305

DR   RCB; RCB0409

ST   Source(s): RCB

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 8,9

ST   D16S539: 9,12

ST   D5S818: 11

ST   D7S820: 11

ST   TH01: 9,10

ST   TPOX: 8,11

ST   vWA: 16,18

DI   NCIt; C3447; Werner syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_J711 ! WS1TKB2

SX   Male

CA   Finite cell line

//

ID   WS1TKB2

AC   CVCL_J711

DR   CLO; CLO_0050655

DR   RCB; RCB0433

ST   Source(s): RCB

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 8,9

ST   D16S539: 9,12

ST   D5S818: 11

ST   D7S820: 11

ST   TH01: 9,10

ST   TPOX: 8,11

ST   vWA: 16,18

DI   NCIt; C3447; Werner syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_J710 ! WS1TKB

SX   Male

CA   Finite cell line

//

ID   WS2RGB

AC   CVCL_T329

DR   CLO; CLO_0050696

DR   BioSample; SAMN03472337

DR   RCB; GMC0006

DR   RCB; RCB0154

CC   Discontinued: RCB; RCB0154; true.

ST   Source(s): RCB

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 8,11

ST   D16S539: 9

ST   D5S818: 12

ST   D7S820: 10,12

ST   TH01: 6,7

ST   TPOX: 8

ST   vWA: 14

DI   NCIt; C3447; Werner syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   WS2TKB

AC   CVCL_J712

DR   CLO; CLO_0050653

DR   BioSample; SAMN03472304

DR   RCB; RCB0407

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 12,14

ST   D16S539: 9,12

ST   D5S818: 11,12

ST   D7S820: 10,12

ST   TH01: 7,9

ST   TPOX: 8,11

ST   vWA: 17,18

DI   NCIt; C3447; Werner syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   WS3RGB

AC   CVCL_T330

DR   CLO; CLO_0050699

DR   BioSample; SAMN03472338

DR   RCB; GMC0007

DR   RCB; RCB0155

CC   Discontinued: RCB; RCB0155; true.

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 8

ST   D16S539: 11

ST   D5S818: 11,12

ST   D7S820: 12

ST   TH01: 7

ST   TPOX: 11

ST   vWA: 16,17

DI   NCIt; C3447; Werner syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   WS6RGB

AC   CVCL_T331

DR   CLO; CLO_0050694

DR   BioSample; SAMN03472353

DR   RCB; GMC0009

DR   RCB; RCB0387

CC   Discontinued: RCB; RCB0387; true.

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 10

ST   D16S539: 9,10

ST   D5S818: 7,10

ST   D7S820: 8

ST   TH01: 7,9

ST   TPOX: 8

ST   vWA: 17

DI   NCIt; C3447; Werner syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   WSB

AC   CVCL_J514

SY   Mel-WSB

DR   Cosmic; 889041

DR   Cosmic; 928704

DR   Cosmic; 1211151

DR   GEO; GSM170983

RX   PubMed=8980186;

RX   PubMed=9354451;

RX   PubMed=15048078;

RX   PubMed=17516929;

RX   PubMed=23039341;

WW   http://biogps.org/dataset/1409/63-melanoma-cell-lines/

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   WSBM

AC   CVCL_R928

SY   White Sturgeon Body Muscle

RX   PubMed=15801167;

CC   Group: Fish cell line.

OX   NCBI_TaxID=7904; ! Acipenser transmontanus

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   WSCU01 iPS#02

AC   CVCL_IN40

SY   WSCU01-derived iPSC clone 02

RX   PubMed=25390333;

DI   NCIt; C3447; Werner syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_IN41 ! WSCU01 iPS#13

OI   CVCL_IN42 ! WSCU01 iPS#14

SX   Male

CA   Induced pluripotent stem cell

//

ID   WSCU01 iPS#13

AC   CVCL_IN41

SY   WSCU01-derived iPSC clone 13

RX   PubMed=25390333;

DI   NCIt; C3447; Werner syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_IN40 ! WSCU01 iPS#02

OI   CVCL_IN42 ! WSCU01 iPS#14

SX   Male

CA   Induced pluripotent stem cell

//

ID   WSCU01 iPS#14

AC   CVCL_IN42

SY   WSCU01-derived iPSC clone 14

RX   PubMed=25390333;

DI   NCIt; C3447; Werner syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_IN40 ! WSCU01 iPS#02

OI   CVCL_IN41 ! WSCU01 iPS#13

SX   Male

CA   Induced pluripotent stem cell

//

ID   WSF

AC   CVCL_R929

SY   White Sturgeon Fin

RX   PubMed=15801167;

CC   Group: Fish cell line.

OX   NCBI_TaxID=7904; ! Acipenser transmontanus

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   WSG-R

AC   CVCL_0I77

DR   CCLV; CCLV-RIE 0378

CC   Breed/subspecies: Wild boar.

OX   NCBI_TaxID=9823; ! Sus scrofa

CA   Spontaneously immortalized cell line

//

ID   WSGO

AC   CVCL_R930

SY   White Sturgeon Gonad

RX   PubMed=9676244;

CC   Group: Fish cell line.

OX   NCBI_TaxID=7904; ! Acipenser transmontanus

OI   CVCL_R932 ! WSHO

OI   CVCL_R934 ! WSLV

OI   CVCL_R935 ! WSNV

OI   CVCL_R936 ! WSSB

SX   Male

CA   Spontaneously immortalized cell line

//

ID   WSH-1

AC   CVCL_R931

SY   White Sturgeon Heart-1

RX   DOI=10.1577/1548-8659(1991)120<0528:TCLFWS>2.3.CO;2;

CC   Group: Fish cell line.

OX   NCBI_TaxID=7904; ! Acipenser transmontanus

OI   CVCL_R937 ! WSS-2

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   WSHO

AC   CVCL_R932

SY   White Sturgeon Hematopoeitic Organ

RX   PubMed=9676244;

CC   Group: Fish cell line.

OX   NCBI_TaxID=7904; ! Acipenser transmontanus

OI   CVCL_R930 ! WSGO

OI   CVCL_R934 ! WSLV

OI   CVCL_R935 ! WSNV

OI   CVCL_R936 ! WSSB

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   WSHST

AC   CVCL_R933

SY   White Sturgeon Head Soft Tissue

RX   PubMed=15801167;

CC   Group: Fish cell line.

OX   NCBI_TaxID=7904; ! Acipenser transmontanus

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   WSL-R

AC   CVCL_0I66

DR   CCLV; CCLV-RIE 0379

RX   PubMed=19941903;

CC   Breed/subspecies: Wild boar.

OX   NCBI_TaxID=9823; ! Sus scrofa

CA   Spontaneously immortalized cell line

//

ID   WSLV

AC   CVCL_R934

SY   White Sturgeon LiVer

RX   PubMed=9676244;

CC   Group: Fish cell line.

OX   NCBI_TaxID=7904; ! Acipenser transmontanus

OI   CVCL_R930 ! WSGO

OI   CVCL_R932 ! WSHO

OI   CVCL_R935 ! WSNV

OI   CVCL_R936 ! WSSB

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   WSN

AC   CVCL_9881

RX   DOI=10.1007/0-306-46872-7_2;

RX   PubMed=7579408;

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   WSNV

AC   CVCL_R935

RX   PubMed=9676244;

CC   Group: Fish cell line.

OX   NCBI_TaxID=7904; ! Acipenser transmontanus

OI   CVCL_R930 ! WSGO

OI   CVCL_R932 ! WSHO

OI   CVCL_R934 ! WSLV

OI   CVCL_R936 ! WSSB

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   WSS-1

AC   CVCL_2767

SY   WS-1

DR   BTO; BTO:0004920

DR   CLO; CLO_0009635

DR   ATCC; CRL-2029

DR   BioSample; SAMN03471421

RX   PubMed=1336119;

CC   Transfected with: RGD; 61855; Gabra1.

CC   Transfected with: RGD; 61966; Gabrg2.

CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 12,14

ST   D16S539: 9,13

ST   D5S818: 8

ST   D7S820: 11,12

ST   TH01: 7,9.3

ST   TPOX: 11

ST   vWA: 16,19

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0045 ! HEK293

SX   Female

CA   Transformed cell line

//

ID   WSS-2

AC   CVCL_R937

SY   White Sturgeon Spleen-2

RX   DOI=10.1577/1548-8659(1991)120<0528:TCLFWS>2.3.CO;2;

CC   Group: Fish cell line.

OX   NCBI_TaxID=7904; ! Acipenser transmontanus

OI   CVCL_R931 ! WSH-1

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   WSSB

AC   CVCL_R936

SY   White Sturgeon Swim Bladder

RX   PubMed=9676244;

CC   Group: Fish cell line.

OX   NCBI_TaxID=7904; ! Acipenser transmontanus

OI   CVCL_R930 ! WSGO

OI   CVCL_R932 ! WSHO

OI   CVCL_R934 ! WSLV

OI   CVCL_R935 ! WSNV

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   WSSK-1

AC   CVCL_S954

SY   WSSK; White Sturgeon SKin-1

RX   DOI=10.3354/dao011049;

CC   Group: Fish cell line.

OX   NCBI_TaxID=7904; ! Acipenser transmontanus

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   WSU-1

AC   CVCL_HG33

SY   WSU1

DR   GEO; GSM1985

RX   PubMed=10676951;

CC   Omics: Transcriptome analysis.

DI   NCIt; C8851; Diffuse large B-cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   WSU-ALCL

AC   CVCL_A036

DR   BioSample; SAMN03151623

DR   Cosmic; 1086369

RX   CelloPub=CLPUB00128;

RX   PubMed=12592342;

RX   PubMed=20143388;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a CCRF-CEM derivative (PubMed=12592342, PubMed=20143388).

DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0207 ! CCRF-CEM

SX   Female

CA   Cancer cell line

//

ID   WSU-AML

AC   CVCL_5607

WW   http://www.asterandbio.com/biospecimens/human-tissue-derived-products/cell-lines/

WW   http://www.prnewswire.com/news-releases/asterand-introduces-nine-ways-to-accelerate-cancer-research-55450592.html

DI   NCIt; C3171; Acute myeloid leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   WSU-BL

AC   CVCL_M552

RX   DOI=10.1111/j.1749-6632.1989.tb16491.x;

RX   PubMed=2527086;

WW   http://www.prnewswire.com/news-releases/asterand-introduces-nine-ways-to-accelerate-cancer-research-55450592.html

CC   Characteristics: EBV-negative.

CC   Doubling time: 19 hours (PubMed=2527086).

DI   NCIt; C7954; Adult Burkitt leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   WSU-CLL

AC   CVCL_A049

DR   BioSample; SAMN03151907

RX   PubMed=8558918;

RX   PubMed=12200708;

RX   PubMed=12592342;

RX   PubMed=20143388;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a Reh derivative (PubMed=12200708, PubMed=12592342, PubMed=20143388). Was originally thought to originate from a male patient chronic lymphocytic leukemia.

DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1650 ! Reh

SX   Female

CA   Cancer cell line

//

ID   WSU-DLCL

AC   CVCL_M580

DR   Cosmic; 1086347

DR   DSMZ; ACC-779

RX   PubMed=1540884;

WW   http://www.prnewswire.com/news-releases/asterand-introduces-nine-ways-to-accelerate-cancer-research-55450592.html

CC   Doubling time: 20 hours (PubMed=1540884); ~48-72 hours (DSMZ).

ST   Source(s): DSMZ

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 12,13

ST   D16S539: 9,12

ST   D5S818: 11

ST   D7S820: 8,12

ST   TH01: 8,9.3

ST   TPOX: 9

ST   vWA: 16,18

DI   NCIt; C8851; Diffuse large B-cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   WSU-DLCL2

AC   CVCL_1902

SY   WSU-DLCL(2); WSUDLCL2

DR   EFO; EFO_0006775

DR   ATCC; CRL-11585

DR   BioSample; SAMN03473225

DR   CCLE; WSUDLCL2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE

DR   Cosmic; 1329090

DR   Cosmic; 1629937

DR   Cosmic; 1714159

DR   Cosmic-CLP; 1331050

DR   DSMZ; ACC-575

DR   GDSC; 1331050

DR   GEO; GSM887741

DR   GEO; GSM888836

DR   GEO; GSM1670582

RX   PubMed=9607591;

RX   PubMed=19358282;

RX   PubMed=22460905;

RX   PubMed=23699601;

RX   PubMed=25355872;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://www.asterandbio.com/biospecimens/human-tissue-derived-products/cell-lines/

WW   http://www.prnewswire.com/news-releases/asterand-introduces-nine-ways-to-accelerate-cancer-research-55450592.html

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Doubling time: 18 hours (PubMed=9607591); ~50-70 hours (DSMZ).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Genome sequenced.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Omics: Virome analysis using RNAseq.

CC   Misspelling: 'WSU-DCL2' in GEO GSM1374991.

CC   Discontinued: ATCC; CRL-11585; probable.

ST   Source(s): Cosmic-CLP; DSMZ; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 11

ST   D13S317: 11,14

ST   D16S539: 10,13

ST   D18S51: 15,16

ST   D21S11: 29,32.2

ST   D3S1358: 14,16

ST   D5S818: 11,12

ST   D7S820: 10,12

ST   D8S1179: 12,13

ST   FGA: 22

ST   Penta D: 10,13

ST   Penta E: 14,19

ST   TH01: 8,9

ST   TPOX: 8

ST   vWA: 16,17

DI   NCIt; C8851; Diffuse large B-cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   WSU-FSCCL

AC   CVCL_1903

SY   WSUFSCCL

DR   EFO; EFO_0006776

DR   BioSample; SAMN03472504

DR   DSMZ; ACC-612

RX   PubMed=8221615;

RX   PubMed=25485619;

RX   PubMed=28196595;

WW   http://www.asterandbio.com/biospecimens/human-tissue-derived-products/cell-lines/

WW   http://www.prnewswire.com/news-releases/asterand-introduces-nine-ways-to-accelerate-cancer-research-55450592.html

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Doubling time: ~26 hours (PubMed=8221615); ~20-30 hours (DSMZ).

CC   Omics: Deep RNAseq analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

ST   Source(s): DSMZ; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 11,13

ST   D16S539: 11,13

ST   D18S51: 13,14

ST   D21S11: 30

ST   D3S1358: 15,16

ST   D5S818: 12

ST   D7S820: 10,13

ST   D8S1179: 12,14

ST   FGA: 22,24

ST   Penta D: 9,13

ST   Penta E: 7,12

ST   TH01: 9.3

ST   TPOX: 11

ST   vWA: 18,20

DI   NCIt; C27810; Malignant non-Hodgkin's lymphoma, cleaved cell

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   WSU-HN11

AC   CVCL_AX28

RX   PubMed=7705939;

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   WSU-HN12

AC   CVCL_5518

SY   HN12; HN-12

DR   BTO; BTO:0005040

DR   Cosmic; 922079

DR   Cosmic; 2043897

DR   Cosmic; 2296297

DR   Cosmic; 2513908

RX   PubMed=7705939;

RX   PubMed=8001221;

RX   PubMed=9049184;

RX   PubMed=9389571;

RX   PubMed=25275298;

CC   Part of: OPC-22 oral and pharyngeal cancer cell line panel.

CC   Omics: Deep exome analysis.

CC   Derived from metastatic site: Lymph node.

ST   Source(s): PubMed=25275298

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 13

ST   D16S539: 9

ST   D18S51: 14

ST   D21S11: 32,33.2

ST   D3S1358: 15

ST   D5S818: 11,12

ST   D7S820: 10

ST   D8S1179: 13

ST   FGA: 20,26

ST   Penta D: 9,10

ST   Penta E: 7

ST   TH01: 7,9

ST   TPOX: 11

ST   vWA: 16,17

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_5515 ! WSU-HN4

SX   Female

CA   Cancer cell line

//

ID   WSU-HN13

AC   CVCL_5519

SY   HN13

DR   Cosmic; 922088

DR   Cosmic; 2296298

DR   Cosmic; 2513909

RX   PubMed=7705939;

RX   PubMed=8001221;

RX   PubMed=9049184;

RX   PubMed=9389571;

RX   PubMed=25275298;

CC   Part of: OPC-22 oral and pharyngeal cancer cell line panel.

CC   Omics: Deep exome analysis.

ST   Source(s): PubMed=25275298

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 10,12

ST   D16S539: 12

ST   D18S51: 14,15

ST   D21S11: 31.2

ST   D3S1358: 14,16

ST   D5S818: 12

ST   D7S820: 9,10

ST   D8S1179: 13,15

ST   FGA: 21,26

ST   Penta D: 9,11

ST   Penta E: 12,14

ST   TH01: 7,9

ST   TPOX: 8,11

ST   vWA: 18

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   WSU-HN14

AC   CVCL_AX29

RX   PubMed=7705939;

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   WSU-HN17

AC   CVCL_5520

SY   HN17

DR   Cosmic; 922089

RX   PubMed=7705939;

RX   PubMed=8001221;

RX   PubMed=9049184;

RX   PubMed=9389571;

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AX30 ! WSU-HN18

CA   Cancer cell line

//

ID   WSU-HN18

AC   CVCL_AX30

RX   PubMed=7705939;

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_5520 ! WSU-HN17

CA   Cancer cell line

//

ID   WSU-HN19

AC   CVCL_5521

SY   HN19

DR   Cosmic; 922090

RX   PubMed=7705939;

RX   PubMed=8001221;

RX   PubMed=9389571;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   WSU-HN22

AC   CVCL_5522

SY   HN22

DR   Cosmic; 922081

RX   PubMed=7705939;

RX   PubMed=8001221;

RX   PubMed=9389571;

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_5517 ! WSU-HN8

SX   Male

CA   Cancer cell line

//

ID   WSU-HN24

AC   CVCL_AX31

RX   PubMed=7705939;

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   WSU-HN25

AC   CVCL_AX32

RX   PubMed=7705939;

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   WSU-HN26

AC   CVCL_5523

SY   HN26

DR   Cosmic; 922082

RX   PubMed=7705939;

RX   PubMed=8001221;

RX   PubMed=9049184;

RX   PubMed=9389571;

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_5524 ! WSU-HN27

CA   Cancer cell line

//

ID   WSU-HN27

AC   CVCL_5524

SY   HN27

DR   Cosmic; 922083

RX   PubMed=7705939;

RX   PubMed=8001221;

RX   PubMed=9389571;

CC   Derived from metastatic site: Larynx.

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_5523 ! WSU-HN26

CA   Cancer cell line

//

ID   WSU-HN28

AC   CVCL_AX33

RX   PubMed=7705939;

DI   NCIt; C4943; Pyriform fossa squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   WSU-HN3

AC   CVCL_W196

SY   HN3

DR   Cosmic; 922086

RX   PubMed=7705939;

RX   PubMed=8001221;

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   WSU-HN30

AC   CVCL_5525

SY   HN30; HN-30

DR   BTO; BTO:0005039

DR   Cosmic; 922084

DR   Cosmic; 2131844

DR   Cosmic; 2296299

RX   PubMed=7705939;

RX   PubMed=8001221;

RX   PubMed=9049184;

RX   PubMed=9389571;

RX   PubMed=21868764;

RX   PubMed=25275298;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: OPC-22 oral and pharyngeal cancer cell line panel.

CC   Omics: Deep exome analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

ST   Source(s): PubMed=21868764; PubMed=25275298

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 11,12 (PubMed=21868764)

ST   D13S317: 11 (PubMed=25275298)

ST   D16S539: 11,12

ST   D18S51: 13,16

ST   D21S11: 28

ST   D3S1358: 16

ST   D5S818: 12,13

ST   D7S820: 10

ST   D8S1179: 15,17

ST   FGA: 20,24

ST   Penta D: 2.2

ST   Penta E: 8,12

ST   TH01: 7,9

ST   TPOX: 6,11

ST   vWA: 15,18

DI   NCIt; C102872; Pharyngeal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_5526 ! WSU-HN31

SX   Male

CA   Cancer cell line

//

ID   WSU-HN31

AC   CVCL_5526

SY   HN31

DR   Cosmic; 922085

DR   Cosmic; 2043893

DR   Cosmic; 2131845

DR   Cosmic; 2439754

RX   PubMed=7705939;

RX   PubMed=8001221;

RX   PubMed=9389571;

RX   PubMed=21868764;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Derived from metastatic site: Lymph node.

ST   Source(s): PubMed=21868764

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 11,12

ST   D16S539: 11,12

ST   D5S818: 12,13

ST   D7S820: 10

ST   TH01: 7,9

ST   TPOX: 6,11

ST   vWA: 15,18

DI   NCIt; C102872; Pharyngeal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_5525 ! WSU-HN30

SX   Male

CA   Cancer cell line

//

ID   WSU-HN4

AC   CVCL_5515

SY   HN4

DR   Cosmic; 922078

DR   Cosmic; 2043894

DR   Cosmic; 2131846

DR   Cosmic; 2513906

RX   PubMed=7705939;

RX   PubMed=8001221;

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_5518 ! WSU-HN12

SX   Female

CA   Cancer cell line

//

ID   WSU-HN6

AC   CVCL_5516

SY   HN6

DR   Cosmic; 922087

DR   Cosmic; 2043895

DR   Cosmic; 2296295

DR   Cosmic; 2513907

RX   PubMed=7705939;

RX   PubMed=8001221;

RX   PubMed=9049184;

RX   PubMed=9389571;

RX   PubMed=25275298;

CC   Part of: OPC-22 oral and pharyngeal cancer cell line panel.

CC   Omics: Deep exome analysis.

ST   Source(s): PubMed=25275298

ST   Amelogenin: X,Y

ST   CSF1PO: 11

ST   D13S317: 13

ST   D16S539: 10,12

ST   D18S51: 13

ST   D21S11: 32.2,33.2

ST   D3S1358: 18

ST   D5S818: 11

ST   D7S820: 10,11

ST   D8S1179: 13,14

ST   FGA: 21,25

ST   Penta D: 9

ST   Penta E: 8,14

ST   TH01: 6,9

ST   TPOX: 8,10

ST   vWA: 18,19

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   WSU-HN8

AC   CVCL_5517

SY   HN8

DR   Cosmic; 922080

DR   Cosmic; 2296296

RX   PubMed=7705939;

RX   PubMed=8001221;

RX   PubMed=9389571;

RX   PubMed=25275298;

CC   Part of: OPC-22 oral and pharyngeal cancer cell line panel.

CC   Omics: Deep exome analysis.

CC   Derived from metastatic site: Lymph node.

ST   Source(s): PubMed=25275298

ST   Amelogenin: X,Y

ST   CSF1PO: 12,13

ST   D13S317: 13

ST   D16S539: 9,12

ST   D18S51: 13,19

ST   D21S11: 30

ST   D3S1358: 17

ST   D5S818: 11,12

ST   D7S820: 8

ST   D8S1179: 11,12

ST   FGA: 22

ST   Penta D: 15

ST   Penta E: 5,13

ST   TH01: 6,9

ST   TPOX: 8

ST   vWA: 17,18

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_5522 ! WSU-HN22

SX   Male

CA   Cancer cell line

//

ID   WSU-NHL

AC   CVCL_1793

SY   WSU-NHL-1; WSUNHL

DR   CLO; CLO_0009636

DR   EFO; EFO_0006777

DR   CLDB; cl4734

DR   ATCC; CRL-11584

DR   BioSample; SAMN03470898

DR   BioSample; SAMN03473486

DR   ChEMBL-Cells; CHEMBL3308281

DR   ChEMBL-Targets; CHEMBL2366193

DR   Cosmic; 798674

DR   Cosmic; 909785

DR   Cosmic; 994177

DR   Cosmic; 1086348

DR   Cosmic; 1945197

DR   Cosmic; 2276344

DR   Cosmic-CLP; 909785

DR   DSMZ; ACC-58

DR   GDSC; 909785

DR   GEO; GSM380153

DR   GEO; GSM552470

DR   GEO; GSM1374992

DR   GEO; GSM1670583

RX   PubMed=3143865;

RX   PubMed=7849311;

RX   PubMed=19278952;

RX   PubMed=23292937;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://www.prnewswire.com/news-releases/asterand-introduces-nine-ways-to-accelerate-cancer-research-55450592.html

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Doubling time: ~45 hours (DSMZ).

CC   Microsatellite instability: Instable (MSI-high) (Sanger).

CC   Omics: Array-based CGH.

CC   Omics: CNV analysis.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: miRNA expression profiling.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Discontinued: ATCC; CRL-11584; probable.

ST   Source(s): Cosmic-CLP; DSMZ; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10,11 (Cosmic-CLP; DSMZ)

ST   CSF1PO: 11,13 (PubMed=25877200)

ST   D13S317: 8,11 (Cosmic-CLP; DSMZ)

ST   D13S317: 8,10,11 (PubMed=25877200)

ST   D16S539: 11,12 (Cosmic-CLP; DSMZ)

ST   D16S539: 10,11,12 (PubMed=25877200)

ST   D18S51: 15

ST   D19S433: 13,14,15,15.2

ST   D21S11: 26,30,31,31.2,32.2

ST   D2S1338: 17,23

ST   D3S1358: 14,15

ST   D5S818: 11,12 (Cosmic-CLP; DSMZ)

ST   D5S818: 10,11,12 (PubMed=25877200)

ST   D7S820: 10,12

ST   D8S1179: 9,12,13,14

ST   FGA: 19,20

ST   Penta D: 9,10,14

ST   Penta E: 5,11,12,13

ST   TH01: 6,9 (DSMZ)

ST   TH01: 9 (Cosmic-CLP; PubMed=25877200)

ST   TPOX: 9,10 (Cosmic-CLP; DSMZ)

ST   TPOX: 8,9,10,11 (PubMed=25877200)

ST   vWA: 16 (Cosmic-CLP; DSMZ)

ST   vWA: 16,17,19 (PubMed=25877200)

DI   NCIt; C3209; Follicular lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   WSU-Pre-B-ALL

AC   CVCL_5608

SY   WSU-preAll

WW   http://www.asterandbio.com/biospecimens/human-tissue-derived-products/cell-lines/

WW   http://www.prnewswire.com/news-releases/asterand-introduces-nine-ways-to-accelerate-cancer-research-55450592.html

DI   NCIt; C8644; B acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   WSU-WM

AC   CVCL_5609

SY   WM-WSU

DR   ATCC; CRL-11586

DR   Cosmic; 1762458

RX   PubMed=8499639;

RX   PubMed=18650470;

RX   PubMed=22950966;

WW   http://www.asterandbio.com/biospecimens/human-tissue-derived-products/cell-lines/

WW   http://www.prnewswire.com/news-releases/asterand-introduces-nine-ways-to-accelerate-cancer-research-55450592.html

CC   Discontinued: ATCC; CRL-11586; probable.

DI   NCIt; C80307; Waldenstrom macroglobulinemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   WT 10-7

AC   CVCL_V443

DR   ATCC; CRL-2834

RX   PubMed=12734101;

CC   Transformant: Ad-SV40.

CC   Discontinued: ATCC; CRL-2834; true.

DI   NCIt; C84578; Autosomal dominant polycystic kidney disease

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_V442 ! TS 10-7

SX   Female

CA   Transformed cell line

//

ID   WT 9-12

AC   CVCL_K230

DR   ATCC; CRL-2833

RX   PubMed=12734101;

CC   Transformant: Ad-SV40.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 8,11

ST   D16S539: 11,12

ST   D5S818: 11,12

ST   D7S820: 8,11

ST   TH01: 6,9.3

ST   TPOX: 8

ST   vWA: 19

DI   NCIt; C84578; Autosomal dominant polycystic kidney disease

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_V444 ! TS 9-7

OI   CVCL_K231 ! WT 9-7

OI   CVCL_V445 ! WT 9-9

SX   Female

CA   Transformed cell line

//

ID   WT 9-7

AC   CVCL_K231

SY   WT97

DR   ATCC; CRL-2830

DR   BioSample; SAMN03471799

RX   PubMed=12734101;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Transformant: Ad-SV40.

CC   Omics: Protein expression by reverse-phase protein arrays.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 8,11

ST   D16S539: 11,12

ST   D5S818: 11,12

ST   D7S820: 8,11

ST   TH01: 6,9.3

ST   TPOX: 8

ST   vWA: 19

DI   NCIt; C84578; Autosomal dominant polycystic kidney disease

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_V444 ! TS 9-7

OI   CVCL_V445 ! WT 9-9

OI   CVCL_K230 ! WT 9-12

SX   Female

CA   Transformed cell line

//

ID   WT 9-9

AC   CVCL_V445

DR   ATCC; CRL-2832

RX   PubMed=12734101;

CC   Transformant: Ad-SV40.

CC   Discontinued: ATCC; CRL-2832; true.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 8,11

ST   D16S539: 11,12

ST   D5S818: 11,12

ST   D7S820: 8,11

ST   TH01: 6,9.3

ST   TPOX: 8

ST   vWA: 19

DI   NCIt; C84578; Autosomal dominant polycystic kidney disease

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_V444 ! TS 9-7

OI   CVCL_K231 ! WT 9-7

OI   CVCL_K230 ! WT 9-12

SX   Female

CA   Transformed cell line

//

ID   Wt MEFs

AC   CVCL_L690

DR   ATCC; CRL-2991

RX   PubMed=12527753;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   WT SV40 MEF

AC   CVCL_U630

DR   ATCC; CRL-2907

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   WT-126

AC   CVCL_HA44

DR   GEO; GSM1153513

RX   PubMed=21074045;

RX   PubMed=24153179;

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   WT-31

AC   CVCL_CW51

SY   WT31

RX   PubMed=2410507;

RX   PubMed=2809225;

WW   http://www.bdbiosciences.com/ds/is/tds/23-3974.pdf

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   WT-33

AC   CVCL_HA45

DR   GEO; GSM1153509

DR   GEO; GSM1153510

RX   PubMed=21074045;

RX   PubMed=24153179;

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   WT-9

AC   CVCL_HA46

DR   GEO; GSM1153512

RX   PubMed=24153179;

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1P27 ! GM22159

SX   Male

CA   Induced pluripotent stem cell

//

ID   WT-ADRC-40

AC   CVCL_HA43

SY   ADRC-40; ADRC40

DR   GEO; GSM1153501

DR   GEO; GSM1153507

RX   PubMed=21074045;

RX   PubMed=24153179;

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   WT-CLS1

AC   CVCL_5904

SY   CLS1

DR   CLS; 300379-SF/p9957_WT-CLS1

DR   Cosmic; 1314022

ST   Source(s): CLS

ST   Amelogenin: X

ST   CSF1PO: 11,13

ST   D13S317: 9,11

ST   D16S539: 9,11

ST   D18S51: 13,15

ST   D21S11: 30,31.2

ST   D3S1358: 14,19

ST   D5S818: 11,12

ST   D7S820: 8,10

ST   D8S1179: 13,14

ST   FGA: 22,25

ST   Penta D: 9

ST   Penta E: 9,12

ST   TH01: 9,9.3

ST   TPOX: 8

ST   vWA: 15,19

DI   NCIt; C40407; Renal Wilms tumor

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   WT-E

AC   CVCL_0C31

RX   PubMed=7736387;

RX   PubMed=10100721;

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C3493; Squamous cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   WT-iPS 3F-1

AC   CVCL_W316

RX   PubMed=22405424;

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   WT-iPS 4F-1

AC   CVCL_W317

RX   PubMed=22405424;

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Induced pluripotent stem cell

//

ID   WT-iPSC1

AC   CVCL_GQ07

RX   PubMed=27558599;

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   WT-iPSC2

AC   CVCL_GQ08

RX   PubMed=27558597;

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   WT-iPSC4

AC   CVCL_GQ09

RX   PubMed=27558598;

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   WT-Pe.1

AC   CVCL_M844

RX   PubMed=18558285;

CC   Doubling time: ~65 hours (PubMed=18558285).

DI   NCIt; C40407; Renal Wilms tumor

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   WT-R

AC   CVCL_0I65

DR   CCLV; CCLV-RIE 0728

OX   NCBI_TaxID=9902; ! Bison bonasus

CA   Spontaneously immortalized cell line

//

ID   WT:CS3

AC   CVCL_Z880

SY   WT-CS3

RX   DOI=10.1016/B978-012229460-0/50004-X;

RX   PubMed=3919453;

CC   Group: Insect cell line.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   WT:CS5

AC   CVCL_Z881

SY   WT-CS5

RX   DOI=10.1016/B978-012229460-0/50004-X;

RX   PubMed=3919453;

CC   Group: Insect cell line.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   WT:LM6

AC   CVCL_Z882

SY   WT-LM6

RX   DOI=10.1016/B978-012229460-0/50004-X;

RX   PubMed=3919453;

CC   Group: Insect cell line.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   WT100

AC   CVCL_E919

SY   WT-100; GM08602

DR   BTO; BTO:0004551

DR   CLO; CLO_0010610

DR   Coriell; GM08602

DR   IMGT/HLA; 13141

CC   Part of: International Histocompatibility Workshop cell lines.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   WT100BIS

AC   CVCL_E883

DR   dbMHC; 49073

DR   ECACC; 88052006

DR   IHW; IHW9006

DR   IMGT/HLA; 11652

RX   PubMed=8307784;

WW   http://bioinformatics.hsanmartino.it/ecbr/cl6.html

CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   WT17

AC   CVCL_F522

SY   GM08599

DR   CLO; CLO_0010591

DR   Coriell; GM08599

CC   Part of: International Histocompatibility Workshop cell lines.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   WT20

AC   CVCL_F524

SY   GM08067

DR   CLO; CLO_0010026

DR   Coriell; GM08067

CC   Part of: International Histocompatibility Workshop cell lines.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   WT24

AC   CVCL_E884

DR   dbMHC; 49074

DR   IHW; IHW9015

DR   IMGT/HLA; 11651

WW   http://bioinformatics.hsanmartino.it/ecbr/cl15.html

CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   WT46

AC   CVCL_E885

SY   GM08068

DR   CLO; CLO_0010027

DR   Coriell; GM08068

DR   dbMHC; 49075

DR   IHW; IHW9305

DR   IMGT/HLA; 11571

WW   http://bioinformatics.hsanmartino.it/ecbr/cl305.html

CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   WT47

AC   CVCL_E886

DR   dbMHC; 49076

DR   ECACC; 88052063

DR   IHW; IHW9063

DR   IMGT/HLA; 11572

WW   http://bioinformatics.hsanmartino.it/ecbr/cl63.html

CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   WT49

AC   CVCL_2242

SY   WT-49; TER98; TER180; GM03098

DR   CLO; CLO_0013483

DR   Coriell; GM03098

DR   dbMHC; 49077

DR   ECACC; 86052108

DR   IHW; IHW9285

DR   IMGT/HLA; 11573

WW   http://bioinformatics.hsanmartino.it/ecbr/cl285.html

CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   WT51

AC   CVCL_E887

SY   WT-51; GM03103

DR   BTO; BTO:0004497

DR   CLO; CLO_0013564

DR   Coriell; GM03103

DR   dbMHC; 49078

DR   ECACC; 86052110

DR   IHW; IHW9029

DR   IMGT/HLA; 11574

WW   http://bioinformatics.hsanmartino.it/ecbr/cl29.html

CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   WT52

AC   CVCL_E888

SY   GM08603

DR   CLO; CLO_0010609

DR   Coriell; GM08603

DR   dbMHC; 49079

DR   IHW; IHW9306

DR   IMGT/HLA; 11575

WW   http://bioinformatics.hsanmartino.it/ecbr/cl306.html

CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   WT8

AC   CVCL_E889

DR   dbMHC; 49080

DR   IHW; IHW9017

DR   IMGT/HLA; 11650

WW   http://bioinformatics.hsanmartino.it/ecbr/cl17.html

CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   WT87

AC   CVCL_F523

SY   GM08601

DR   CLO; CLO_0010593

DR   Coriell; GM08601

CC   Part of: International Histocompatibility Workshop cell lines.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   WTC-EGFP-PXN-cl50

AC   CVCL_IR30

SY   AICS0005; AICS-0005

DR   Coriell; AICS0005

WW   http://www.allencell.org/cellline/AICS-0005

CC   Characteristics: Using CRISPR/Cas9 PXN has been endogenously tagged at the C-terminus with EGFP.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_Y803 ! GM25256

SX   Male

CA   Induced pluripotent stem cell

//

ID   WTC-mEGFP-DSP-cl65

AC   CVCL_IR31

SY   AICS0017; AICS-0017

DR   Coriell; AICS0017

WW   http://www.allencell.org/cellline/AICS-0017

CC   Characteristics: Using CRISPR/Cas9 DSP has been endogenously tagged at the C-terminus with mEGFP.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_Y803 ! GM25256

SX   Male

CA   Induced pluripotent stem cell

//

ID   WTC-mEGFP-LMNB1-cl210

AC   CVCL_IR32

SY   AICS0013; AICS-0013

DR   Coriell; AICS0013

WW   http://www.allencell.org/cellline/AICS-0013

CC   Characteristics: Using CRISPR/Cas9 LMNB1 has been endogenously tagged at the N-terminus with mEGFP.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_Y803 ! GM25256

SX   Male

CA   Induced pluripotent stem cell

//

ID   WTC-mEGFP-TOMM20-cl27

AC   CVCL_IR33

SY   AICS0011; AICS-0011

DR   Coriell; AICS0011

WW   http://www.allencell.org/cellline/AICS-0011

CC   Characteristics: Using CRISPR/Cas9 TOMM20 has been endogenously tagged at the C-terminus with mEGFP.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_Y803 ! GM25256

SX   Male

CA   Induced pluripotent stem cell

//

ID   WTC-mEGFP-TUBA1B-cl105

AC   CVCL_IR34

SY   AICS0012; AICS-0012

DR   Coriell; AICS0012

WW   http://www.allencell.org/cellline/AICS-0012

CC   Characteristics: Using CRISPR/Cas9 TUBA1B has been endogenously tagged at the N-terminus with mEGFP.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_Y803 ! GM25256

SX   Male

CA   Induced pluripotent stem cell

//

ID   WTK-1

AC   CVCL_6742

SY   WTK1

DR   BTO; BTO:0003706

RX   PubMed=7744731;

RX   PubMed=11566342;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C97074; Hereditary spherocytosis

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_6544 ! WIL2

SX   Male

CA   Transformed cell line

//

ID   WU E-14

AC   CVCL_F812

SY   WUE-14; 29CE12-1

DR   CLO; CLO_0009637

DR   ATCC; CRL-2255

CC   Monoclonal antibody target: UniProtKB; P02649; Human APOE.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   WU E-4

AC   CVCL_F813

SY   WUE-4; 1506 A1.4

DR   CLO; CLO_0009638

DR   ATCC; CRL-2247

RX   PubMed=2466929;

RX   PubMed=3973009;

CC   Monoclonal antibody target: UniProtKB; P02649; Human APOE.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   WU E-7

AC   CVCL_2G80

SY   WU-E-7

RX   PubMed=2466929;

CC   Monoclonal antibody target: UniProtKB; P02649; Human APOE.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   WU-CcE-1

AC   CVCL_Z976

SY   CcE-1

RX   PubMed=20471390;

CC   Group: Insect cell line.

OX   NCBI_TaxID=749652; ! Chrysodeixis chalcites

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   WUZH1

AC   CVCL_E890

SY   WUZHI

DR   dbMHC; 49081

DR   IHW; IHW9459

DR   IMGT/HLA; 26054

CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Transformed cell line

//

ID   WVB-Pcr-02

AC   CVCL_Z953

RX   DOI=10.14188/j.1671-8836.1997.02.019;

CC   Group: Insect cell line.

OX   NCBI_TaxID=7127; ! Samia cynthia

SX   Female

CA   Spontaneously immortalized cell line

//

ID   WW

AC   CVCL_U798

DR   Cosmic; 889042

DR   Cosmic; 928722

DR   GEO; GSM228379

RX   PubMed=9354451;

RX   PubMed=15048078;

RX   PubMed=17363583;

CC   Omics: CNV analysis.

CC   Omics: SNP array analysis.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   WW0008

AC   CVCL_8Z01

DR   ECACC; 89060702

CC   Part of: ECACC chromosomal abnormality collection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   WW0240

AC   CVCL_8Z02

DR   ECACC; 95080208

CC   Part of: ECACC chromosomal abnormality collection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   WW1

AC   CVCL_N782

RX   PubMed=7638196;

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Female

CA   Embryonic stem cell

//

ID   WW165

AC   CVCL_G321

DR   Cosmic; 1197385

DR   Cosmic; 1548845

RX   PubMed=20149136;

RX   PubMed=21521745;

RX   PubMed=26214590;

CC   Omics: Deep exome analysis.

CC   Omics: Transcriptome analysis.

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   WW6

AC   CVCL_N783

SY   ES-WW6

DR   EFO; EFO_0005915

DR   ATCC; CRL-2239

DR   ENCODE; ENCBS120ENC

DR   ENCODE; ENCBS121ENC

DR   ENCODE; ENCBS134ZWP

DR   ENCODE; ENCBS480DYF

DR   GEO; GSM1014159

DR   GEO; GSM1014160

RX   PubMed=7638196;

CC   Part of: ENCODE project mouse cell lines.

CC   Discontinued: ATCC; CRL-2239; true.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Female

CA   Embryonic stem cell

//

ID   WWAI

AC   CVCL_F821

DR   IMGT/HLA; 11577

CC   Part of: International Histocompatibility Workshop cell lines.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   WX310

AC   CVCL_3434

DR   CLO; CLO_0009639

DR   CLDB; cl4736

DR   ECACC; 85022818

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   Wx67

AC   CVCL_A742

SY   WX67

DR   Cosmic; 687461

RX   PubMed=12068308;

DI   NCIt; C4912; Bladder carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   WY005

AC   CVCL_F407

DR   CLO; CLO_0051099

DR   RCB; HSC0072

RX   PubMed=21383383;

CC   Part of: Sonoda-Tajima cell collection.

CC   Population: Colombia.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   WY020

AC   CVCL_F408

DR   CLO; CLO_0051097

DR   RCB; HSC0069

RX   PubMed=21383383;

CC   Part of: Sonoda-Tajima cell collection.

CC   Population: Colombia.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   WY034

AC   CVCL_F409

DR   CLO; CLO_0051118

DR   RCB; HSC0095

RX   PubMed=21383383;

CC   Part of: Sonoda-Tajima cell collection.

CC   Population: Colombia.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   WY035

AC   CVCL_F410

DR   CLO; CLO_0051103

DR   RCB; HSC0076

RX   PubMed=21383383;

CC   Part of: Sonoda-Tajima cell collection.

CC   Population: Colombia.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   WY036

AC   CVCL_F411

DR   CLO; CLO_0051104

DR   RCB; HSC0077

RX   PubMed=21383383;

CC   Part of: Sonoda-Tajima cell collection.

CC   Population: Colombia.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   WY037

AC   CVCL_F412

DR   CLO; CLO_0051105

DR   RCB; HSC0078

RX   PubMed=21383383;

CC   Part of: Sonoda-Tajima cell collection.

CC   Population: Colombia.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   WY038

AC   CVCL_F413

DR   CLO; CLO_0051106

DR   RCB; HSC0079

RX   PubMed=21383383;

CC   Part of: Sonoda-Tajima cell collection.

CC   Population: Colombia.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   WY039

AC   CVCL_F414

DR   CLO; CLO_0051114

DR   RCB; HSC0090

RX   PubMed=21383383;

CC   Part of: Sonoda-Tajima cell collection.

CC   Population: Colombia.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   WY040

AC   CVCL_F415

DR   CLO; CLO_0051107

DR   RCB; HSC0080

RX   PubMed=21383383;

CC   Part of: Sonoda-Tajima cell collection.

CC   Population: Colombia.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   WY043

AC   CVCL_F416

DR   CLO; CLO_0051070

DR   RCB; HSC0035

RX   PubMed=21383383;

CC   Part of: Sonoda-Tajima cell collection.

CC   Population: Colombia.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   WY046

AC   CVCL_F417

DR   CLO; CLO_0051108

DR   RCB; HSC0081

RX   PubMed=21383383;

CC   Part of: Sonoda-Tajima cell collection.

CC   Population: Colombia.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   WY047

AC   CVCL_F418

DR   CLO; CLO_0051110

DR   RCB; HSC0084

RX   PubMed=21383383;

CC   Part of: Sonoda-Tajima cell collection.

CC   Population: Colombia.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   WY048

AC   CVCL_F419

DR   CLO; CLO_0051109

DR   RCB; HSC0082

RX   PubMed=21383383;

CC   Part of: Sonoda-Tajima cell collection.

CC   Population: Colombia.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   WY049

AC   CVCL_F420

DR   CLO; CLO_0051101

DR   RCB; HSC0074

RX   PubMed=21383383;

CC   Part of: Sonoda-Tajima cell collection.

CC   Population: Colombia.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   WY050

AC   CVCL_F421

DR   CLO; CLO_0051074

DR   RCB; HSC0042

RX   PubMed=21383383;

CC   Part of: Sonoda-Tajima cell collection.

CC   Population: Colombia.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   WY051

AC   CVCL_F422

DR   CLO; CLO_0051167

DR   RCB; HSC0130

RX   PubMed=21383383;

CC   Part of: Sonoda-Tajima cell collection.

CC   Population: Colombia.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   WY053

AC   CVCL_F423

DR   CLO; CLO_0051159

DR   RCB; HSC0122

RX   PubMed=21383383;

CC   Part of: Sonoda-Tajima cell collection.

CC   Population: Colombia.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   WY054

AC   CVCL_F424

DR   CLO; CLO_0051168

DR   RCB; HSC0132

RX   PubMed=21383383;

CC   Part of: Sonoda-Tajima cell collection.

CC   Population: Colombia.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   WY055

AC   CVCL_F425

DR   CLO; CLO_0051160

DR   RCB; HSC0123

RX   PubMed=21383383;

CC   Part of: Sonoda-Tajima cell collection.

CC   Population: Colombia.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   WY057

AC   CVCL_F426

DR   CLO; CLO_0051075

DR   RCB; HSC0043

RX   PubMed=21383383;

CC   Part of: Sonoda-Tajima cell collection.

CC   Population: Colombia.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   WY058

AC   CVCL_F427

DR   CLO; CLO_0051079

DR   RCB; HSC0048

RX   PubMed=21383383;

CC   Part of: Sonoda-Tajima cell collection.

CC   Population: Colombia.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   WY059

AC   CVCL_F428

DR   CLO; CLO_0051089

DR   RCB; HSC0059

RX   PubMed=21383383;

CC   Part of: Sonoda-Tajima cell collection.

CC   Population: Colombia.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   WY064

AC   CVCL_F429

DR   CLO; CLO_0051085

DR   RCB; HSC0054

RX   PubMed=21383383;

CC   Part of: Sonoda-Tajima cell collection.

CC   Population: Colombia.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   WY065

AC   CVCL_F430

DR   CLO; CLO_0051086

DR   RCB; HSC0055

RX   PubMed=21383383;

CC   Part of: Sonoda-Tajima cell collection.

CC   Population: Colombia.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   WY071

AC   CVCL_F431

DR   CLO; CLO_0051180

DR   RCB; HSC0091

RX   PubMed=21383383;

CC   Part of: Sonoda-Tajima cell collection.

CC   Population: Colombia.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   WY072

AC   CVCL_F432

DR   CLO; CLO_0051132

DR   RCB; HSC0083

RX   PubMed=21383383;

CC   Part of: Sonoda-Tajima cell collection.

CC   Population: Colombia.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   WY073

AC   CVCL_F433

DR   CLO; CLO_0051113

DR   RCB; HSC0089

RX   PubMed=21383383;

CC   Part of: Sonoda-Tajima cell collection.

CC   Population: Colombia.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   WY074

AC   CVCL_F434

DR   CLO; CLO_0051111

DR   RCB; HSC0086

RX   PubMed=21383383;

CC   Part of: Sonoda-Tajima cell collection.

CC   Population: Colombia.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   WY075

AC   CVCL_F435

DR   CLO; CLO_0051115

DR   RCB; HSC0092

RX   PubMed=21383383;

CC   Part of: Sonoda-Tajima cell collection.

CC   Population: Colombia.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   WY076

AC   CVCL_F436

DR   CLO; CLO_0051112

DR   RCB; HSC0088

RX   PubMed=21383383;

CC   Part of: Sonoda-Tajima cell collection.

CC   Population: Colombia.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   WY077

AC   CVCL_F437

DR   CLO; CLO_0051179

DR   RCB; HSC0087

RX   PubMed=21383383;

CC   Part of: Sonoda-Tajima cell collection.

CC   Population: Colombia.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   WY078

AC   CVCL_F438

SY   WY-078

DR   CLO; CLO_0051066

DR   RCB; HSC0031

RX   PubMed=21383383;

CC   Part of: Sonoda-Tajima cell collection.

CC   Population: Colombia.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   WY080

AC   CVCL_F439

DR   CLO; CLO_0051073

DR   RCB; HSC0040

RX   PubMed=21383383;

CC   Part of: Sonoda-Tajima cell collection.

CC   Population: Colombia.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   WY083

AC   CVCL_F440

DR   CLO; CLO_0051337

DR   RCB; HSC0063

RX   PubMed=21383383;

CC   Part of: Sonoda-Tajima cell collection.

CC   Population: Colombia.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   WY084

AC   CVCL_6E41

RX   PubMed=21383383;

CC   Part of: Sonoda-Tajima cell collection.

CC   Population: Colombia.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   WY086

AC   CVCL_F441

DR   CLO; CLO_0051095

DR   RCB; HSC0067

RX   PubMed=21383383;

CC   Part of: Sonoda-Tajima cell collection.

CC   Population: Colombia.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   WY091

AC   CVCL_F442

DR   CLO; CLO_0051094

DR   RCB; HSC0066

RX   PubMed=21383383;

CC   Part of: Sonoda-Tajima cell collection.

CC   Population: Colombia.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   WY092

AC   CVCL_F443

DR   CLO; CLO_0051096

DR   RCB; HSC0068

RX   PubMed=21383383;

CC   Part of: Sonoda-Tajima cell collection.

CC   Population: Colombia.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   WY102

AC   CVCL_F444

DR   CLO; CLO_0051080

DR   RCB; HSC0049

RX   PubMed=21383383;

CC   Part of: Sonoda-Tajima cell collection.

CC   Population: Colombia.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   X-01

AC   CVCL_C656

DR   ISCR; 1777

RX   PubMed=21338948;

CC   From: Shanghai Institutes for Biological Sciences; Shanghai; China.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   X-02

AC   CVCL_C657

DR   ISCR; 1778

RX   PubMed=21338948;

CC   From: Shanghai Institutes for Biological Sciences; Shanghai; China.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   X1/5

AC   CVCL_2768

SY   HtTA-1 clone X1/5

DR   CLO; CLO_0009640

DR   CLDB; cl4737

DR   ECACC; 95051229

RX   PubMed=1319065;

CC   Transfected with: UniProtKB; P04483; E.coli Tn10 tetR.

CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).

DI   NCIt; C4029; Cervical adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_2523 ! HtTA-1

SX   Female

CA   Cancer cell line

//

ID   X16C8.5

AC   CVCL_0208

SY   X16C

DR   CLO; CLO_0009641

DR   ATCC; TIB-209

RX   PubMed=310843;

CC   Breed/subspecies: BALB/cAnN.

DI   NCIt; C21602; Mouse lymphoma

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   X19

AC   CVCL_CW58

RX   PubMed=2415533;

CC   Monoclonal antibody target: UniProtKB; Q00610; Human CLTC.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   X22

AC   CVCL_F814

DR   CLO; CLO_0009642

DR   ATCC; CRL-2228

RX   PubMed=2415533;

CC   Monoclonal antibody target: UniProtKB; Q00610; Human CLTC (also reacts with other species).

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   X25-4

AC   CVCL_BW59

RX   PubMed=218224;

RX   PubMed=223286;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_BW60 ! X25-6

OI   CVCL_BW61 ! X25-9

CA   Transformed cell line

//

ID   X25-6

AC   CVCL_BW60

RX   PubMed=218224;

RX   PubMed=223286;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_BW59 ! X25-4

OI   CVCL_BW61 ! X25-9

CA   Transformed cell line

//

ID   X25-9

AC   CVCL_BW61

RX   PubMed=218224;

RX   PubMed=223286;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_BW59 ! X25-4

OI   CVCL_BW60 ! X25-6

CA   Transformed cell line

//

ID   X50-7

AC   CVCL_8277

RX   Patent=US5178999;

RX   PubMed=218224;

RX   PubMed=223286;

RX   PubMed=3033285;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   X50-7.8

AC   CVCL_J031

DR   ATCC; CRL-9694

RX   Patent=US5178999;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Discontinued: ATCC; CRL-9694; probable.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_8277 ! X50-7

CA   Transformed cell line

//

ID   X5563

AC   CVCL_H719

SY   X-5563; x5563

DR   ChEMBL-Cells; CHEMBL3307487

DR   ChEMBL-Targets; CHEMBL614250

DR   TKG; TKG 0174

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   X63-omIL-2

AC   CVCL_Y272

SY   X63/OMIL2; XR63-IL2

DR   BCRJ; 0250

RX   PubMed=2831066;

CC   Transfected with: MGI; MGI:96548; Il2.

CC   Breed/subspecies: BALB/c.

DI   NCIt; C125417; Mouse plasma cell myeloma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

SX   Female

CA   Cancer cell line

//

ID   X63-omIL-3

AC   CVCL_M352

SY   X63/OMIL3; XR63-IL3

DR   BCRJ; 0251

DR   ChEMBL-Cells; CHEMBL3307917

DR   ChEMBL-Targets; CHEMBL614312

RX   PubMed=2831066;

CC   Transfected with: MGI; MGI:96552; Il3.

CC   Breed/subspecies: BALB/c.

DI   NCIt; C125417; Mouse plasma cell myeloma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

SX   Female

CA   Cancer cell line

//

ID   X63-omIL-4

AC   CVCL_Y273

SY   X63/OMIL4; XR63-IL4

DR   BCRJ; 0252

RX   PubMed=2831066;

CC   Transfected with: MGI; MGI:96556; Il4.

CC   Breed/subspecies: BALB/c.

DI   NCIt; C125417; Mouse plasma cell myeloma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

SX   Female

CA   Cancer cell line

//

ID   X63-omIL-5

AC   CVCL_Y274

SY   X63/OMIL5; XR63-IL5

DR   BCRJ; 0253

RX   PubMed=2831066;

CC   Transfected with: MGI; MGI:96557; Il5.

CC   Breed/subspecies: BALB/c.

DI   NCIt; C125417; Mouse plasma cell myeloma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

SX   Female

CA   Cancer cell line

//

ID   X9

AC   CVCL_II79

DR   ATCC; CRL-3282

RX   PubMed=22796012;

CC   Breed/subspecies: 129S6/SvEvTac.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Spontaneously immortalized cell line

//

ID   XB-2

AC   CVCL_3624

SY   XB2; XB

DR   CLO; CLO_0009644

DR   ATCC; CL-177

DR   BCRC; 60546

DR   IZSLER; BS CL 128

RX   Patent=US4016036;

RX   PubMed=730781;

RX   PubMed=1052770;

RX   PubMed=1690090;

CC   Breed/subspecies: CXBGB/By.

DI   NCIt; C129859; Mouse teratocarcinoma

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Cancer cell line

//

ID   XC

AC   CVCL_1891

DR   BTO; BTO:0005227

DR   CLO; CLO_0009645

DR   CLO; CLO_0050824

DR   CLDB; cl4738

DR   CLDB; cl4739

DR   CLDB; cl4740

DR   CLDB; cl4741

DR   CLDB; cl4742

DR   ATCC; CCL-165

DR   ATCC; CRL-6603

DR   BCRC; 60098

DR   DSMZ; ACC-118

DR   ChEMBL-Cells; CHEMBL3307251

DR   ChEMBL-Targets; CHEMBL612812

DR   ECACC; 88120601

DR   ICLC; ATL96013

DR   IFO; IFO50017

DR   IZSLER; BS TCL 66

DR   RCB; RCB1831

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-6603; true.

CC   Breed/subspecies: White-Weston.

DI   NCIt; C60505; Rat sarcoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

CA   Cancer cell line

//

ID   XC-v

AC   CVCL_D623

DR   BTO; BTO:0005229

RX   PubMed=4359877;

CC   Breed/subspecies: White-Weston.

DI   NCIt; C60505; Rat sarcoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_1891 ! XC

CA   Cancer cell line

//

ID   XC1.5/51

AC   CVCL_3625

DR   CLO; CLO_0009646

DR   ATCC; TIB-16

CC   Breed/subspecies: C3H.

DI   NCIt; C125417; Mouse plasma cell myeloma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3493 ! C1.18.4

CA   Cancer cell line

//

ID   XCIII-1F8-D7

AC   CVCL_U049

SY   P-1

DR   ECACC; 08041723

RX   PubMed=2450920;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   XCIII-3D8-D8

AC   CVCL_U050

SY   P-2

DR   ECACC; 08041724

RX   PubMed=2450920;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   XCIV-1H2-A8

AC   CVCL_U051

SY   T-11

DR   ECACC; 08041728

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   XCp

AC   CVCL_7229

DR   CLO; CLO_0009648

DR   CLDB; cl4744

CC   Breed/subspecies: White-Weston.

DI   NCIt; C60505; Rat sarcoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_1891 ! XC

CA   Cancer cell line

//

ID   XEM1

AC   CVCL_GR61

RX   PubMed=1441600;

RX   PubMed=1692605;

CC   Transfected with: RGD; 2458; Cyp1a1.

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_4V36 ! V79MZ

SX   Male

CA   Spontaneously immortalized cell line

//

ID   XEM2

AC   CVCL_GR62

SY   V79-XEM2

RX   PubMed=1441600;

RX   PubMed=1692605;

RX   PubMed=1800893;

CC   Transfected with: RGD; 2458; Cyp1a1.

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_4V36 ! V79MZ

SX   Male

CA   Spontaneously immortalized cell line

//

ID   XEMd-MZ

AC   CVCL_GR63

SY   XEMd.MZ

RX   PubMed=1441600;

RX   PubMed=1793487;

RX   PubMed=1800893;

CC   Transfected with: RGD; 2459; Cyp1a2.

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_4V36 ! V79MZ

SX   Male

CA   Spontaneously immortalized cell line

//

ID   XEMd-NH

AC   CVCL_GR64

SY   XEMd.NH

RX   PubMed=1441600;

RX   PubMed=1793487;

CC   Transfected with: RGD; 2459; Cyp1a2.

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_4V38 ! V79NH

SX   Male

CA   Spontaneously immortalized cell line

//

ID   XF

AC   CVCL_6E64

SY   Xenopus Fibroblast

RX   PubMed=2335521;

CC   Group: Amphibian cell line.

OX   NCBI_TaxID=8355; ! Xenopus laevis

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   XF 498

AC   CVCL_8928

SY   XF-498; XF498

DR   BTO; BTO:0003414

DR   ChEMBL-Cells; CHEMBL3308037

DR   ChEMBL-Targets; CHEMBL613533

WW   https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   XFiPS-F44-3F-1

AC   CVCL_C106

SY   XF-iPSF44-3F-1; iPSXFII+III-1; ESi031-A

DR   BioSamples; SAMEA7781668

DR   hPSCreg; ESi031-A

WW   http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/XFiPS-F44-3F-1.pdf

CC   From: Center of Regenerative Medicine in Barcelona; Barcelona; Spain.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_V191 ! FiPS-3F-1

OI   CVCL_9S07 ! FiPS-4F-7

OI   CVCL_9S08 ! FiPS-4F-8

OI   CVCL_C107 ! XFiPS-F44-3F-2

SX   Male

CA   Induced pluripotent stem cell

//

ID   XFiPS-F44-3F-2

AC   CVCL_C107

SY   XF-iPSF44-3F-2; iPSXFII+III-2; ESi032-A

DR   hPSCreg; ESi032-A

WW   http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/XFiPS-F44-3F-2.pdf

CC   From: Center of Regenerative Medicine in Barcelona; Barcelona; Spain.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_V191 ! FiPS-3F-1

OI   CVCL_9S07 ! FiPS-4F-7

OI   CVCL_9S08 ! FiPS-4F-8

OI   CVCL_C106 ! XFiPS-F44-3F-1

SX   Male

CA   Induced pluripotent stem cell

//

ID   XG-1

AC   CVCL_4797

SY   XG1; XG 1

DR   Cosmic; 742957

DR   Cosmic; 2081411

DR   Cosmic; 2367276

RX   PubMed=1753108;

RX   PubMed=8204890;

RX   PubMed=10087940;

RX   PubMed=10557056;

RX   PubMed=10936422;

RX   PubMed=16956823;

RX   PubMed=21173094;

WW   http://www.cells-talk.com/index.php/page/copelibrary?key=XG-1

CC   Characteristics: IL6 dependent.

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   XG-10

AC   CVCL_HX11

SY   XG10

RX   PubMed=10557056;

RX   PubMed=19718049;

RX   PubMed=21173094;

CC   Characteristics: IL6 dependent.

CC   Omics: Transcriptome analysis.

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   XG-11

AC   CVCL_HX12

SY   XG11

RX   PubMed=19718049;

RX   PubMed=21173094;

CC   Characteristics: IL6 dependent.

CC   Omics: Transcriptome analysis.

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   XG-12

AC   CVCL_HX13

SY   XG12

RX   PubMed=21173094;

CC   Characteristics: IL6 dependent.

CC   Omics: Transcriptome analysis.

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   XG-13

AC   CVCL_HX14

SY   XG13

RX   PubMed=21173094;

CC   Characteristics: IL6 dependent.

CC   Omics: Transcriptome analysis.

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   XG-14

AC   CVCL_HX15

SY   XG14

RX   PubMed=21173094;

CC   Characteristics: IL6 dependent.

CC   Omics: Transcriptome analysis.

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   XG-16

AC   CVCL_HX16

SY   XG16

RX   PubMed=21173094;

CC   Characteristics: IL6 dependent.

CC   Omics: Transcriptome analysis.

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   XG-19

AC   CVCL_HX17

SY   XG19

RX   PubMed=21173094;

CC   Characteristics: IL6 dependent.

CC   Omics: Transcriptome analysis.

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   XG-2

AC   CVCL_4798

SY   XG2; XG 2

DR   Cosmic; 742959

DR   Cosmic; 2081412

DR   Cosmic; 2367291

RX   PubMed=1753108;

RX   PubMed=8204890;

RX   PubMed=10557056;

RX   PubMed=10583232;

RX   PubMed=10936422;

RX   PubMed=16956823;

RX   PubMed=21173094;

CC   Characteristics: IL6 dependent.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   XG-20

AC   CVCL_HX18

SY   XG20

RX   PubMed=21173094;

CC   Characteristics: IL6 dependent.

CC   Omics: Transcriptome analysis.

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   XG-21

AC   CVCL_HX19

SY   XG21

RX   PubMed=21173094;

CC   Characteristics: IL6 dependent.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   XG-24

AC   CVCL_HX20

SY   XG24

RX   PubMed=21173094;

CC   Characteristics: IL6 dependent.

CC   Omics: Transcriptome analysis.

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   XG-3

AC   CVCL_4799

SY   XG3; XG 3; XG-3P; XG3P

DR   Cosmic; 742960

RX   PubMed=1753108;

RX   PubMed=8204890;

RX   PubMed=10936422;

RX   PubMed=21173094;

CC   Characteristics: IL6 dependent.

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_HX21 ! XG-3E

SX   Female

CA   Cancer cell line

//

ID   XG-3E

AC   CVCL_HX21

SY   XG3E

RX   PubMed=8204890;

CC   Characteristics: IL6 dependent.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_4799 ! XG-3

SX   Female

CA   Cancer cell line

//

ID   XG-4

AC   CVCL_4800

SY   XG4; XG 4

DR   Cosmic; 742961

RX   PubMed=1753108;

RX   PubMed=8204890;

RX   PubMed=10557056;

RX   PubMed=10936422;

RX   PubMed=21173094;

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   XG-5

AC   CVCL_4801

SY   XG5; XG 5

DR   Cosmic; 742962

RX   PubMed=1753108;

RX   PubMed=8204890;

RX   PubMed=10557056;

RX   PubMed=10583232;

RX   PubMed=10936422;

RX   PubMed=16956823;

RX   PubMed=21173094;

CC   Characteristics: IL6 dependent.

CC   Omics: Transcriptome analysis.

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   XG-6

AC   CVCL_A771

SY   XG6; XG 6

DR   Cosmic; 2081413

DR   Cosmic; 2367259

DR   Lonza; 94

RX   PubMed=8204890;

RX   PubMed=10557056;

RX   PubMed=10583232;

RX   PubMed=10936422;

RX   PubMed=16956823;

RX   PubMed=21173094;

CC   Characteristics: IL6 dependent.

CC   Omics: Transcriptome analysis.

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   XG-7

AC   CVCL_A772

SY   XG7; XG 7

DR   Cosmic; 2081414

DR   Cosmic; 2367269

RX   PubMed=8204890;

RX   PubMed=10557056;

RX   PubMed=10936422;

RX   PubMed=11429052;

RX   PubMed=16956823;

RX   PubMed=21173094;

CC   Characteristics: IL6 dependent.

CC   Omics: Transcriptome analysis.

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   XG-8

AC   CVCL_A773

SY   XG8; XG 8

RX   PubMed=8204890;

RX   PubMed=10936422;

CC   Characteristics: IL6 dependent.

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   XG-9

AC   CVCL_A774

SY   XG9; XG 9

RX   PubMed=8204890;

RX   PubMed=10936422;

CC   Characteristics: IL6 dependent.

CC   Derived from metastatic site: Bone marrow.

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   XGC-2

AC   CVCL_HA22

RX   PubMed=27633271;

CC   Doubling time: ~60 hours (PubMed=27633271).

DI   NCIt; C4004; Gastric adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   XGC9811

AC   CVCL_0U26

SY   XGC-9811; GC9811

RX   DOI=10.3321/j.issn:1000-2790.2003.10.004;

RX   DOI=10.3969/j.issn.1001-5949.2008.05.004;

RX   PubMed=16458253;

RX   PubMed=17404872;

CC   Omics: Proteome analysis by 2D-DE.

DI   NCIt; C4004; Gastric adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   XGC9811-L

AC   CVCL_0U27

SY   XGC-9811L

RX   DOI=10.3969/j.issn.1001-5949.2008.05.004;

RX   PubMed=16458253;

CC   Omics: Proteome analysis by 2D-DE.

DI   NCIt; C4004; Gastric adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0U26 ! XGC9811

CA   Cancer cell line

//

ID   XGL

AC   CVCL_DR23

DR   CCRID; 3153C0001000000040

DR   KCB; KCB 83002

CC   Group: Fish cell line.

CC   Breed/subspecies: Var. singuonensis.

OX   NCBI_TaxID=7962; ! Cyprinus carpio

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   XH1

AC   CVCL_T292

RX   PubMed=1911212;

DI   NCIt; C4028; Cervical squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   XIII-3E6-B11

AC   CVCL_U043

SY   B-16; B16

RX   PubMed=8734946;

CC   Monoclonal antibody target: Leishmania braziliensis.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   XIII-3H6-A12

AC   CVCL_U042

SY   B-12; B12

RX   PubMed=8734946;

CC   Monoclonal antibody target: Leishmania brazilensis and Leishmania panamensis.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   XIV-2A5-A10

AC   CVCL_U044

SY   B-18; B18

RX   PubMed=8734946;

CC   Monoclonal antibody target: Leishmania brazilensis.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   XL-177

AC   CVCL_T684

RX   PubMed=562840;

RX   PubMed=2416614;

RX   PubMed=8327476;

CC   Group: Amphibian cell line.

OX   NCBI_TaxID=8355; ! Xenopus laevis

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   XL-2

AC   CVCL_2H45

RX   PubMed=26134302;

CC   Derived from metastatic site: Ascites.

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   XL-2sci

AC   CVCL_2H46

RX   PubMed=26134302;

CC   Derived from metastatic site: Ascites.

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_2H45 ! XL-2

SX   Male

CA   Cancer cell line

//

ID   Xl1

AC   CVCL_6E60

SY   Xenopus laevis 1

RX   PubMed=23054192;

CC   Group: Amphibian cell line.

OX   NCBI_TaxID=8355; ! Xenopus laevis

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   XL110

AC   CVCL_T702

RX   PubMed=2335521;

CC   Group: Amphibian cell line.

OX   NCBI_TaxID=8355; ! Xenopus laevis

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   XL2

AC   CVCL_6743

RX   PubMed=7239540;

CC   Group: Amphibian cell line.

CC   Doubling time: 39 hours (PubMed=7239540).

OX   NCBI_TaxID=8355; ! Xenopus laevis

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   XLA-07

AC   CVCL_J033

RX   PubMed=22883674;

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   XLC002

AC   CVCL_IS77

SY   QualiCell Human Embryonic Stem Cell-XLC002

WW   http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC002-CSC-C00009-item-2659.htm

CC   From: Creative Bioarray.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   XLC004

AC   CVCL_IS78

SY   QualiCell Human Embryonic Stem Cell-XLC004

WW   http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC004-CSC-C00002-item-2652.htm

CC   From: Creative Bioarray.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   XLC007

AC   CVCL_IS79

SY   QualiCell Human Embryonic Stem Cell-XLC007

WW   http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC007-CSC-C00005-item-2655.htm

CC   From: Creative Bioarray.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   XLC009

AC   CVCL_IS80

SY   QualiCell Human Embryonic Stem Cell-XLC009

WW   http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC009-CSC-C00021-item-2671.htm

CC   From: Creative Bioarray.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   XLC011

AC   CVCL_IS81

SY   QualiCell Human Embryonic Stem Cell-XLC011

WW   http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC011-CSC-C00018-item-2668.htm

CC   From: Creative Bioarray.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   XLC012

AC   CVCL_IS82

SY   QualiCell Human Embryonic Stem Cell-XLC012

WW   http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC012-CSC-C00010-item-2660.htm

CC   From: Creative Bioarray.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   XLC013

AC   CVCL_IS83

SY   QualiCell Human Embryonic Stem Cell-XLC013

WW   http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC013-CSC-C00001-item-2651.htm

CC   From: Creative Bioarray.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   XLC015

AC   CVCL_IS84

SY   QualiCell Human Embryonic Stem Cell-XLC015

WW   http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC015-CSC-C00014-item-2664.htm

CC   From: Creative Bioarray.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   XLC016

AC   CVCL_IS85

SY   QualiCell Human Embryonic Stem Cell-XLC016

WW   http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC016-CSC-C00004-item-2654.htm

CC   From: Creative Bioarray.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   XLC017

AC   CVCL_IS86

SY   QualiCell Human Embryonic Stem Cell-XLC017

WW   http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC017-CSC-C00020-item-2670.htm

CC   From: Creative Bioarray.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   XLC018

AC   CVCL_IS87

SY   QualiCell Human Embryonic Stem Cell-XLC018

WW   http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC018-CSC-C00003-item-2653.htm

CC   From: Creative Bioarray.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   XLC020

AC   CVCL_IS88

SY   QualiCell Human Embryonic Stem Cell-XLC020

WW   http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC020-CSC-C00008-item-2658.htm

CC   From: Creative Bioarray.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   XLC021

AC   CVCL_IS89

SY   QualiCell Human Embryonic Stem Cell-XLC021

WW   http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC021-CSC-C00016-item-2666.htm

CC   From: Creative Bioarray.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   XLC023

AC   CVCL_IS90

SY   QualiCell Human Embryonic Stem Cell-XLC023

WW   http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC023-CSC-C00011-item-2661.htm

CC   From: Creative Bioarray.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   XLC025

AC   CVCL_IS91

SY   QualiCell Human Embryonic Stem Cell-XLC025

WW   http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC025-CSC-C00013-item-2663.htm

CC   From: Creative Bioarray.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   XLC027

AC   CVCL_IS92

SY   QualiCell Human Embryonic Stem Cell-XLC027

WW   http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC027-CSC-C00015-item-2665.htm

CC   From: Creative Bioarray.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   XLC029

AC   CVCL_IS93

SY   QualiCell Human Embryonic Stem Cell-XLC029

WW   http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC029-CSC-C00007-item-2657.htm

CC   From: Creative Bioarray.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   XLC030

AC   CVCL_IS94

SY   QualiCell Human Embryonic Stem Cell-XLC030

WW   http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC030-CSC-C00019-item-2669.htm

CC   From: Creative Bioarray.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   XLC033

AC   CVCL_IS95

SY   QualiCell Human Embryonic Stem Cell-XLC033

WW   http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC033-CSC-C00017-item-2667.htm

CC   From: Creative Bioarray.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   XLC034

AC   CVCL_IS96

SY   QualiCell Human Embryonic Stem Cell-XLC034

WW   http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC034-CSC-C00012-item-2662.htm

CC   From: Creative Bioarray.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   XLC038

AC   CVCL_IS97

SY   QualiCell Human Embryonic Stem Cell-XLC038

WW   http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC038-CSC-C00006-item-2656.htm

CC   From: Creative Bioarray.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   XLC041

AC   CVCL_IS98

SY   QualiCell Human Embryonic Stem Cell-XLC041

WW   http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC041-CSC-C00022-item-2672.htm

CC   From: Creative Bioarray.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   XLC042

AC   CVCL_IS99

SY   QualiCell Human Embryonic Stem Cell-XLC042

DR   ISCR; 2370

WW   http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC042-CSC-C00034-item-2684.htm

CC   From: Creative Bioarray.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   XLC044

AC   CVCL_IT00

SY   QualiCell Human Embryonic Stem Cell-XLC044

WW   http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC044-CSC-C00026-item-2676.htm

CC   From: Creative Bioarray.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   XLC046

AC   CVCL_IT01

SY   QualiCell Human Embryonic Stem Cell-XLC046

WW   http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC046-CSC-C00024-item-2674.htm

CC   From: Creative Bioarray.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   XLC048

AC   CVCL_IT02

SY   QualiCell Human Embryonic Stem Cell-XLC048

WW   http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC048-CSC-C00028-item-2678.htm

CC   From: Creative Bioarray.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   XLC049

AC   CVCL_IT03

SY   QualiCell Human Embryonic Stem Cell-XLC049

DR   ISCR; 2385

WW   http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC049-CSC-C00030-item-2680.htm

CC   From: Creative Bioarray.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   XLC050

AC   CVCL_IT04

SY   QualiCell Human Embryonic Stem Cell-XLC050

DR   ISCR; 2381

WW   http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC050-CSC-C00033-item-2683.htm

CC   From: Creative Bioarray.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   XLC051

AC   CVCL_IT05

SY   QualiCell Human Embryonic Stem Cell-XLC051

WW   http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC051-CSC-C00027-item-2677.htm

CC   From: Creative Bioarray.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   XLC052

AC   CVCL_IT06

SY   QualiCell Human Embryonic Stem Cell-XLC052

DR   ISCR; 2383

WW   http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC052-CSC-C00032-item-2682.htm

CC   From: Creative Bioarray.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   XLC053

AC   CVCL_IT07

SY   QualiCell Human Embryonic Stem Cell-XLC053

DR   ISCR; 2369

WW   http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC053-CSC-C00035-item-2685.htm

CC   From: Creative Bioarray.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   XLC054

AC   CVCL_IT08

SY   QualiCell Human Embryonic Stem Cell-XLC054

WW   http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC054-CSC-C00023-item-2673.htm

CC   From: Creative Bioarray.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   XLC055

AC   CVCL_IT09

SY   QualiCell Human Embryonic Stem Cell-XLC055

DR   ISCR; 2386

WW   http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC055-CSC-C00029-item-2679.htm

CC   From: Creative Bioarray.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   XLC056

AC   CVCL_IT10

SY   QualiCell Human Embryonic Stem Cell-XLC056

DR   ISCR; 2367

WW   http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC056-CSC-C00037-item-2687.htm

CC   From: Creative Bioarray.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   XLC057

AC   CVCL_IT11

SY   QualiCell Human Embryonic Stem Cell-XLC057

WW   http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC057-CSC-C00025-item-2675.htm

CC   From: Creative Bioarray.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   XLC060

AC   CVCL_IT12

SY   QualiCell Human Embryonic Stem Cell-XLC060

DR   ISCR; 2384

WW   http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC060-CSC-C00031-item-2681.htm

CC   From: Creative Bioarray.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   XLC061

AC   CVCL_IT13

SY   QualiCell Human Embryonic Stem Cell-XLC061

DR   ISCR; 2368

WW   http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC061-CSC-C00036-item-2686.htm

CC   From: Creative Bioarray.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   XLC064

AC   CVCL_IT14

SY   QualiCell Human Embryonic Stem Cell-XLC064

DR   ISCR; 2362

WW   http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC064-CSC-C00042-item-2692.htm

CC   From: Creative Bioarray.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   XLC065

AC   CVCL_IT15

SY   QualiCell Human Embryonic Stem Cell-XLC065

DR   ISCR; 2365

WW   http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC065-CSC-C00039-item-2689.htm

CC   From: Creative Bioarray.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   XLC068

AC   CVCL_IT16

SY   QualiCell Human Embryonic Stem Cell-XLC068

DR   ISCR; 2348

WW   http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC068-CSC-C00046-item-2696.htm

CC   From: Creative Bioarray.

CC   Characteristics: Has Lox sites for Cre-mediated gene insertion and constitutive transgene expression.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   XLC069

AC   CVCL_IT17

SY   QualiCell Human Embryonic Stem Cell-XLC069

DR   ISCR; 2361

WW   http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC069-CSC-C00043-item-2693.htm

CC   From: Creative Bioarray.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   XLC070

AC   CVCL_IT18

SY   QualiCell Human Embryonic Stem Cell-XLC070

DR   ISCR; 2364

WW   http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC070-CSC-C00040-item-2690.htm

CC   From: Creative Bioarray.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   XLC072

AC   CVCL_IT19

SY   QualiCell Human Embryonic Stem Cell-XLC072

DR   ISCR; 2350

WW   http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC072-CSC-C00044-item-2694.htm

CC   From: Creative Bioarray.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   XLC073

AC   CVCL_IT20

SY   QualiCell Human Embryonic Stem Cell-XLC073

DR   ISCR; 2347

WW   http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC073-CSC-C00047-item-2697.htm

CC   From: Creative Bioarray.

CC   Transfected with: UniProtKB; P42212; GFP.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   XLC074

AC   CVCL_IT21

SY   QualiCell Human Embryonic Stem Cell-XLC074

DR   ISCR; 2366

WW   http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC074-CSC-C00038-item-2688.htm

CC   From: Creative Bioarray.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   XLC076

AC   CVCL_IT22

SY   QualiCell Human Embryonic Stem Cell-XLC076

DR   ISCR; 2341

WW   http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC076-CSC-C00051-item-2701.htm

CC   From: Creative Bioarray.

CC   Transfected with: UniProtKB; P42212; GFP.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   XLC077

AC   CVCL_IT23

SY   QualiCell Human Embryonic Stem Cell-XLC077

DR   ISCR; 2363

WW   http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC077-CSC-C00041-item-2691.htm

CC   From: Creative Bioarray.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   XLC080

AC   CVCL_IT24

SY   QualiCell Human Embryonic Stem Cell-XLC080

DR   ISCR; 2349

WW   http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC080-CSC-C00045-item-2695.htm

CC   From: Creative Bioarray.

CC   Characteristics: Has a EGFP-POU5F1 knock-in.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   XLC081

AC   CVCL_IT25

SY   QualiCell Human Embryonic Stem Cell-XLC081

DR   ISCR; 2322

WW   http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC081-CSC-C00052-item-2702.htm

CC   From: Creative Bioarray.

CC   Characteristics: A GFP cassette is inserted to the OLIG2 locus via homologous recombination.

CC   Transfected with: UniProtKB; P42212; GFP.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_9726 ! BG01

SX   Male

CA   Embryonic stem cell

//

ID   XLC083

AC   CVCL_IT26

SY   QualiCell Human Embryonic Stem Cell-XLC083

DR   ISCR; 2345

WW   http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC083-CSC-C00049-item-2699.htm

CC   From: Creative Bioarray.

CC   Transfected with: UniProtKB; P42212; GFP.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   XLC088

AC   CVCL_IT27

SY   QualiCell Human Embryonic Stem Cell-XLC088

DR   ISCR; 2346

WW   http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC088-CSC-C00048-item-2698.htm

CC   From: Creative Bioarray.

CC   Characteristics: POU5F1 promoter driving GFP expression and Zeo resistance.

CC   Transfected with: UniProtKB; P42212; GFP.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   XLC090

AC   CVCL_IT28

SY   QualiCell Human Embryonic Stem Cell-XLC090

DR   ISCR; 2344

WW   http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC090-CSC-C00050-item-2700.htm

CC   From: Creative Bioarray.

CC   Characteristics: Cardiac specific troponin T promoter driving GFP expression and Zeo resistance.

CC   Transfected with: UniProtKB; P42212; GFP.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   XLC303

AC   CVCL_IT52

SY   XLC-303; CBi002-A

DR   BioSamples; SAMEA103988342

DR   hPSCreg; CBi002-A

WW   http://www.creative-bioarray.com/QualiCell-Induced-Pluripotent-Stem-Cell-XLC303-CSC-C00122-item-2745.htm

CC   From: Creative Bioarray.

DI   NCIt; C3362; Schizophrenia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   XLC348

AC   CVCL_IT53

SY   XLC-348; CBi001-A

DR   BioSamples; SAMEA4458267

DR   hPSCreg; CBi001-A

WW   http://www.creative-bioarray.com/QualiCell-Induced-Pluripotent-Stem-Cell-XLC348-CSC-C00123-item-2746.htm

CC   From: Creative Bioarray.

DI   NCIt; C3362; Schizophrenia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   XLC449

AC   CVCL_IT29

SY   QualiCell Human Embryonic Stem Cell-XLC449

DR   ISCR; 2321

WW   http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC449-CSC-C00317-item-2873.htm

CC   From: Creative Bioarray.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   XLI-ND

AC   CVCL_E891

SY   TER341

DR   dbMHC; 49082

DR   ECACC; 94022554

DR   IHW; IHW9220

DR   IMGT/HLA; 11580

WW   http://bioinformatics.hsanmartino.it/ecbr/cl220.html

CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   XLIV-5A2-B9

AC   CVCL_U045

SY   B-19; B19

RX   PubMed=8734946;

CC   Monoclonal antibody target: Leishmania guyanensis.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   XLK-WG

AC   CVCL_5655

SY   XLKWG; Xenopus Laevis Kidney - Wu & Gall

DR   CLO; CLO_0009649

DR   ATCC; CRL-2527

CC   Group: Amphibian cell line.

OX   NCBI_TaxID=8355; ! Xenopus laevis

SX   Female

CA   Finite cell line

//

ID   XLK2

AC   CVCL_H009

SY   XlK2; XLK-2; XlK-2; XL-K2; Xl K2

RX   PubMed=2342463;

CC   Group: Amphibian cell line.

OX   NCBI_TaxID=8355; ! Xenopus laevis

SX   Sex undetermined

CA   Finite cell line

//

ID   XLT-15

AC   CVCL_6744

SY   XLT15

DR   BTO; BTO:0001956

RX   PubMed=9030578;

CC   Group: Amphibian cell line.

OX   NCBI_TaxID=8355; ! Xenopus laevis

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   XM

AC   CVCL_R938

SY   Xiphophorus Melanoma

RX   PubMed=18377217;

CC   Group: Fish cell line.

OX   NCBI_TaxID=8086; ! Xiphophorus xiphidium

SX   Sex undetermined

CA   Cancer cell line

//

ID   XMG1.2

AC   CVCL_2H37

SY   XMG 1.2; XMG-1.2

DR   BCRJ; 0249

RX   PubMed=2960769;

CC   Monoclonal antibody target: UniProtKB; P01580; Mouse Ifng.

OX   NCBI_TaxID=10090; ! Mus musculus

OX   NCBI_TaxID=10116; ! Rattus norvegicus

CA   Hybridoma

//

ID   XMMCO-791

AC   CVCL_F815

DR   CLO; CLO_0009650

DR   ATCC; HB-9173

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   XMMEN-OE5

AC   CVCL_F816

SY   AAB-647; AAB647

DR   CLO; CLO_0009651

DR   ATCC; HB-9081

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   XMMME-001

AC   CVCL_F817

DR   CLO; CLO_0009652

DR   ATCC; HB-8759

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3411 ! P3X63Ag8

CA   Hybridoma

//

ID   XMMME-002

AC   CVCL_F818

DR   CLO; CLO_0009653

DR   ATCC; HB-8760

CC   Discontinued: ATCC; HB-8760; probable.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3411 ! P3X63Ag8

CA   Hybridoma

//

ID   XP-1

AC   CVCL_Z271

RX   PubMed=10614871;

CC   Group: Insect cell line.

OX   NCBI_TaxID=1191636; ! Xylotrechus pyrrhoderus

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   XP-4

AC   CVCL_U695

SY   XP4RO

DR   ATCC; CRL-1260

RX   PubMed=7471106;

CC   Discontinued: ATCC; CRL-1260; true.

DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   XP0006

AC   CVCL_8Z03

DR   ECACC; 03060734

CC   Part of: ECACC chromosomal abnormality collection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   XP0007

AC   CVCL_8Z04

DR   ECACC; 03060735

CC   Part of: ECACC chromosomal abnormality collection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   XP0008

AC   CVCL_8Z05

DR   ECACC; 00306116

CC   Part of: ECACC chromosomal abnormality collection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C110940; Panhypopituitarism

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_8Z10 ! XP0013

SX   Male

CA   Transformed cell line

//

ID   XP0009

AC   CVCL_8Z06

DR   ECACC; 03061162

CC   Part of: ECACC chromosomal abnormality collection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C110940; Panhypopituitarism

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   XP0010

AC   CVCL_8Z07

DR   ECACC; 03081426

CC   Part of: ECACC chromosomal abnormality collection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   XP0011

AC   CVCL_8Z08

DR   ECACC; 03081427

CC   Part of: ECACC chromosomal abnormality collection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C110940; Panhypopituitarism

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   XP0012

AC   CVCL_8Z09

DR   ECACC; 03082243

CC   Part of: ECACC chromosomal abnormality collection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   XP0013

AC   CVCL_8Z10

DR   ECACC; 03082244

CC   Part of: ECACC chromosomal abnormality collection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C110940; Panhypopituitarism

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_8Z05 ! XP0008

SX   Male

CA   Transformed cell line

//

ID   XP0014

AC   CVCL_8Z11

DR   ECACC; 03082351

CC   Part of: ECACC chromosomal abnormality collection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C110940; Panhypopituitarism

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   XP10OS

AC   CVCL_9S67

DR   JCRB; KURB1320

RX   PubMed=1372102;

DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   XP11BR

AC   CVCL_W049

DI   NCIt; C3452; Xeroderma pigmentosum

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_2556 ! LB205

SX   Male

CA   Finite cell line

//

ID   XP125LO

AC   CVCL_W053

DI   NCIt; C3969; Xeroderma pigmentosum, complementation group G

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_2572 ! LB83

SX   Female

CA   Finite cell line

//

ID   XP12SE

AC   CVCL_U870

DR   JCRB; KURB1042

RX   PubMed=202381;

RX   PubMed=6865988;

DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_8767 ! XPL 12

SX   Male

CA   Finite cell line

//

ID   XP15OS

AC   CVCL_9S68

DR   JCRB; KURB1326

RX   PubMed=1372102;

DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   XP15SE

AC   CVCL_U869

DR   JCRB; KURB1363

RX   PubMed=202381;

RX   PubMed=6865988;

DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_8768 ! XPL 15

SX   Male

CA   Finite cell line

//

ID   XP165MA

AC   CVCL_4T40

RX   PubMed=23370536;

DI   NCIt; C3969; Xeroderma pigmentosum, complementation group G

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   XP17BE

AC   CVCL_3815

SY   GM10428

DR   CLO; CLO_0009661

DR   CLO; CLO_0028646

DR   ATCC; CRL-1360

DR   BioSample; SAMN03471356

DR   Coriell; GM10428

ST   Source(s): ATCC

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 11,12

ST   D16S539: 9,10

ST   D5S818: 12,13

ST   D7S820: 9,11

ST   TH01: 6,7

ST   TPOX: 9,11

ST   vWA: 15,19

DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_L778 ! GM02253

SX   Male

CA   Finite cell line

//

ID   XP17SE

AC   CVCL_W724

RX   PubMed=202381;

DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_8769 ! XPL 17

SX   Female

CA   Finite cell line

//

ID   XP18SE

AC   CVCL_U866

DR   JCRB; KURB1182

RX   PubMed=6865988;

DI   NCIt; C3452; Xeroderma pigmentosum

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_U865 ! XPL 18

SX   Male

CA   Finite cell line

//

ID   XP19SE

AC   CVCL_U867

DR   JCRB; KURB1183

RX   PubMed=6865988;

DI   NCIt; C3452; Xeroderma pigmentosum

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_8770 ! XPL 19

SX   Male

CA   Finite cell line

//

ID   XP24KO

AC   CVCL_F514

DR   JCRB; JCRB3012

DR   JCRB; KURB1081

RX   PubMed=10771487;

DI   NCIt; C114771; Xeroderma pigmentosum, complementation group E

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   XP27OS

AC   CVCL_9S69

DR   JCRB; KURB1335

RX   PubMed=1372102;

DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   XP2OS(SV)

AC   CVCL_3242

SY   XP2OS-SV; XP20S-SV40; XP20s(SV40)

DR   JCRB; JCRB0301

DR   JCRB; KURB1008

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 9

ST   D16S539: 12

ST   D5S818: 11

ST   D7S820: 8,12

ST   TH01: 9

ST   TPOX: 11

ST   vWA: 14,16

DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_F510 ! GM04312

SX   Female

CA   Transformed cell line

//

ID   XP2SA

AC   CVCL_3243

DR   JCRB; JCRB0305

DR   JCRB; KURB1123

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 8,9

ST   D16S539: 9

ST   D5S818: 11,12

ST   D7S820: 11

ST   TH01: 6

ST   TPOX: 11

ST   vWA: 18

DI   NCIt; C3452; Xeroderma pigmentosum

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   XP2YO

AC   CVCL_F598

SY   GM04313; GM04313D

DR   CLO; CLO_0019547

DR   Coriell; GM04313

DR   JCRB; KURB1092

DR   JCRB; KURB1093

DI   NCIt; C3968; Xeroderma pigmentosum, complementation group F

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   XP2YO(SV)

AC   CVCL_3244

SY   XP2YO-SV; GM08437; GM08437B

DR   CLO; CLO_0010546

DR   BioSample; SAMN03471615

DR   Coriell; GM08437

DR   JCRB; JCRB0302

DR   JCRB; KURB1094

DR   JCRB; KURB1095

RX   PubMed=1660831;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 8,10

ST   D16S539: 11

ST   D5S818: 10,13

ST   D7S820: 11,12

ST   TH01: 9

ST   TPOX: 8

ST   vWA: 13,17

DI   NCIt; C3968; Xeroderma pigmentosum, complementation group F

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_F598 ! XP2YO

SX   Female

CA   Transformed cell line

//

ID   XP30RO

AC   CVCL_7395

AS   CVCL_G334

SY   XP-V XP30RO; XP-V (XP30RO); GM03617; GM3617

DR   BTO; BTO:0004753

DR   CLO; CLO_0017188

DR   Coriell; GM03617

RX   PubMed=7471106;

RX   PubMed=7565859;

DI   NCIt; C3452; Xeroderma pigmentosum

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   XP35OS

AC   CVCL_3247

DR   JCRB; JCRB0304

DR   JCRB; KURB1164

RX   PubMed=1372102;

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 9,12

ST   D13S317: 9,10

ST   D16S539: 9,10

ST   D5S818: 11,13

ST   D7S820: 10,11

ST   TH01: 9

ST   TPOX: 8

ST   vWA: 14,17

DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   XP35OS(SVT)

AC   CVCL_4Y31

DR   JCRB; KURB1165

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3247 ! XP35OS

CA   Transformed cell line

//

ID   XP39OS

AC   CVCL_3248

DR   JCRB; JCRB0326

DR   JCRB; KURB1013

RX   PubMed=1372102;

RX   PubMed=3814505;

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 9,11

ST   D16S539: 10,12

ST   D5S818: 11,12

ST   D7S820: 11,12

ST   TH01: 6,7

ST   TPOX: 8,11

ST   vWA: 17,18

DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   XP39OS(SVT)

AC   CVCL_4Y32

DR   JCRB; KURB1014

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3248 ! XP39OS

SX   Female

CA   Transformed cell line

//

ID   XP39OSTERT

AC   CVCL_3249

SY   XP39OS hTERT

DR   BioSample; SAMN03472494

DR   JCRB; JCRB1057

DR   JCRB; KURB1015

DR   JCRB; NIHS0307

CC   Transfected with: HGNC; 11730; TERT.

CC   Discontinued: JCRB; NIHS0307; true.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 9,11

ST   D16S539: 10,12

ST   D5S818: 11,12

ST   D7S820: 11,12

ST   TH01: 6,7

ST   TPOX: 8,11

ST   vWA: 17,18

DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3248 ! XP39OS

SX   Female

CA   Telomerase immortalized cell line

//

ID   XP39R

AC   CVCL_9S66

RX   PubMed=26090552;

DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3248 ! XP39OS

SX   Female

CA   Induced pluripotent stem cell

//

ID   XP3OS

AC   CVCL_3245

AS   CVCL_F511

SY   XP30S; GM04314

DR   CLO; CLO_0019557

DR   Coriell; GM04314

DR   JCRB; JCRB0303

DR   JCRB; KURB1002

DR   JCRB; KURB1003

DR   JCRB; KURB1004

RX   PubMed=1372102;

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 9,11

ST   D16S539: 9,12

ST   D5S818: 10,11

ST   D7S820: 11,12

ST   TH01: 7

ST   TPOX: 8,11

ST   vWA: 14,16

DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   XP3OS(SVT)

AC   CVCL_3246

DR   BioSample; SAMN03472492

DR   JCRB; JCRB1055

DR   JCRB; KURB1005

DR   JCRB; NIHS0304

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Discontinued: JCRB; NIHS0304; true.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 9,11

ST   D16S539: 9,12

ST   D5S818: 10,11

ST   D7S820: 11,12

ST   TH01: 7

ST   TPOX: 8,11

ST   vWA: 14,16

DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3245 ! XP3OS

SX   Female

CA   Transformed cell line

//

ID   XP3R

AC   CVCL_9S65

RX   PubMed=26090552;

DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3245 ! XP3OS

SX   Female

CA   Induced pluripotent stem cell

//

ID   XP40GO

AC   CVCL_4T42

RX   PubMed=23370536;

DI   NCIt; C3969; Xeroderma pigmentosum, complementation group G

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   XP40OS

AC   CVCL_3250

DR   BioSample; SAMN03793112

DR   JCRB; JCRB0327

DR   JCRB; KURB1168

DR   JCRB; KURB1169

RX   PubMed=26697316;

CC   Omics: Deep exome analysis.

ST   Source(s): JCRB

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 8,9

ST   D16S539: 10,12

ST   D5S818: 10,13,14

ST   D7S820: 10,12

ST   TH01: 9

ST   TPOX: 8

ST   vWA: 17,18

DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   XP40OS iPS

AC   CVCL_CV31

RX   PubMed=26697316;

CC   Omics: Deep exome analysis.

DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3250 ! XP40OS

SX   Male

CA   Induced pluripotent stem cell

//

ID   XP40OSTERT

AC   CVCL_3251

DR   BioSample; SAMN03472495

DR   JCRB; JCRB1058

DR   JCRB; NIHS0308

CC   Transfected with: HGNC; 11730; TERT.

CC   Discontinued: JCRB; NIHS0308; true.

ST   Source(s): JCRB

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 8,9

ST   D16S539: 10,12

ST   D5S818: 10,14

ST   D7S820: 10,12

ST   TH01: 9

ST   TPOX: 8

ST   vWA: 17,18

DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3250 ! XP40OS

SX   Male

CA   Telomerase immortalized cell line

//

ID   XP44RO

AC   CVCL_M221

DI   NCIt; C3452; Xeroderma pigmentosum

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_8013 ! XP44RO(Mel)

SX   Male

CA   Finite cell line

//

ID   XP44RO(Mel)

AC   CVCL_8013

SY   XP44RO(MEL); GM13030

DR   CLO; CLO_0014031

DR   Coriell; GM13030

RX   PubMed=2645048;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_M221 ! XP44RO

SX   Male

CA   Cancer cell line

//

ID   XP4PA(SV)

AC   CVCL_6E33

SY   XP4PA-SV

DR   JCRB; KURB1064

RX   PubMed=1660831;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   XP4PA-SE1

AC   CVCL_F627

SY   GM16247

DR   CLO; CLO_0019445

DR   Coriell; GM16247

RX   PubMed=10681431;

CC   Transfected with: HGNC; 12816; XPC.

CC   Transfected with: UniProtKB; P03211; EBV EBNA1.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_F625 ! XP4PA-SV-EB

SX   Male

CA   Transformed cell line

//

ID   XP4PA-SE2

AC   CVCL_F628

SY   GM16248

DR   CLO; CLO_0019446

DR   Coriell; GM16248

RX   PubMed=10681431;

CC   Transfected with: HGNC; 12816; XPC.

CC   Transfected with: UniProtKB; P03211; EBV EBNA1.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_F625 ! XP4PA-SV-EB

SX   Male

CA   Transformed cell line

//

ID   XP4PA-SV-EB

AC   CVCL_F625

SY   GM15983

DR   CLO; CLO_0018741

DR   Coriell; GM15983

RX   PubMed=1660831;

RX   PubMed=10681431;

CC   Transfected with: UniProtKB; P03211; EBV EBNA1.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_6E33 ! XP4PA(SV)

SX   Male

CA   Transformed cell line

//

ID   XP5BE

AC   CVCL_U762

SY   XP5 BE; Be Wen

DR   ATCC; CRL-1160

DR   JCRB; KURB1071

CC   Discontinued: ATCC; CRL-1160; probable.

DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   XP5SE

AC   CVCL_U871

DR   JCRB; KURB1358

RX   PubMed=202381;

RX   PubMed=6865988;

DI   NCIt; C114771; Xeroderma pigmentosum, complementation group E

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_8773 ! XPL 5

SX   Male

CA   Finite cell line

//

ID   XP6TO

AC   CVCL_9S70

DR   JCRB; KURB1370

RX   PubMed=1372102;

DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   XP70TO

AC   CVCL_F513

DR   JCRB; JCRB3013

DR   JCRB; JCRB3014

DR   JCRB; KURB1082

DR   JCRB; KURB1083

RX   PubMed=1376435;

RX   PubMed=10771487;

DI   NCIt; C114771; Xeroderma pigmentosum, complementation group E

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   XP72MA

AC   CVCL_4T41

RX   PubMed=23370536;

DI   NCIt; C3969; Xeroderma pigmentosum, complementation group G

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   XP7TO

AC   CVCL_9S71

DR   JCRB; KURB1043

RX   PubMed=1372102;

DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   XP80TO

AC   CVCL_DE29

DR   JCRB; KURB1084

RX   PubMed=1376435;

DI   NCIt; C114771; Xeroderma pigmentosum, complementation group E

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   XP81TO

AC   CVCL_DE30

DR   JCRB; KURB1085

RX   PubMed=1376435;

DI   NCIt; C114771; Xeroderma pigmentosum, complementation group E

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   XP8BR

AC   CVCL_W051

DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_2560 ! LB316

SX   Male

CA   Finite cell line

//

ID   XP95TO

AC   CVCL_4Y29

RX   PubMed=1376435;

RX   PubMed=9539981;

DI   NCIt; C114771; Xeroderma pigmentosum, complementation group E

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   XPA-1

AC   CVCL_9502

SY   XPA1; PX-184; PX184; PXA184

DR   Cosmic; 1198218

RX   PubMed=14520411;

RX   PubMed=16912165;

CC   From: Maitra A.; Johns Hopkins University; Baltimore; USA.

DI   NCIt; C8294; Pancreatic adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   XPA-2

AC   CVCL_9503

SY   XPA2; PX-196; PX196; PXA196

RX   PubMed=14520411;

RX   PubMed=16912165;

CC   From: Maitra A.; Johns Hopkins University; Baltimore; USA.

DI   NCIt; C8294; Pancreatic adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   XPA-3

AC   CVCL_9504

SY   XPA3; XPa3; PX-154; PX154

DR   Cosmic; 1198219

RX   PubMed=14520411;

RX   PubMed=16912165;

CC   From: Maitra A.; Johns Hopkins University; Baltimore; USA.

DI   NCIt; C8294; Pancreatic adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   XPA-4

AC   CVCL_9505

SY   XPA4; XPa4

DR   Cosmic; 1198220

CC   From: Maitra A.; Johns Hopkins University; Baltimore; USA.

DI   NCIt; C8294; Pancreatic adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   XPBHBE

AC   CVCL_U763

SY   XP1MI

DR   ATCC; CRL-1333

DR   JCRB; KURB1117

CC   Discontinued: ATCC; CRL-1333; true.

DI   NCIt; C3452; Xeroderma pigmentosum

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   XPEMB-1

AC   CVCL_3252

SY   XPEMB1

DR   JCRB; JCRB0325

RX   PubMed=1372102;

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 11,13

ST   D16S539: 11,12

ST   D5S818: 11,12

ST   D7S820: 11,14

ST   TH01: 7,9

ST   TPOX: 8,9

ST   vWA: 18

DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   XPET6/1

AC   CVCL_4Y30

RX   PubMed=9539981;

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV3-neo].

DI   NCIt; C114771; Xeroderma pigmentosum, complementation group E

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_4Y29 ! XP95TO

CA   Transformed cell line

//

ID   XPKMSF

AC   CVCL_U764

DR   ATCC; CRL-1203

CC   Discontinued: ATCC; CRL-1203; probable.

DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   XPL 12

AC   CVCL_8767

SY   XPL12

RX   PubMed=202381;

RX   PubMed=6865988;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_U870 ! XP12SE

SX   Male

CA   Transformed cell line

//

ID   XPL 15

AC   CVCL_8768

SY   XPL15

DR   TKG; TKG 0310

RX   PubMed=202381;

RX   PubMed=1906129;

RX   PubMed=6865988;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_U869 ! XP15SE

SX   Male

CA   Transformed cell line

//

ID   XPL 17

AC   CVCL_8769

SY   XPL17

DR   CLO; CLO_0051020

DR   BioSample; SAMN03471955

DR   RCB; RCB2286

DR   TKG; TKG 0311

RX   PubMed=202381;

RX   PubMed=1906129;

RX   PubMed=6865988;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

ST   Source(s): RCB; TKG

ST   Amelogenin: X

ST   CSF1PO: 13

ST   D13S317: 11

ST   D16S539: 9

ST   D5S818: 10,12

ST   D7S820: 8,11

ST   TH01: 6,7

ST   TPOX: 11

ST   vWA: 15,17

DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_W724 ! XP17SE

SX   Female

CA   Transformed cell line

//

ID   XPL 18

AC   CVCL_U865

SY   XPL18

RX   PubMed=6865988;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C3452; Xeroderma pigmentosum

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_U866 ! XP18SE

SX   Male

CA   Transformed cell line

//

ID   XPL 19

AC   CVCL_8770

SY   XPL19

DR   CLO; CLO_0050493

DR   BioSample; SAMN03471924

DR   RCB; RCB2539

DR   TKG; TKG 0312

RX   PubMed=1906129;

RX   PubMed=6865988;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

ST   Source(s): RCB

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 12

ST   D16S539: 10,11

ST   D5S818: 10,13

ST   D7S820: 8,14

ST   TH01: 5,6

ST   TPOX: 8,11

ST   vWA: 14,18

DI   NCIt; C3452; Xeroderma pigmentosum

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_U867 ! XP19SE

SX   Male

CA   Transformed cell line

//

ID   XPL 20

AC   CVCL_8771

SY   XPL20

DR   CLO; CLO_0050477

DR   BioSample; SAMN03471956

DR   RCB; RCB2287

DR   TKG; TKG 0313

RX   PubMed=1906129;

RX   PubMed=6865988;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

ST   Source(s): RCB; TKG

ST   Amelogenin: X,Y

ST   CSF1PO: 13,14

ST   D13S317: 12,14

ST   D16S539: 10,13

ST   D5S818: 9,12

ST   D7S820: 11,12

ST   TH01: 6

ST   TPOX: 8

ST   vWA: 14

DI   NCIt; C3452; Xeroderma pigmentosum

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   XPL 24

AC   CVCL_8772

SY   XPL24

DR   CLO; CLO_0051021

DR   BioSample; SAMN03471925

DR   RCB; RCB2540

DR   TKG; TKG 0314

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 8,13

ST   D16S539: 10,12

ST   D5S818: 11

ST   D7S820: 10,12

ST   TH01: 7

ST   TPOX: 8

ST   vWA: 17,19

DI   NCIt; C3452; Xeroderma pigmentosum

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   XPL 5

AC   CVCL_8773

SY   XPL5

DR   CLO; CLO_0050476

DR   BioSample; SAMN03472081

DR   RCB; RCB1875

DR   TKG; TKG 0309

RX   PubMed=202381;

RX   PubMed=6865988;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

ST   Source(s): RCB; TKG

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 10,11

ST   D16S539: 10,11

ST   D5S818: 13

ST   D7S820: 11,12

ST   TH01: 9

ST   TPOX: 8,11

ST   vWA: 17

DI   NCIt; C114771; Xeroderma pigmentosum, complementation group E

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_U871 ! XP5SE

SX   Male

CA   Transformed cell line

//

ID   XPL15OS

AC   CVCL_3253

DR   JCRB; JCRB0307

DR   JCRB; KURB1281

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 9,10

ST   D16S539: 11,13

ST   D5S818: 12,13

ST   D7S820: 12

ST   TH01: 8,9

ST   TPOX: 8

ST   vWA: 17,18

DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   XPL3KA

AC   CVCL_3254

DR   JCRB; JCRB0306

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

ST   Source(s): JCRB

ST   Amelogenin: X,Y

ST   CSF1PO: 10,11

ST   D13S317: 8,13

ST   D16S539: 10,11

ST   D5S818: 9,11

ST   D7S820: 8,11

ST   TH01: 9

ST   TPOX: 11

ST   vWA: 14,17

DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   XPML17

AC   CVCL_F907

RX   PubMed=202381;

RX   PubMed=1906129;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   XPPL17

AC   CVCL_F908

RX   PubMed=202381;

RX   PubMed=1906129;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   XPTS-1

AC   CVCL_9U60

RX   PubMed=21575431;

RX   PubMed=22932480;

CC   Misspelling: 'XTPS-1' in PubMed=22932480 (everywhere in the paper including in the title).

DI   NCIt; C7394; Juvenile capillary hemangioma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   XQH

AC   CVCL_J129

DR   ATCC; CRL-11864

RX   Patent=US5976860;

CC   Discontinued: ATCC; CRL-11864; probable.

DI   NCIt; C9154; Adult acute myeloid leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0002 ! HL-60

SX   Female

CA   Cancer cell line

//

ID   XR-1

AC   CVCL_K253

SY   CHO XR-1; CHO.XR-1; GM16147

DR   CLO; CLO_0019811

DR   CLO; CLO_0050426

DR   Coriell; GM16147

DR   RCB; RCB2331

RX   PubMed=2164147;

RX   PubMed=6836453;

RX   PubMed=10047779;

CC   Characteristics: Both alleles of Xrcc4 are deleted in this cell line.

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_K254 ! CHO 4364

SX   Female

CA   Spontaneously immortalized cell line

//

ID   XR-C1

AC   CVCL_S146

SY   XRC-1; XRC1; GM16135

DR   CLO; CLO_0018814

DR   Coriell; GM16135

RX   PubMed=9628911;

CC   Transformant: ChEBI; CHEBI:23995; N-ethyl-N-nitrosourea (ENU).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_D898 ! CHO-9

SX   Female

CA   Spontaneously immortalized cell line

//

ID   XR-V10B

AC   CVCL_F517

RX   PubMed=9742232;

CC   Transformant: ChEBI; CHEBI:23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_6296 ! V79B

SX   Male

CA   Spontaneously immortalized cell line

//

ID   XR-V11B

AC   CVCL_F518

RX   PubMed=9742232;

CC   Transformant: ChEBI; CHEBI:23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_6296 ! V79B

SX   Male

CA   Spontaneously immortalized cell line

//

ID   XR-V12B

AC   CVCL_F519

RX   PubMed=9742232;

CC   Transformant: ChEBI; CHEBI:23995; N-ethyl-N-nitrosourea (ENU).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_6296 ! V79B

SX   Male

CA   Spontaneously immortalized cell line

//

ID   XR-V13B

AC   CVCL_F520

RX   PubMed=9742232;

CC   Transformant: ChEBI; CHEBI:23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_6296 ! V79B

SX   Male

CA   Spontaneously immortalized cell line

//

ID   XR-V15B

AC   CVCL_3271

SY   GM16144

DR   CLO; CLO_0009694

DR   CLO; CLO_0018891

DR   CLO; CLO_0051580

DR   ATCC; CRL-2349

DR   Coriell; GM16144

DR   RCB; RCB2339

RX   PubMed=2460764;

RX   PubMed=8657125;

CC   Transformant: ChEBI; CHEBI:23995; N-ethyl-N-nitrosourea (ENU).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_6296 ! V79B

SX   Male

CA   Spontaneously immortalized cell line

//

ID   XR-V16B

AC   CVCL_F521

SY   GM16145

DR   CLO; CLO_0018890

DR   Coriell; GM16145

RX   PubMed=9742232;

CC   Transformant: ChEBI; CHEBI:23995; N-ethyl-N-nitrosourea (ENU).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_6296 ! V79B

SX   Male

CA   Spontaneously immortalized cell line

//

ID   XR-V9B

AC   CVCL_HM60

RX   PubMed=1438689;

RX   PubMed=8657125;

CC   Transformant: ChEBI; CHEBI:23995; N-ethyl-N-nitrosourea (ENU).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_6296 ! V79B

SX   Male

CA   Spontaneously immortalized cell line

//

ID   XR-V9B-4

AC   CVCL_8651

DR   CLO; CLO_0051581

DR   RCB; RCB2338

CC   Transformant: ChEBI; CHEBI:23995; N-ethyl-N-nitrosourea (ENU).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HM60 ! XR-V9B

SX   Male

CA   Spontaneously immortalized cell line

//

ID   XR1

AC   CVCL_T691

SY   Xenopus retina 1

RX   DOI=10.1006/ncmn.1993.1060;

RX   PubMed=2659410;

RX   PubMed=3257022;

CC   Group: Amphibian cell line.

OX   NCBI_TaxID=8355; ! Xenopus laevis

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   XR8

AC   CVCL_T692

SY   Xenopus retina 8

RX   PubMed=2659410;

CC   Group: Amphibian cell line.

OX   NCBI_TaxID=8355; ! Xenopus laevis

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   XR9

AC   CVCL_T693

SY   Xenopus retina 9

RX   PubMed=2659410;

CC   Group: Amphibian cell line.

OX   NCBI_TaxID=8355; ! Xenopus laevis

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   XRpe1

AC   CVCL_T694

RX   DOI=10.1006/ncmn.1993.1060;

CC   Group: Amphibian cell line.

OX   NCBI_TaxID=8355; ! Xenopus laevis

CA   Spontaneously immortalized cell line

//

ID   XRpe2

AC   CVCL_T695

RX   DOI=10.1006/ncmn.1993.1060;

CC   Group: Amphibian cell line.

OX   NCBI_TaxID=8355; ! Xenopus laevis

CA   Spontaneously immortalized cell line

//

ID   XRpe4

AC   CVCL_T696

RX   DOI=10.1006/ncmn.1993.1060;

CC   Group: Amphibian cell line.

OX   NCBI_TaxID=8355; ! Xenopus laevis

CA   Spontaneously immortalized cell line

//

ID   XRpe5

AC   CVCL_T697

RX   DOI=10.1006/ncmn.1993.1060;

CC   Group: Amphibian cell line.

OX   NCBI_TaxID=8355; ! Xenopus laevis

CA   Spontaneously immortalized cell line

//

ID   XS20

AC   CVCL_AV87

RX   PubMed=7490479;

RX   PubMed=7876542;

CC   Breed/subspecies: BALB/c.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Female

CA   Spontaneously immortalized cell line

//

ID   XS52

AC   CVCL_K270

RX   PubMed=7490479;

RX   PubMed=7876542;

CC   Breed/subspecies: BALB/c.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Female

CA   Spontaneously immortalized cell line

//

ID   XS63

AC   CVCL_3626

DR   CLO; CLO_0009695

DR   ATCC; TIB-17

RX   PubMed=5439579;

CC   Breed/subspecies: BALB/c.

DI   NCIt; C125417; Mouse plasma cell myeloma

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   XT67E1

AC   CVCL_AS08

SY   XT

DR   GEO; GSM397402

DR   GEO; GSM397403

DR   GEO; GSM397404

DR   GEO; GSM397405

DR   GEO; GSM397406

DR   GEO; GSM397407

RX   PubMed=8538762;

RX   PubMed=19581487;

RX   PubMed=23850244;

CC   Omics: DNA methylation analysis.

CC   Omics: H3K27me3 ChIP-seq epigenome analysis.

CC   Omics: H3K4me3 ChIP-seq epigenome analysis.

CC   Breed/subspecies: PGK x 129/Ola/Hsd.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_AS07 ! PGK12.1

SX   Female

CA   Embryonic stem cell

//

ID   XTC-1

AC   CVCL_9916

SY   XTC1; XTC; XTC-UC1; XTC.UC1

DR   Cosmic; 1084281

DR   Cosmic; 1162844

DR   Cosmic; 2036689

DR   Cosmic; 2328761

RX   PubMed=9669284;

RX   PubMed=11349830;

RX   PubMed=16646677;

RX   PubMed=17725429;

RX   PubMed=19087340;

CC   Derived from metastatic site: Breast.

DI   NCIt; C4946; Thyroid gland oncocytic follicular carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   XTC-YF

AC   CVCL_5610

SY   XTC-2

DR   CLO; CLO_0050158

DR   RCB; RCB0771

RX   PubMed=4708349;

CC   Group: Amphibian cell line.

CC   Caution: According to RCB0771 XTC-YF and XTC-2 are identical.

OX   NCBI_TaxID=8355; ! Xenopus laevis

CA   Spontaneously immortalized cell line

//

ID   XTH-2

AC   CVCL_1892

DR   CLO; CLO_0009696

DR   CLDB; cl4785

DR   DSMZ; ACC-190

RX   CelloPub=CLPUB00129;

RX   PubMed=3091251;

CC   Group: Amphibian cell line.

CC   Doubling time: ~10-12 days (DSMZ).

OX   NCBI_TaxID=8355; ! Xenopus laevis

CA   Spontaneously immortalized cell line

//

ID   XTK0

AC   CVCL_7228

DR   CLO; CLO_0009697

DR   CLDB; cl4786

RX   PubMed=6278782;

CC   Transformant: NCBI_TaxID; 10310; Human herpesvirus 2 (HSV-2).

OX   NCBI_TaxID=10036; ! Mesocricetus auratus

HI   CVCL_3256 ! XTK2

CA   Transformed cell line

//

ID   XTK1

AC   CVCL_3255

DR   CLO; CLO_0009698

DR   CLDB; cl4787

RX   PubMed=6278782;

CC   Transformant: NCBI_TaxID; 10310; Human herpesvirus 2 (HSV-2).

OX   NCBI_TaxID=10036; ! Mesocricetus auratus

CA   Transformed cell line

//

ID   XTK2

AC   CVCL_3256

DR   CLO; CLO_0009699

DR   CLDB; cl4788

RX   PubMed=6278782;

CC   Transformant: NCBI_TaxID; 10310; Human herpesvirus 2 (HSV-2).

OX   NCBI_TaxID=10036; ! Mesocricetus auratus

CA   Transformed cell line

//

ID   XTUU 139/30

AC   CVCL_9V36

RX   PubMed=1335463;

CC   Group: Hybridoma fusion partner cell line.

OX   NCBI_TaxID=9606; ! Homo sapiens

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybrid cell line

//

ID   XTUU D10

AC   CVCL_9V37

RX   PubMed=1335463;

CC   Group: Hybridoma fusion partner cell line.

OX   NCBI_TaxID=9606; ! Homo sapiens

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybrid cell line

//

ID   XTY

AC   CVCL_5611

DR   CLO; CLO_0050157

DR   RCB; RCB0770

RX   PubMed=1737584;

CC   Group: Amphibian cell line.

OX   NCBI_TaxID=8355; ! Xenopus laevis

CA   Cancer cell line

//

ID   XVI E6E6G10

AC   CVCL_F819

DR   CLO; CLO_0009700

DR   ATCC; HB-9496

RX   Patent=US4816417;

CC   Monoclonal antibody target: UniProtKB; A3RGC1; Pig VDR.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   XWLC-05

AC   CVCL_IQ71

SY   XuanWei Lung Cancer-05

RX   PubMed=17222362;

CC   Doubling time: 32.8 hours (PubMed=17222362).

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   XX406

AC   CVCL_F543

SY   TER165; TER250; TER269

DR   IMGT/HLA; 11581

CC   Part of: International Histocompatibility Workshop cell lines.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   Y-17

AC   CVCL_E991

DR   CLO; CLO_0009704

DR   ATCC; HB-179

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   Y-1K

AC   CVCL_8774

RX   PubMed=7918028;

DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Y-3

AC   CVCL_E990

DR   CLO; CLO_0009705

DR   ATCC; HB-176

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   Y-3P

AC   CVCL_E989

DR   CLO; CLO_0009708

DR   ATCC; HB-183

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   Y-79

AC   CVCL_1893

SY   Y79; GM01232

DR   BTO; BTO:0002920

DR   CLO; CLO_0009709

DR   CLO; CLO_0030277

DR   CLO; CLO_0051564

DR   EFO; EFO_0002392

DR   CLDB; cl4796

DR   CLDB; cl4797

DR   CLDB; cl4798

DR   CLDB; cl4984

DR   ATCC; HTB-18

DR   BCRC; 60422

DR   BCRJ; 0380

DR   BioSample; SAMN01821607

DR   BioSample; SAMN03472733

DR   BioSample; SAMN03473388

DR   CCRID; 3111C0001CCC000269

DR   ChEMBL-Cells; CHEMBL3308054

DR   ChEMBL-Targets; CHEMBL613820

DR   CLS; 300382/p661_Y-79

DR   Cosmic; 688120

DR   Cosmic; 808507

DR   Cosmic; 1071899

DR   Cosmic; 1176623

DR   DSMZ; ACC-246

DR   ECACC; 86093003

DR   Coriell; GM01232

DR   ICLC; HTL99029

DR   IGRhCellID; Y79

DR   NCBI_Iran; C201

DR   RCB; RCB0427

DR   RCB; RCB1645

RX   DOI=10.5795/jjscc.24.451;

RX   PubMed=1679230;

RX   PubMed=4135597;

RX   PubMed=18799932;

RX   PubMed=21697133;

CC   Doubling time: ~40 hours (DSMZ).

CC   Omics: Array-based CGH.

CC   Omics: Transcriptome analysis.

CC   Anecdotal: Named Y-79 because it was the result of the 79th attempt of a group at Yale to establish a retinoblastoma cell line.

CC   Discontinued: RCB; RCB0427; true.

ST   Source(s): ATCC; CLS; DSMZ; ECACC; ICLC; RCB

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 11,12

ST   D16S539: 13,14

ST   D18S51: 13,16

ST   D21S11: 30,32

ST   D3S1358: 15,16

ST   D5S818: 11,12 (ATCC; CLS; DSMZ; ECACC; RCB)

ST   D5S818: 11 (ICLC)

ST   D7S820: 8,9

ST   D8S1179: 13,16

ST   FGA: 22

ST   Penta D: 12

ST   Penta E: 13,18

ST   TH01: 6,9.3 (ATCC; CLS; ECACC; ICLC; RCB)

ST   TH01: 6,10 (DSMZ)

ST   TPOX: 8

ST   vWA: 15,18

DI   NCIt; C7541; Retinoblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Y-MESO-12

AC   CVCL_5178

DR   GEO; GSM552526

RX   PubMed=19380521;

RX   PubMed=22286761;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Y-MESO-14

AC   CVCL_5179

SY   Y-Meso-14

DR   GEO; GSM552527

RX   PubMed=19380521;

RX   PubMed=22286761;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Y-MESO-21

AC   CVCL_5180

DR   GEO; GSM552528

RX   PubMed=19380521;

RX   PubMed=22286761;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Y-MESO-22

AC   CVCL_5181

DR   GEO; GSM552529

RX   PubMed=19380521;

RX   PubMed=22286761;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Y-MESO-25

AC   CVCL_5182

DR   GEO; GSM552530

RX   PubMed=19380521;

RX   PubMed=22286761;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Y-MESO-26B

AC   CVCL_5183

DR   GEO; GSM552531

RX   PubMed=19380521;

RX   PubMed=22286761;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Y-MESO-27

AC   CVCL_5184

DR   GEO; GSM552533

RX   PubMed=19380521;

RX   PubMed=22286761;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Y-MESO-28

AC   CVCL_5185

DR   GEO; GSM552534

RX   PubMed=19380521;

RX   PubMed=22286761;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Y-MESO-29

AC   CVCL_5186

DR   GEO; GSM552535

RX   PubMed=19380521;

RX   PubMed=22286761;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Y-MESO-30

AC   CVCL_5187

DR   GEO; GSM552536

RX   PubMed=19380521;

RX   PubMed=22286761;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Y-MESO-32

AC   CVCL_M203

RX   PubMed=22286761;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Y-MESO-37

AC   CVCL_M204

RX   PubMed=22286761;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Y-MESO-43

AC   CVCL_M205

RX   PubMed=22286761;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Y-MESO-45

AC   CVCL_M206

RX   PubMed=22286761;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Y-MESO-8A

AC   CVCL_5188

RX   PubMed=16630136;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_5189 ! Y-MESO-8D

SX   Male

CA   Cancer cell line

//

ID   Y-MESO-8D

AC   CVCL_5189

DR   GEO; GSM552524

RX   PubMed=16630136;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_5188 ! Y-MESO-8A

SX   Male

CA   Cancer cell line

//

ID   Y-MESO-9

AC   CVCL_5190

DR   GEO; GSM552525

RX   PubMed=19380521;

RX   PubMed=22286761;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Y-ML-1B

AC   CVCL_4779

RX   PubMed=12377411;

WW   http://www.cells-talk.com/index.php/page/copelibrary?key=Y-ML-1B

DI   NCIt; C4450; Large cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Y.I.

AC   CVCL_E892

SY   YI

DR   dbMHC; 49086

DR   ECACC; 94061620

DR   IHW; IHW9352

DR   IMGT/HLA; 11583

WW   http://bioinformatics.hsanmartino.it/ecbr/cl352.html

CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   Y0

AC   CVCL_2783

SY   YO; YB2/3.0Ag30

DR   CLO; CLO_0009715

DR   CLDB; cl4804

DR   ECACC; 85110501

DR   NCBI_Iran; C133

RX   PubMed=22358559;

CC   Group: Hybridoma fusion partner cell line.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_8984 ! YB2/0

CA   Hybrid cell line

//

ID   Y1

AC   CVCL_0585

SY   Y-1; Y 1; Clone Y-1; Clone Y1; GM05384

DR   BTO; BTO:0000046

DR   CLO; CLO_0009701

DR   CLO; CLO_0024853

DR   CLO; CLO_0051608

DR   MCCL; MCC:0000491

DR   CLDB; cl4789

DR   CLDB; cl4791

DR   CLDB; cl4792

DR   CLDB; cl4793

DR   ATCC; CCL-79

DR   BCRC; 60363

DR   BCRJ; 0254

DR   CCRID; 3131C0001000300014

DR   ChEMBL-Cells; CHEMBL3307727

DR   ChEMBL-Targets; CHEMBL614872

DR   CLS; 400477/NA

DR   Coriell; GM05384

DR   ECACC; 85062807

DR   IZSLER; BS TCL 67

DR   JCRB; JCRB9056

DR   NCBI_Iran; C199

DR   RCB; RCB0533

RX   PubMed=423792;

RX   PubMed=5930699;

RX   PubMed=15541570;

CC   Discontinued: CLS; 400477; true.

CC   Breed/subspecies: LAF1.

OX   NCBI_TaxID=10090; ! Mus musculus

OI   CVCL_5F74 ! Y6

SX   Male

CA   Cancer cell line

//

ID   Y1-8BrcAMPr-1

AC   CVCL_5G24

SY   8BrcAMPr-1

RX   PubMed=200506;

RX   PubMed=215599;

CC   Selected for resistance to: ChEBI; CHEBI:64211; 8-bromo-3',5'-cyclic AMP (8-bromoadenosine 3',5'-cyclic monophosphate; 8-Br-cAMP).

CC   Breed/subspecies: LAF1.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_W154 ! Y1-BS1

SX   Male

CA   Cancer cell line

//

ID   Y1-BS1

AC   CVCL_W154

SY   Y1BS1

DR   BTO; BTO:0004236

RX   PubMed=423792;

RX   PubMed=2713387;

RX   PubMed=6270152;

CC   Breed/subspecies: LAF1.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0585 ! Y1

SX   Male

CA   Cancer cell line

//

ID   Y1-Cyc-101

AC   CVCL_5G15

SY   Cyc-101; Cyc 101

RX   PubMed=221910;

RX   PubMed=6270152;

CC   Selected for resistance to: ChEBI; CHEBI:64211; 8-bromo-3',5'-cyclic AMP (8-bromoadenosine 3',5'-cyclic monophosphate; 8-Br-cAMP).

CC   Breed/subspecies: LAF1.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_W154 ! Y1-BS1

SX   Male

CA   Cancer cell line

//

ID   Y1-Cyc-102

AC   CVCL_5G16

SY   Cyc-102; Cyc 102

RX   PubMed=221910;

RX   PubMed=6270152;

CC   Selected for resistance to: ChEBI; CHEBI:64211; 8-bromo-3',5'-cyclic AMP (8-bromoadenosine 3',5'-cyclic monophosphate; 8-Br-cAMP).

CC   Breed/subspecies: LAF1.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_W154 ! Y1-BS1

SX   Male

CA   Cancer cell line

//

ID   Y1-Cyc-103

AC   CVCL_5G17

SY   Cyc-103; Cyc 103

RX   PubMed=221910;

RX   PubMed=6270152;

CC   Selected for resistance to: ChEBI; CHEBI:64211; 8-bromo-3',5'-cyclic AMP (8-bromoadenosine 3',5'-cyclic monophosphate; 8-Br-cAMP).

CC   Breed/subspecies: LAF1.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_W154 ! Y1-BS1

SX   Male

CA   Cancer cell line

//

ID   Y1-Forsk-10r-1

AC   CVCL_5G18

SY   Forsk-10r-1

RX   PubMed=6538878;

CC   Selected for resistance to: ChEBI; CHEBI:42471; Forskolin.

CC   Breed/subspecies: LAF1.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_W154 ! Y1-BS1

SX   Male

CA   Cancer cell line

//

ID   Y1-Forsk-10r-6

AC   CVCL_5G19

SY   Forsk-10r-6; 10r6

RX   PubMed=6538878;

RX   PubMed=15541570;

CC   Selected for resistance to: ChEBI; CHEBI:42471; Forskolin.

CC   Breed/subspecies: LAF1.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_W154 ! Y1-BS1

SX   Male

CA   Cancer cell line

//

ID   Y1-Forsk-10r-9

AC   CVCL_5G20

SY   Forsk-10r-9; 10r9

RX   PubMed=6538878;

RX   PubMed=15541570;

CC   Selected for resistance to: ChEBI; CHEBI:42471; Forskolin.

CC   Breed/subspecies: LAF1.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_W154 ! Y1-BS1

SX   Male

CA   Cancer cell line

//

ID   Y1-HGPRT-

AC   CVCL_5G26

RX   PubMed=198663;

RX   PubMed=6270152;

CC   Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).

CC   Breed/subspecies: LAF1.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0585 ! Y1

SX   Male

CA   Cancer cell line

//

ID   Y1-Kin-2

AC   CVCL_5G21

SY   Kin-2; Kin 2

RX   PubMed=221910;

RX   PubMed=6270152;

RX   PubMed=8388994;

RX   PubMed=15541570;

CC   Selected for resistance to: ChEBI; CHEBI:64211; 8-bromo-3',5'-cyclic AMP (8-bromoadenosine 3',5'-cyclic monophosphate; 8-Br-cAMP).

CC   Breed/subspecies: LAF1.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_W154 ! Y1-BS1

SX   Male

CA   Cancer cell line

//

ID   Y1-Kin-7

AC   CVCL_5G22

SY   Kin-7; Kin 7

RX   PubMed=221910;

RX   PubMed=6270152;

RX   PubMed=8388994;

RX   PubMed=15541570;

CC   Selected for resistance to: ChEBI; CHEBI:64211; 8-bromo-3',5'-cyclic AMP (8-bromoadenosine 3',5'-cyclic monophosphate; 8-Br-cAMP).

CC   Breed/subspecies: LAF1.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_W154 ! Y1-BS1

SX   Male

CA   Cancer cell line

//

ID   Y1-Kin-8

AC   CVCL_5G23

SY   Kin-8; Kin 8

RX   PubMed=221910;

RX   PubMed=6270152;

RX   PubMed=8388994;

RX   PubMed=15541570;

CC   Selected for resistance to: ChEBI; CHEBI:64211; 8-bromo-3',5'-cyclic AMP (8-bromoadenosine 3',5'-cyclic monophosphate; 8-Br-cAMP).

CC   Breed/subspecies: LAF1.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_W154 ! Y1-BS1

SX   Male

CA   Cancer cell line

//

ID   Y13-238

AC   CVCL_8982

DR   CLO; CLO_0009702

DR   ATCC; CRL-1741

DR   ECACC; 89111411

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_4342 ! Y3-Ag 1.2.3

CA   Hybridoma

//

ID   Y13-259

AC   CVCL_8983

DR   CLO; CLO_0009703

DR   ATCC; CRL-1742

DR   ECACC; 89111412

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_4342 ! Y3-Ag 1.2.3

CA   Hybridoma

//

ID   Y16

AC   CVCL_5416

SY   Y-16

RX   PubMed=2265612;

WW   http://www.cells-talk.com/index.php/page/copelibrary?key=Y16

CC   Characteristics: IL5 dependent.

CC   Breed/subspecies: BALB/c.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Factor-dependent cell line

//

ID   Y3-Ag 1.2.3

AC   CVCL_4342

SY   Y3.AG.1.2.3; Y3-Ag1.2.3; Y3-Ag1,2,3; Y3Ag1.2.3; 210RCY3-Ag1.2.3; Y3; Y3M

DR   CLO; CLO_0009706

DR   CLO; CLO_0009707

DR   CLDB; cl4794

DR   CLDB; cl4795

DR   ATCC; CRL-1631

DR   CCRID; 3131C0001001200008

DR   ECACC; 85110502

DR   JCRB; JCRB9091

DR   TKG; TKG 0283

RX   PubMed=310519;

RX   PubMed=22358559;

CC   Group: Hybridoma fusion partner cell line.

CC   Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.

CC   Breed/subspecies: LOU/C.

DI   NCIt; C125416; Rat plasma cell myeloma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

CA   Cancer cell line

//

ID   Y6

AC   CVCL_5F74

SY   Y-6

RX   PubMed=4311571;

RX   PubMed=6270152;

RX   PubMed=7588376;

RX   PubMed=15541570;

CC   Breed/subspecies: LAF1.

OX   NCBI_TaxID=10090; ! Mus musculus

OI   CVCL_0585 ! Y1

SX   Male

CA   Cancer cell line

//

ID   Y8-10C2

AC   CVCL_2Z37

SY   Sa11; WC00004

DR   CLO; CLO_0013430

DR   BioSamples; SAME17761

DR   Coriell; WC00004

RX   PubMed=9712021;

CC   Discontinued: Coriell; WC00004; probable.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3411 ! P3X63Ag8

CA   Hybridoma

//

ID   Y9-iPSC

AC   CVCL_DD56

SY   Y09-iPSC

RX   PubMed=25843045;

RX   PubMed=27191603;

ST   Source(s): PubMed=27191603

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 12

ST   D16S539: 11

ST   D21S11: 28

ST   D5S818: 11,13

ST   D7S820: 9,10

ST   TH01: 9,9.3

ST   TPOX: 8,11

ST   vWA: 16,17

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_DD55 ! ND34791

SX   Female

CA   Induced pluripotent stem cell

//

ID   YAA

AC   CVCL_8466

DR   BioSample; SAMN03151986

RX   PubMed=9067707;

RX   PubMed=12592342;

RX   PubMed=20143388;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a U-937 derivative (PubMed=12592342, PubMed=20143388).

DI   NCIt; C8263; Adult acute monocytic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0007 ! U-937

SX   Male

CA   Cancer cell line

//

ID   YAC-1

AC   CVCL_2244

SY   Yac-1

DR   CLO; CLO_0009710

DR   CLO; CLO_0050173

DR   CLO; CLO_0050187

DR   CLDB; cl4800

DR   CLDB; cl4801

DR   CLDB; cl4802

DR   CLDB; cl4803

DR   ATCC; TIB-160

DR   BCRC; 60147

DR   BCRJ; 0255

DR   CCRID; 3111C0001CCC000089

DR   CCRID; 3131C0001000800028

DR   CCRID; 3142C0001000000001

DR   ChEMBL-Cells; CHEMBL3308419

DR   ChEMBL-Targets; CHEMBL612814

DR   CLS; 400383/p711_Yac-1

DR   DSMZ; ACC-96

DR   ECACC; 86022801

DR   IZSLER; BS TCL 243

DR   KCB; KCB 93031YJ

DR   KCLB; 40160

DR   NCBI_Iran; C552

DR   RCB; RCB1165

DR   RCB; RCB2799

DR   TKG; TKG 0387

WW   http://www.cells-talk.com/index.php/page/copelibrary?key=YAC-1

CC   Doubling time: ~20 hours (DSMZ).

CC   Breed/subspecies: A/Sn.

DI   NCIt; C21602; Mouse lymphoma

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   YADK-04

AC   CVCL_6F17

RX   Patent=RU2335537;

OX   NCBI_TaxID=9925; ! Capra hircus

HI   CVCL_M729 ! CG-91

SX   Female

CA   Spontaneously immortalized cell line

//

ID   YaFuSS

AC   CVCL_L809

DR   Cosmic; 1319810

RX   PubMed=15814652;

DI   NCIt; C3400; Synovial sarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Yak-BL

AC   CVCL_7212

SY   Yak

RX   PubMed=9882297;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   YAM-P

AC   CVCL_F445

DR   CLO; CLO_0051139

DR   RCB; HSC0006

RX   PubMed=21383383;

CC   Part of: Sonoda-Tajima cell collection.

CC   Population: Venezuela.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   YAM-RTK1

AC   CVCL_8014

SY   YAM-RTK-1

CC   From: Sugita K.; Yamanashi Medical University; Kofu; Japan.

DI   NCIt; C8715; Rhabdoid tumor of the kidney

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Yamada

AC   CVCL_FA16

RX   PubMed=21908323;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Misidentified. Originally thought to be an osteosarcoma cell line of dog origin but found to be from mouse (PubMed=21908323).

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Sex undetermined

CA   Undefined cell line type

//

ID   Yamane

AC   CVCL_DN30

DR   GEO; GSM1974801

RX   PubMed=27197945;

CC   Part of: FACC canine tumor cell line panel.

CC   Omics: Transcriptome analysis.

DI   NCIt; C120045; Canine osteosarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

CA   Cancer cell line

//

ID   Yamato-SS

AC   CVCL_6C44

DR   RCB; RCB3577

RX   PubMed=20518020;

DI   NCIt; C3400; Synovial sarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YAMB-1

AC   CVCL_A292

RX   PubMed=20519628;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   YAMB-3

AC   CVCL_A293

RX   PubMed=20519628;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   YAMB-4

AC   CVCL_A294

RX   PubMed=20519628;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   YAMB-9

AC   CVCL_A295

RX   PubMed=20519628;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   YAMC

AC   CVCL_6E40

SY   Young Adult Mouse Colon

RX   PubMed=7678459;

WW   https://www.abmgood.com/Immortalized-(Conditionally)-Mouse-Colonic-Epithelial-Cells-(YAMC)-T0567.html

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Conditionally immortalized cell line

//

ID   YAML 501.4

AC   CVCL_J777

DR   ECACC; 11060812

CC   Monoclonal antibody target: UniProtKB; P08575; Human PTPRC/CD45.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_4342 ! Y3-Ag 1.2.3

CA   Hybridoma

//

ID   YAML 555.6

AC   CVCL_J778

DR   ECACC; 11060816

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_4342 ! Y3-Ag 1.2.3

CA   Hybridoma

//

ID   YAMN-73

AC   CVCL_8015

SY   YAMN73

RX   PubMed=10360377;

RX   PubMed=10942233;

RX   PubMed=12506034;

RX   PubMed=20519628;

DI   NCIt; C68659; Childhood B acute lymphoblastic leukemia with t(9;22)(q34;q11.2) BCR-ABL1

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   YAMN-74

AC   CVCL_W272

SY   YAMN74

RX   PubMed=10360377;

DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   YAMN-90

AC   CVCL_A079

SY   YAMN90

RX   PubMed=20519628;

DI   NCIt; C80347; B acute lymphoblastic leukemia with t(1;19)(q23;p13.3) E2A-PBX1 (TCF3-PBX1)

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   YAMN-91

AC   CVCL_8016

SY   YAMN91

RX   PubMed=12506034;

RX   PubMed=20519628;

DI   NCIt; C68659; Childhood B acute lymphoblastic leukemia with t(9;22)(q34;q11.2) BCR-ABL1

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   YAMN-92

AC   CVCL_A080

SY   YAMN92

RX   PubMed=20519628;

DI   NCIt; C80347; B acute lymphoblastic leukemia with t(1;19)(q23;p13.3) E2A-PBX1 (TCF3-PBX1)

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   YAMRT

AC   CVCL_EJ26

DR   Cosmic; 2144787

RX   PubMed=24418192;

DI   NCIt; C8715; Rhabdoid tumor of the kidney

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   YAMT-12

AC   CVCL_A081

RX   PubMed=20519628;

CC   Miscellaneous: Only mentioned as a T-ALL cell line in PubMed=20519628.

DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   YAN3102

AC   CVCL_F446

DR   CLO; CLO_0051166

DR   RCB; HSC0128

RX   PubMed=21383383;

CC   Part of: Sonoda-Tajima cell collection.

CC   Population: Venezuela.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   YAN3103

AC   CVCL_F447

DR   CLO; CLO_0051164

DR   RCB; HSC0124

RX   PubMed=21383383;

CC   Part of: Sonoda-Tajima cell collection.

CC   Population: Venezuela.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   YAN3119

AC   CVCL_F448

DR   CLO; CLO_0051052

DR   RCB; HSC0010

RX   PubMed=21383383;

CC   Part of: Sonoda-Tajima cell collection.

CC   Population: Venezuela.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   YAN3136

AC   CVCL_F449

DR   CLO; CLO_0051175

DR   RCB; HSC0136

RX   PubMed=21383383;

CC   Part of: Sonoda-Tajima cell collection.

CC   Population: Venezuela.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   YAN3140

AC   CVCL_F450

DR   CLO; CLO_0051053

DR   RCB; HSC0011

RX   PubMed=21383383;

CC   Part of: Sonoda-Tajima cell collection.

CC   Population: Venezuela.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   YAN3141

AC   CVCL_F451

DR   CLO; CLO_0051060

DR   RCB; HSC0022

RX   PubMed=21383383;

CC   Part of: Sonoda-Tajima cell collection.

CC   Population: Venezuela.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   YAN3142

AC   CVCL_F452

DR   CLO; CLO_0051051

DR   RCB; HSC0008

RX   PubMed=21383383;

CC   Part of: Sonoda-Tajima cell collection.

CC   Population: Venezuela.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   YAN3143

AC   CVCL_F453

DR   CLO; CLO_0051054

DR   RCB; HSC0012

RX   PubMed=21383383;

CC   Part of: Sonoda-Tajima cell collection.

CC   Population: Venezuela.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   YAN3150

AC   CVCL_F454

DR   CLO; CLO_0051055

DR   RCB; HSC0014

RX   PubMed=21383383;

CC   Part of: Sonoda-Tajima cell collection.

CC   Population: Venezuela.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   YAN3152

AC   CVCL_F455

DR   CLO; CLO_0051087

DR   RCB; HSC0057

RX   PubMed=21383383;

CC   Part of: Sonoda-Tajima cell collection.

CC   Population: Venezuela.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   YAN3154

AC   CVCL_F456

DR   CLO; CLO_0051063

DR   RCB; HSC0025

RX   PubMed=21383383;

CC   Part of: Sonoda-Tajima cell collection.

CC   Population: Venezuela.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   YAN3161

AC   CVCL_F457

DR   CLO; CLO_0051057

DR   RCB; HSC0018

RX   PubMed=21383383;

CC   Part of: Sonoda-Tajima cell collection.

CC   Population: Venezuela.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   YAN3191

AC   CVCL_F458

DR   CLO; CLO_0051144

DR   RCB; HSC0019

RX   PubMed=21383383;

CC   Part of: Sonoda-Tajima cell collection.

CC   Population: Venezuela.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   YAN3206

AC   CVCL_F459

DR   CLO; CLO_0051093

DR   RCB; HSC0065

RX   PubMed=21383383;

CC   Part of: Sonoda-Tajima cell collection.

CC   Population: Venezuela.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   YAN3241

AC   CVCL_F460

DR   CLO; CLO_0051120

DR   RCB; HSC0099

RX   PubMed=21383383;

CC   Part of: Sonoda-Tajima cell collection.

CC   Population: Venezuela.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   YAN3242

AC   CVCL_F461

DR   CLO; CLO_0051067

DR   RCB; HSC0032

RX   PubMed=21383383;

CC   Part of: Sonoda-Tajima cell collection.

CC   Population: Venezuela.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   YAN3244

AC   CVCL_F462

DR   CLO; CLO_0051116

DR   RCB; HSC0093

RX   PubMed=21383383;

CC   Part of: Sonoda-Tajima cell collection.

CC   Population: Venezuela.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   YAN3245

AC   CVCL_F463

DR   CLO; CLO_0051056

DR   RCB; HSC0015

RX   PubMed=21383383;

CC   Part of: Sonoda-Tajima cell collection.

CC   Population: Venezuela.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   YAN3252

AC   CVCL_F464

DR   CLO; CLO_0051058

DR   RCB; HSC0020

RX   PubMed=21383383;

CC   Part of: Sonoda-Tajima cell collection.

CC   Population: Venezuela.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   YAN3255

AC   CVCL_F465

DR   CLO; CLO_0051165

DR   RCB; HSC0129

RX   PubMed=21383383;

CC   Part of: Sonoda-Tajima cell collection.

CC   Population: Venezuela.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   YAN3259

AC   CVCL_F466

DR   CLO; CLO_0051126

DR   RCB; HSC0104

RX   PubMed=21383383;

CC   Part of: Sonoda-Tajima cell collection.

CC   Population: Venezuela.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   YAN3260

AC   CVCL_F467

DR   CLO; CLO_0051158

DR   RCB; HSC0121

RX   PubMed=21383383;

CC   Part of: Sonoda-Tajima cell collection.

CC   Population: Venezuela.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   YAN3261

AC   CVCL_F468

DR   CLO; CLO_0051061

DR   RCB; HSC0023

RX   PubMed=21383383;

CC   Part of: Sonoda-Tajima cell collection.

CC   Population: Venezuela.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   YAN3264

AC   CVCL_F469

DR   CLO; CLO_0051062

DR   RCB; HSC0024

RX   PubMed=21383383;

CC   Part of: Sonoda-Tajima cell collection.

CC   Population: Venezuela.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   YAN3265

AC   CVCL_F470

DR   CLO; CLO_0051147

DR   RCB; HSC0030

RX   PubMed=21383383;

CC   Part of: Sonoda-Tajima cell collection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   YAN3268

AC   CVCL_F471

DR   CLO; CLO_0051059

DR   RCB; HSC0021

RX   PubMed=21383383;

CC   Part of: Sonoda-Tajima cell collection.

CC   Population: Venezuela.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   YAN3269

AC   CVCL_F472

DR   CLO; CLO_0051122

DR   RCB; HSC0098

RX   PubMed=21383383;

CC   Part of: Sonoda-Tajima cell collection.

CC   Population: Venezuela.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   YAN3270

AC   CVCL_F473

DR   CLO; CLO_0051125

DR   RCB; HSC0103

RX   PubMed=21383383;

CC   Part of: Sonoda-Tajima cell collection.

CC   Population: Venezuela.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   YAN3273

AC   CVCL_F474

DR   CLO; CLO_0051128

DR   RCB; HSC0110

RX   PubMed=21383383;

CC   Part of: Sonoda-Tajima cell collection.

CC   Population: Venezuela.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   YAN3274

AC   CVCL_F475

DR   CLO; CLO_0051121

DR   RCB; HSC0100

RX   PubMed=21383383;

CC   Part of: Sonoda-Tajima cell collection.

CC   Population: Venezuela.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   YAN3275

AC   CVCL_F476

DR   CLO; CLO_0051117

DR   RCB; HSC0094

RX   PubMed=21383383;

CC   Part of: Sonoda-Tajima cell collection.

CC   Population: Venezuela.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   YAN3280

AC   CVCL_F477

DR   CLO; CLO_0051065

DR   RCB; HSC0029

RX   PubMed=21383383;

CC   Part of: Sonoda-Tajima cell collection.

CC   Population: Venezuela.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   YAN3285

AC   CVCL_F478

DR   CLO; CLO_0051090

DR   RCB; HSC0060

RX   PubMed=21383383;

CC   Part of: Sonoda-Tajima cell collection.

CC   Population: Venezuela.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   YAN3286

AC   CVCL_F479

DR   CLO; CLO_0051064

DR   RCB; HSC0026

RX   PubMed=21383383;

CC   Part of: Sonoda-Tajima cell collection.

CC   Population: Venezuela.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   YAN3301

AC   CVCL_F480

DR   CLO; CLO_0051050

DR   RCB; HSC0005

RX   PubMed=21383383;

CC   Part of: Sonoda-Tajima cell collection.

CC   Population: Venezuela.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   YAP

AC   CVCL_8467

DR   BioSample; SAMN03151987

RX   PubMed=8738564;

RX   PubMed=12592342;

RX   PubMed=20143388;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a U-937 derivative (PubMed=12592342, PubMed=20143388).

DI   NCIt; C8263; Adult acute monocytic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0007 ! U-937

SX   Male

CA   Cancer cell line

//

ID   YAPC

AC   CVCL_1794

DR   CLO; CLO_0009711

DR   EFO; EFO_0006778

DR   BioSample; SAMN03472904

DR   BioSample; SAMN03473329

DR   CCLE; YAPC_PANCREAS

DR   ChEMBL-Cells; CHEMBL3307253

DR   ChEMBL-Targets; CHEMBL612815

DR   Cosmic; 909904

DR   Cosmic; 2046537

DR   Cosmic; 2434108

DR   Cosmic-CLP; 909904

DR   DSMZ; ACC-382

DR   GDSC; 909904

DR   GEO; GSM887742

DR   GEO; GSM888837

DR   GEO; GSM1670584

DR   IGRhCellID; YAPC

RX   PubMed=22460905;

RX   PubMed=25167228;

RX   PubMed=25485619;

RX   PubMed=27397505;

WW   http://www.cells-talk.com/index.php/page/copelibrary?key=YAPC

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Doubling time: ~48 hours (DSMZ).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Misspelling: 'YPAC' in EFO EFO_0002393.

ST   Source(s): Cosmic-CLP; DSMZ; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 8,12

ST   D16S539: 9

ST   D18S51: 17

ST   D21S11: 31,31.2

ST   D3S1358: 17

ST   D5S818: 11,13

ST   D7S820: 9,11

ST   D8S1179: 13,15

ST   FGA: 21,22

ST   Penta D: 10,13

ST   Penta E: 5,19.4

ST   TH01: 7,9

ST   TPOX: 8

ST   vWA: 16,17 (Cosmic-CLP; DSMZ)

ST   vWA: 17 (PubMed=25877200)

DI   NCIt; C3850; Pancreatic carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YAR

AC   CVCL_2192

DR   dbMHC; 49083

DR   ECACC; 95042721

DR   IHW; IHW9026

DR   IMGT/HLA; 11587

RX   PubMed=8307784;

WW   http://bioinformatics.hsanmartino.it/ecbr/cl26.html

CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   YB2/0

AC   CVCL_8984

SY   YB2/O; YB2/3HL.P2.G11.16Ag.20; YB2/3.0 Ag20; YB2/3.0Ag20

DR   CLO; CLO_0009712

DR   ATCC; CRL-1662

RX   PubMed=6811596;

CC   Group: Hybridoma fusion partner cell line.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_4342 ! Y3-Ag 1.2.3

CA   Hybrid cell line

//

ID   YBM 15.1.6

AC   CVCL_G181

SY   YBM15.1.6

DR   ECACC; 89040602

RX   PubMed=3330997;

CC   Monoclonal antibody target: UniProtKB; P05555; Mouse Itgam/Cd11b.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_4342 ! Y3-Ag 1.2.3

CA   Hybridoma

//

ID   YBM 29.2.1

AC   CVCL_G182

SY   YBM29.2.1

DR   ECACC; 11060806

CC   Monoclonal antibody target: UniProtKB; P01831; Mouse Thy1/Cd90.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_4342 ! Y3-Ag 1.2.3

CA   Hybridoma

//

ID   YBM 5.10.4

AC   CVCL_G183

SY   YBM5.10.4

DR   ECACC; 11060805

RX   PubMed=3330997;

CC   Monoclonal antibody target: UniProtKB; P24807; Mouse Cd24.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_4342 ! Y3-Ag 1.2.3

CA   Hybridoma

//

ID   YBM 6.1.10

AC   CVCL_G184

SY   YBM6.1.10

DR   ECACC; 89040601

RX   PubMed=3330997;

CC   Monoclonal antibody target: UniProtKB; P05555; Mouse Itgam/Cd11b.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_4342 ! Y3-Ag 1.2.3

CA   Hybridoma

//

ID   YCC-1

AC   CVCL_9646

SY   YCC1

DR   EFO; EFO_0002876

DR   Cosmic; 1482082

DR   GEO; GSM562409

DR   GEO; GSM1237682

DR   GEO; GSM1237707

RX   PubMed=10402490;

RX   PubMed=18804159;

CC   From: Yonsei Cancer Center; Seoul; South Korea.

CC   Omics: Transcriptome analysis.

DI   NCIt; C4004; Gastric adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YCC-10

AC   CVCL_9647

SY   YCC10

DR   EFO; EFO_0002877

DR   GEO; GSM562399

RX   PubMed=18804159;

CC   From: Yonsei Cancer Center; Seoul; South Korea.

CC   Omics: Transcriptome analysis.

DI   NCIt; C4004; Gastric adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YCC-11

AC   CVCL_9648

SY   YCC11

DR   EFO; EFO_0002878

DR   Cosmic; 1482084

DR   GEO; GSM562412

DR   GEO; GSM1237683

DR   GEO; GSM1237708

RX   PubMed=18804159;

CC   From: Yonsei Cancer Center; Seoul; South Korea.

CC   Omics: Transcriptome analysis.

DI   NCIt; C4004; Gastric adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YCC-16

AC   CVCL_9649

SY   YCC16

DR   EFO; EFO_0002879

DR   GEO; GSM562413

DR   GEO; GSM1237684

DR   GEO; GSM1237709

RX   PubMed=18804159;

RX   PubMed=18922971;

CC   From: Yonsei Cancer Center; Seoul; South Korea.

CC   Omics: Transcriptome analysis.

DI   NCIt; C4004; Gastric adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   YCC-17

AC   CVCL_X027

SY   YCC17

CC   From: Yonsei Cancer Center; Seoul; South Korea.

DI   NCIt; C4004; Gastric adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YCC-18

AC   CVCL_9650

SY   YCC18

CC   From: Yonsei Cancer Center; Seoul; South Korea.

DI   NCIt; C4004; Gastric adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YCC-19

AC   CVCL_9651

SY   YCC19

CC   From: Yonsei Cancer Center; Seoul; South Korea.

DI   NCIt; C4004; Gastric adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YCC-2

AC   CVCL_9652

SY   YCC2

DR   GEO; GSM562414

DR   GEO; GSM1237685

DR   GEO; GSM1237710

RX   PubMed=10402490;

RX   PubMed=18804159;

RX   PubMed=18922971;

CC   From: Yonsei Cancer Center; Seoul; South Korea.

CC   Omics: Transcriptome analysis.

DI   NCIt; C4004; Gastric adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YCC-20

AC   CVCL_9653

SY   YCC20

CC   From: Yonsei Cancer Center; Seoul; South Korea.

DI   NCIt; C4004; Gastric adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   YCC-21

AC   CVCL_9654

SY   YCC21

CC   From: Yonsei Cancer Center; Seoul; South Korea.

DI   NCIt; C4004; Gastric adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   YCC-22

AC   CVCL_9655

SY   YCC22

CC   From: Yonsei Cancer Center; Seoul; South Korea.

DI   NCIt; C4004; Gastric adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YCC-23

AC   CVCL_9656

SY   YCC23

CC   From: Yonsei Cancer Center; Seoul; South Korea.

DI   NCIt; C4004; Gastric adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   YCC-3

AC   CVCL_9657

SY   YCC3

DR   EFO; EFO_0002880

DR   Cosmic; 1482083

DR   GEO; GSM562415

DR   GEO; GSM1237686

DR   GEO; GSM1237711

RX   PubMed=10402490;

RX   PubMed=18804159;

CC   From: Yonsei Cancer Center; Seoul; South Korea.

CC   Omics: Transcriptome analysis.

DI   NCIt; C4004; Gastric adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YCC-3/R

AC   CVCL_9658

RX   PubMed=20661724;

CC   Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).

DI   NCIt; C4004; Gastric adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_9657 ! YCC-3

SX   Male

CA   Cancer cell line

//

ID   YCC-3/TP

AC   CVCL_9659

RX   PubMed=18922971;

CC   Transfected with: HGNC; 3148; TYMP.

DI   NCIt; C4004; Gastric adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_9657 ! YCC-3

SX   Male

CA   Cancer cell line

//

ID   YCC-4

AC   CVCL_9660

SY   YCC4

CC   From: Yonsei Cancer Center; Seoul; South Korea.

DI   NCIt; C4004; Gastric adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   YCC-5

AC   CVCL_9661

SY   YCC5

CC   From: Yonsei Cancer Center; Seoul; South Korea.

DI   NCIt; C4004; Gastric adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   YCC-6

AC   CVCL_9662

SY   YCC6

DR   EFO; EFO_0002881

DR   GEO; GSM562410

DR   GEO; GSM1237687

DR   GEO; GSM1237712

RX   PubMed=18804159;

RX   PubMed=18922971;

CC   From: Yonsei Cancer Center; Seoul; South Korea.

CC   Omics: Transcriptome analysis.

DI   NCIt; C4004; Gastric adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   YCC-7

AC   CVCL_9663

SY   YCC7

DR   EFO; EFO_0002882

DR   GEO; GSM562398

DR   GEO; GSM1237688

DR   GEO; GSM1237713

RX   PubMed=10402490;

RX   PubMed=18804159;

CC   From: Yonsei Cancer Center; Seoul; South Korea.

CC   Omics: Transcriptome analysis.

DI   NCIt; C4004; Gastric adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YCC-9

AC   CVCL_9664

SY   YCC9

DR   GEO; GSM562411

DR   GEO; GSM1237689

DR   GEO; GSM1237714

RX   PubMed=18922971;

CC   From: Yonsei Cancer Center; Seoul; South Korea.

DI   NCIt; C4004; Gastric adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YCCEL1

AC   CVCL_L440

RX   PubMed=23175241;

DI   NCIt; C4911; Gastric carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YCR

AC   CVCL_BT07

SY   Yellow-Checked Rat cell line

DR   CCRID; 3153C0001000000023

DR   KCB; KCB 88001

OX   NCBI_TaxID=69074; ! Rattus flavipectus

CA   Undefined cell line type

//

ID   YCR-1

AC   CVCL_A397

DR   Cosmic; 849377

RX   PubMed=3528602;

RX   PubMed=11146448;

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   YCU-H891

AC   CVCL_8017

DR   Cosmic; 1136975

DR   Cosmic; 1556186

RX   PubMed=18097577;

RX   PubMed=26780976;

RX   PubMed=26781072;

CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=26780976, PubMed=26781072). Originally thought to originate from an hypopharyngeal squamous cell carcinoma.

CC   From: Tsukuda M.; Yokohama City University; Yokohama; Japan.

CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).

DI   NCIt; C4029; Cervical adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0030 ! HeLa

SX   Female

CA   Cancer cell line

//

ID   YCU-L891

AC   CVCL_8018

DR   Cosmic; 1136977

DR   Cosmic; 1556187

RX   PubMed=18097577;

RX   PubMed=26780976;

RX   PubMed=26781072;

CC   Problematic cell line: Contaminated. YCU-L891 and YCU-T891 have been shown to be identical (PubMed=26780976, PubMed=26781072).

CC   From: Tsukuda M.; Yokohama City University; Yokohama; Japan.

DI   NCIt; C4044; Laryngeal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_8023 ! YCU-T891

CA   Cancer cell line

//

ID   YCU-M862

AC   CVCL_8019

DR   Cosmic; 1136972

DR   Cosmic; 1556182

RX   PubMed=18097577;

CC   From: Tsukuda M.; Yokohama City University; Yokohama; Japan.

DI   NCIt; C8181; Oropharyngeal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   YCU-M911

AC   CVCL_8020

DR   Cosmic; 1136974

DR   Cosmic; 1556197

RX   PubMed=18097577;

CC   From: Tsukuda M.; Yokohama City University; Yokohama; Japan.

DI   NCIt; C8181; Oropharyngeal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   YCU-MS861

AC   CVCL_8021

DR   Cosmic; 1136970

DR   Cosmic; 1556183

RX   PubMed=18097577;

CC   From: Tsukuda M.; Yokohama City University; Yokohama; Japan.

DI   NCIt; C6064; Maxillary sinus squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   YCU-OR891

AC   CVCL_8022

DR   Cosmic; 1136962

DR   Cosmic; 1556189

RX   PubMed=18097577;

CC   From: Tsukuda M.; Yokohama City University; Yokohama; Japan.

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   YCU-T891

AC   CVCL_8023

DR   Cosmic; 1136968

DR   Cosmic; 1556188

RX   PubMed=18097577;

RX   PubMed=26780976;

RX   PubMed=26781072;

CC   Problematic cell line: Contaminated. YCU-L891 and YCU-T891 have been shown to be identical (PubMed=26780976, PubMed=26781072).

CC   From: Tsukuda M.; Yokohama City University; Yokohama; Japan.

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_8018 ! YCU-L891

CA   Cancer cell line

//

ID   YCU-T892

AC   CVCL_8024

DR   Cosmic; 1136969

DR   Cosmic; 1556190

RX   PubMed=18097577;

CC   From: Tsukuda M.; Yokohama City University; Yokohama; Japan.

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   YCUB-2

AC   CVCL_A082

SY   YCUB2

RX   PubMed=11417493;

RX   PubMed=19157546;

DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YCUB-4

AC   CVCL_A083

RX   PubMed=19157546;

DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_A084 ! YCUB-4R

SX   Male

CA   Cancer cell line

//

ID   YCUB-4R

AC   CVCL_A084

RX   PubMed=19157546;

DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_A083 ! YCUB-4

SX   Male

CA   Cancer cell line

//

ID   YCUB-5

AC   CVCL_A085

RX   PubMed=19157546;

DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_A086 ! YCUB-5R

SX   Male

CA   Cancer cell line

//

ID   YCUB-5R

AC   CVCL_A086

RX   PubMed=19157546;

DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_A085 ! YCUB-5

SX   Male

CA   Cancer cell line

//

ID   YCUB-6

AC   CVCL_A087

RX   PubMed=19157546;

DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YCUS-5

AC   CVCL_N853

RX   PubMed=10398195;

RX   PubMed=16557275;

DI   NCIt; C3714; Epithelioid sarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   YD-10B

AC   CVCL_8929

SY   YD10B

DR   CCLE; YD10B_UPPER_AERODIGESTIVE_TRACT

DR   GEO; GSM887743

DR   GEO; GSM888838

DR   KCLB; 60503

RX   PubMed=16264262;

RX   PubMed=17404023;

RX   PubMed=22460905;

RX   PubMed=23708675;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): KCLB; PubMed=16264262

ST   Amelogenin: X,Y

ST   CSF1PO: 12,13

ST   D13S317: 8,9 (KCLB)

ST   D13S317: 9 (PubMed=16264262)

ST   D16S539: 10,11

ST   D18S51: 14

ST   D21S11: 30,32

ST   D3S1358: 17

ST   D5S818: 11,13

ST   D7S820: 11

ST   D8S1179: 11

ST   DXS101: 22

ST   FGA: 23

ST   Penta D: 8,9

ST   Penta E: 5,8

ST   TH01: 6,9

ST   TPOX: 8

ST   vWA: 18,19,20 (PubMed=16264262)

ST   vWA: 18,19 (KCLB)

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YD-15

AC   CVCL_8930

SY   YD15

DR   CCLE; YD15_SALIVARY_GLAND

DR   GEO; GSM887744

DR   GEO; GSM888839

DR   KCLB; 60504

RX   PubMed=16264262;

RX   PubMed=21496182;

RX   PubMed=22460905;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): KCLB; PubMed=16264262

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 11,12

ST   D16S539: 9,12

ST   D18S51: 14

ST   D21S11: 30,31.2

ST   D3S1358: 15

ST   D5S818: 12

ST   D7S820: 12,13

ST   D8S1179: 15

ST   FGA: 23

ST   Penta D: 9

ST   Penta E: 14,19

ST   TH01: 6,9

ST   TPOX: 9

ST   vWA: 15

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_L078 ! YD-15M

SX   Male

CA   Cancer cell line

//

ID   YD-15M

AC   CVCL_L078

SY   YD15M

DR   KCLB; 60505

RX   PubMed=16264262;

CC   Derived from metastatic site: Lymph node.

ST   Source(s): KCLB; PubMed=16264262

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 11,12

ST   D16S539: 9,12

ST   D18S51: 14

ST   D21S11: 30,31.2

ST   D3S1358: 15

ST   D5S818: 12

ST   D7S820: 12,13

ST   D8S1179: 15

ST   FGA: 23

ST   Penta D: 9

ST   Penta E: 14,19

ST   TH01: 6,9

ST   TPOX: 9

ST   vWA: 15

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_8930 ! YD-15

SX   Male

CA   Cancer cell line

//

ID   YD-17

AC   CVCL_L081

SY   YD17

RX   PubMed=16264262;

ST   Source(s): PubMed=16264262

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 8

ST   D16S539: 9,12

ST   D18S51: 14,16

ST   D21S11: 28,31

ST   D3S1358: 14,15

ST   D5S818: 12

ST   D7S820: 10,11

ST   D8S1179: 13,15

ST   FGA: 24

ST   Penta D: 9,13

ST   Penta E: 5,12

ST   TH01: 9.3

ST   TPOX: 8,11

ST   vWA: 15,16

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_L082 ! YD-17M

SX   Male

CA   Cancer cell line

//

ID   YD-17M

AC   CVCL_L082

SY   YD17M

RX   PubMed=16264262;

CC   Derived from metastatic site: Lymph node.

ST   Source(s): PubMed=16264262

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 8

ST   D16S539: 9,12

ST   D18S51: 14,16

ST   D21S11: 28,31

ST   D3S1358: 14,15

ST   D5S818: 12

ST   D7S820: 10,11

ST   D8S1179: 13,15

ST   FGA: 24

ST   Penta D: 9,13

ST   Penta E: 5,12

ST   TH01: 9.3

ST   TPOX: 8,11

ST   vWA: 15,16

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_L081 ! YD-17

SX   Male

CA   Cancer cell line

//

ID   YD-38

AC   CVCL_L083

SY   YD38

DR   CCLE; YD38_UPPER_AERODIGESTIVE_TRACT

DR   GEO; GSM887745

DR   GEO; GSM888840

DR   KCLB; 60508

RX   PubMed=16264262;

RX   PubMed=22460905;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): KCLB; PubMed=16264262

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 8

ST   D16S539: 12,13

ST   D18S51: 14

ST   D21S11: 30,31

ST   D3S1358: 16

ST   D5S818: 14

ST   D7S820: 10,11

ST   D8S1179: 14

ST   FGA: 22,25

ST   Penta D: 8,12

ST   Penta E: 12,19

ST   TH01: 6,9

ST   TPOX: 8

ST   vWA: 14,17

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YD-39

AC   CVCL_B482

RX   PubMed=22621906;

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YD-8

AC   CVCL_L079

SY   YD8

DR   CCLE; YD8_UPPER_AERODIGESTIVE_TRACT

DR   GEO; GSM887746

DR   GEO; GSM888841

DR   KCLB; 60501

RX   PubMed=16264262;

RX   PubMed=22460905;

RX   PubMed=23708675;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): KCLB; PubMed=16264262

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 8,10

ST   D16S539: 9,11

ST   D18S51: 15,16

ST   D21S11: 29,30

ST   D3S1358: 15.2 (KLCB)

ST   D3S1358: 15,16 (PubMed=16264262)

ST   D5S818: 12

ST   D7S820: 10,13

ST   D8S1179: 13,16

ST   FGA: 24

ST   Penta D: 13

ST   Penta E: 12,15

ST   TH01: 7,9

ST   TPOX: 8,11

ST   vWA: 14,17

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   YD-9

AC   CVCL_L080

SY   YD9

DR   KCLB; 60502

RX   PubMed=16264262;

ST   Source(s): KCLB; PubMed=16264262

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 13

ST   D16S539: 12,13

ST   D18S51: 13

ST   D21S11: 30

ST   D3S1358: 15,16

ST   D5S818: 10,12

ST   D7S820: 11,12

ST   D8S1179: 11,13

ST   FGA: 25

ST   Penta D: 9

ST   Penta E: 15,17

ST   TH01: 6

ST   TPOX: 8,9

ST   vWA: 14,19

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YDOV-157

AC   CVCL_W954

RX   PubMed=18682896;

CC   Omics: Proteome analysis by 2D-DE.

CC   Omics: Transcriptome analysis.

DI   NCIt; C7550; Ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   YEL-13

AC   CVCL_R989

SY   Yamame Embryonal Liver-13

RX   CelloPub=CLPUB00130;

RX   DOI=10.2331/suisan.54.1881;

CC   Group: Fish cell line.

OX   NCBI_TaxID=8020; ! Oncorhynchus masou

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   YEO,AM

AC   CVCL_E893

SY   YEO, AM

DR   dbMHC; 49084

DR   IHW; IHW9137

DR   IMGT/HLA; 11680

RX   PubMed=8307784;

WW   http://bioinformatics.hsanmartino.it/ecbr/cl137.html

CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Transformed cell line

//

ID   YES-1

AC   CVCL_E321

SY   YES1

DR   GEO; GSM301574

RX   PubMed=1770930;

RX   PubMed=1819237;

DI   NCIt; C4024; Esophageal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YES-2

AC   CVCL_E322

SY   YES2

DR   Cosmic; 2395009

DR   GEO; GSM301575

RX   CelloPub=CLPUB00005;

RX   PubMed=1770930;

CC   Doubling time: 23.7 hours (CelloPub=CLPUB00005).

DI   NCIt; C4024; Esophageal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YES-2CSC

AC   CVCL_S526

RX   PubMed=23983818;

DI   NCIt; C4024; Esophageal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_E322 ! YES-2

SX   Male

CA   Cancer cell line

//

ID   YES-3

AC   CVCL_E323

RX   PubMed=1770930;

DI   NCIt; C4024; Esophageal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   YES-4

AC   CVCL_S528

SY   Yes-4

RX   PubMed=8590302;

DI   NCIt; C4024; Esophageal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   YES-5

AC   CVCL_S529

RX   PubMed=8590302;

DI   NCIt; C4024; Esophageal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   YES-6

AC   CVCL_S530

SY   Yes-6

RX   PubMed=8590302;

DI   NCIt; C4024; Esophageal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   YFC 118.12

AC   CVCL_J779

DR   ECACC; 11072204

CC   Monoclonal antibody target: UniProtKB; P05107; Human ITGB2/CD18.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_4342 ! Y3-Ag 1.2.3

CA   Hybridoma

//

ID   YFC 120.5

AC   CVCL_J780

DR   ECACC; 11060808

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_4342 ! Y3-Ag 1.2.3

CA   Hybridoma

//

ID   YFEF

AC   CVCL_9U61

SY   Yak Fetal Ear Fibroblast

RX   PubMed=23161386;

CC   Doubling time: 35 hours (PubMed=23161386).

OX   NCBI_TaxID=30521; ! Bos mutus grunniens

OI   CVCL_9U62 ! YFLF

SX   Male

CA   Finite cell line

//

ID   YFLF

AC   CVCL_9U62

SY   Yak Fetal Lung Fibroblast

RX   PubMed=23161386;

CC   Doubling time: 30 hours (PubMed=23161386).

OX   NCBI_TaxID=30521; ! Bos mutus grunniens

OI   CVCL_9U61 ! YFEF

SX   Male

CA   Finite cell line

//

ID   YFP-SF1

AC   CVCL_F702

RX   PubMed=21959845;

CC   Group: Cetacean cell line.

CC   Doubling time: 31.45 hours (at 7th passage), 50.24 hours (at 20th passage) (PubMed=21959845).

CC   Breed/subspecies: Asiaeorientalis.

OX   NCBI_TaxID=34892; ! Neophocaena phocaenoides

SX   Male

CA   Finite cell line

//

ID   YG10003

AC   CVCL_8557

DR   JCRB; JCRB0119

DR   JCRB; NIHS0160

RX   PubMed=8137280;

CC   Transfected with: UniProtKB; Q00267; Salmonella typhimurium nhoA.

CC   Discontinued: JCRB; NIHS0160; true.

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_0212 ! CHL

SX   Female

CA   Spontaneously immortalized cell line

//

ID   YG10007

AC   CVCL_8558

DR   JCRB; JCRB0120

DR   JCRB; NIHS0161

RX   PubMed=8137280;

CC   Transfected with: HGNC; 7645; NAT1.

CC   Discontinued: JCRB; NIHS0161; true.

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_0212 ! CHL

SX   Female

CA   Spontaneously immortalized cell line

//

ID   YG10008

AC   CVCL_8559

DR   JCRB; JCRB0121

DR   JCRB; NIHS0162

RX   PubMed=8137280;

CC   Transfected with: HGNC; 7646; NAT2.

CC   Discontinued: JCRB; NIHS0162; true.

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_0212 ! CHL

SX   Female

CA   Spontaneously immortalized cell line

//

ID   YGY 016

AC   CVCL_E894

SY   YGY016

DR   dbMHC; 49085

DR   ECACC; 94082290

DR   IHW; IHW9190

DR   IMGT/HLA; 11732

RX   PubMed=8307784;

WW   http://bioinformatics.hsanmartino.it/ecbr/cl190.html

CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Transformed cell line

//

ID   YH-13

AC   CVCL_1795

SY   YH

DR   BioSample; SAMN03472800

DR   CCLE; YH13_CENTRAL_NERVOUS_SYSTEM

DR   CGH-DB; 158-1

DR   ChEMBL-Cells; CHEMBL3308223

DR   ChEMBL-Targets; CHEMBL2366164

DR   Cosmic; 687591

DR   Cosmic; 909905

DR   Cosmic; 2367556

DR   Cosmic-CLP; 909905

DR   GDSC; 909905

DR   GEO; GSM887747

DR   GEO; GSM888842

DR   GEO; GSM1670585

DR   IFO; IFO50493

RX   PubMed=7947440;

RX   PubMed=8145054;

RX   PubMed=16232199;

RX   PubMed=22460905;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; JCRB

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 9,12

ST   D16S539: 12

ST   D5S818: 10,12

ST   D7S820: 8,12

ST   TH01: 8

ST   TPOX: 8

ST   vWA: 18

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YJ

AC   CVCL_8931

DR   BioSample; SAMN03151778

RX   PubMed=9737693;

RX   PubMed=12592342;

RX   PubMed=19344951;

RX   PubMed=20143388;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a HL-60 derivative (PubMed=12592342, PubMed=19344951, PubMed=20143388).

DI   NCIt; C9154; Adult acute myeloid leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0002 ! HL-60

SX   Female

CA   Cancer cell line

//

ID   YK-M2

AC   CVCL_9919

DR   Cosmic; 975313

DR   Cosmic; 1281363

RX   PubMed=3465438;

DI   NCIt; C9154; Adult acute myeloid leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YI 328-18

AC   CVCL_E987

SY   YI328-18

DR   CLO; CLO_0009713

DR   ATCC; HB-9306

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3412 ! P3X63Ag8U.1

CA   Hybridoma

//

ID   YI 328-51

AC   CVCL_E988

SY   YI328-51

DR   ATCC; HB-9307

CC   Discontinued: ATCC; HB-9307; probable.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3412 ! P3X63Ag8U.1

CA   Hybridoma

//

ID   YKG-1

AC   CVCL_1796

SY   YKG1

DR   CLO; CLO_0050640

DR   BioSample; SAMN01821722

DR   BioSample; SAMN03472510

DR   CCLE; YKG1_CENTRAL_NERVOUS_SYSTEM

DR   CGH-DB; 159-1

DR   ChEMBL-Cells; CHEMBL3308093

DR   ChEMBL-Targets; CHEMBL1075612

DR   Cosmic; 687592

DR   Cosmic; 2367557

DR   Cosmic; 2516045

DR   Cosmic-CLP; 687592

DR   GDSC; 687592

DR   GEO; GSM827215

DR   GEO; GSM887748

DR   GEO; GSM888843

DR   GEO; GSM1670586

DR   JCRB; JCRB0746

DR   RCB; RCB2110

DR   TKG; TKG 0453

RX   PubMed=2589023;

RX   PubMed=9290701;

RX   PubMed=16232199;

RX   PubMed=22460905;

RX   PubMed=25984343;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Doubling time: 28 hours (PubMed=25984343).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: shRNA library screening.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; JCRB; RCB; TKG

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 8,12

ST   D16S539: 11

ST   D5S818: 10,11

ST   D7S820: 10,11

ST   TH01: 6,9

ST   TPOX: 11

ST   vWA: 16,17

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   YL1/2

AC   CVCL_J781

DR   ECACC; 92092402

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_4342 ! Y3-Ag 1.2.3

CA   Hybridoma

//

ID   YLC-KK1

AC   CVCL_L216

RX   PubMed=9290701;

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   YM

AC   CVCL_IU39

RX   PubMed=9747876;

CC   Characteristics: Has lost chromosome Y.

CC   Doubling time: 36-48 hours (PubMed=9747876).

DI   NCIt; C8851; Diffuse large B-cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YM-1

AC   CVCL_AP55

RX   PubMed=26432330;

CC   Doubling time: 40.66 hours (PubMed=26432330).

ST   Source(s): PubMed=26432330

ST   Amelogenin: X

ST   CSF1PO: 9

ST   D13S317: 11

ST   D16S539: 10,12

ST   D18S51: 10,14

ST   D19S433: 14.2,15.2

ST   D21S11: 28

ST   D2S1338: 20,23

ST   D3S1358: 15,16

ST   D5S818: 8

ST   D7S820: 11,12

ST   D8S1179: 12,15

ST   FGA: 24,27

ST   TH01: 8

ST   TPOX: 12

ST   vWA: 16,18

DI   NCIt; C4024; Esophageal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   YMB-1

AC   CVCL_2814

SY   YMB1

DR   BTO; BTO:0002404

DR   EFO; EFO_0006779

DR   BioSample; SAMN03152042

DR   CCLE; YMB1_BREAST

DR   GEO; GSM827238

DR   GEO; GSM887749

DR   GEO; GSM888844

DR   JCRB; JCRB0823

RX   PubMed=6534930;

RX   PubMed=9290701;

RX   PubMed=23136038;

RX   PubMed=22460905;

RX   PubMed=25485619;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a ZR-75-1 derivative (PubMed=23136038).

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Omics: Deep RNAseq analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Ascites.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 9

ST   D16S539: 11

ST   D5S818: 13

ST   D7S820: 10,11

ST   TH01: 7,9.3

ST   TPOX: 8

ST   vWA: 16,18

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0588 ! ZR-75-1

SX   Female

CA   Cancer cell line

//

ID   YMB-1-C

AC   CVCL_B372

CC   Problematic cell line: Contaminated. Parent cell line (YMB-1) has been shown to be a ZR-75-1 derivative.

CC   Derived from metastatic site: Ascites.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_2814 ! YMB-1

SX   Female

CA   Cancer cell line

//

ID   YMB-1-E

AC   CVCL_2815

SY   YMB1-E

DR   BTO; BTO:0002583

DR   EFO; EFO_0006780

DR   BioSample; SAMN03152043

DR   ChEMBL-Cells; CHEMBL3307353

DR   ChEMBL-Targets; CHEMBL614251

DR   Cosmic; 1571791

DR   Cosmic-CLP; 1303911

DR   GDSC; 1303911

DR   GEO; GSM1670587

DR   JCRB; JCRB0825

DR   TKG; TKG 0440

RX   PubMed=9290701;

RX   PubMed=23136038;

RX   PubMed=25485619;

RX   PubMed=27397505;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Parent cell line (YMB-1) has been shown to be a ZR-75-1 derivative (PubMed=23136038).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Derived from metastatic site: Ascites.

ST   Source(s): Cosmic-CLP; JCRB; TKG

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 9

ST   D16S539: 11

ST   D5S818: 13

ST   D7S820: 10,11

ST   TH01: 7,9.3

ST   TPOX: 8

ST   vWA: 16,18

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_2814 ! YMB-1

SX   Female

CA   Cancer cell line

//

ID   YMB-A

AC   CVCL_0586

DR   MCCL; MCC:0000492

RX   PubMed=11179484;

CC   Problematic cell line: Contaminated. Parent cell line (YMB-1) has been shown to be a ZR-75-1 derivative.

CC   Derived from metastatic site: Ascites.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_2814 ! YMB-1

SX   Female

CA   Cancer cell line

//

ID   YMB-S

AC   CVCL_D103

RX   PubMed=8144402;

RX   PubMed=11179484;

CC   Problematic cell line: Contaminated. Parent cell line (YMB-1) has been shown to be a ZR-75-1 derivative.

CC   Derived from metastatic site: Ascites.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_2814 ! YMB-1

SX   Female

CA   Cancer cell line

//

ID   YME4

AC   CVCL_6C73

RX   CelloPub=CLPUB00299;

CC   Transformant: NCBI_TaxID; 28282; Adenovirus 12 [E1A].

CC   Breed/subspecies: Fischer 344.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_4563 ! 3Y1-B clone 1

SX   Female

CA   Transformed cell line

//

ID   Ymnu

AC   CVCL_6F43

RX   PubMed=7733619;

RX   PubMed=7847838;

CC   Transformant: ChEBI; CHEBI:50102; N-methyl-N-nitrosourea (NMU).

CC   Breed/subspecies: NMRI.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   YMU

AC   CVCL_E895

DR   dbMHC; 49087

DR   IHW; IHW9356

DR   IMGT/HLA; 11592

WW   http://bioinformatics.hsanmartino.it/ecbr/cl356.html

CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Transformed cell line

//

ID   YN

AC   CVCL_Y579

RX   PubMed=3541491;

RX   PubMed=23882450;

DI   NCIt; C8971; Embryonal rhabdomyosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YN-1

AC   CVCL_8775

DR   BTO; BTO:0004624

DR   TKG; TKG 0695

RX   PubMed=3476772;

RX   PubMed=7918028;

ST   Source(s): TKG

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 11,12

ST   D16S539: 11,13

ST   D5S818: 9,10

ST   D7S820: 12

ST   TH01: 9.3,10

ST   TPOX: 8,11

ST   vWA: 16,18

DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YN-1-0-A

AC   CVCL_F916

DR   TKG; TKG 0696

ST   Source(s): TKG

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 11,12

ST   D16S539: 11,14

ST   D5S818: 9,10

ST   D7S820: 12

ST   TH01: 9.3,10

ST   TPOX: 8,11

ST   vWA: 17,18

DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_8775 ! YN-1

CA   Cancer cell line

//

ID   YN-4

AC   CVCL_5G86

RX   PubMed=6467198;

RX   PubMed=7306960;

RX   PubMed=24259225;

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Female

CA   Spontaneously immortalized cell line

//

ID   YN1/1.7.4

AC   CVCL_8985

DR   CLO; CLO_0009714

DR   ATCC; CRL-1878

DR   BCRC; 60411

DR   ECACC; 90110706

RX   PubMed=2981916;

CC   Monoclonal antibody target: UniProtKB; P13597; Mouse Icam1/Cd54.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_4342 ! Y3-Ag 1.2.3

CA   Hybridoma

//

ID   YNH-1

AC   CVCL_1927

DR   BioSample; SAMN03473442

DR   Cosmic; 787488

DR   Cosmic; 975314

DR   Cosmic; 996309

DR   Cosmic; 998745

DR   Cosmic; 1037657

DR   Cosmic; 1106592

DR   Cosmic; 1281364

DR   Cosmic; 1295724

DR   Cosmic; 2089649

DR   DSMZ; ACC-692

DR   RCB; RCB1291

RX   PubMed=9096702;

RX   PubMed=10354136;

RX   PubMed=23955599;

CC   Doubling time: ~80 hours (DSMZ).

CC   Discontinued: RCB; RCB1291; true.

ST   Source(s): DSMZ

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 8,13

ST   D16S539: 9

ST   D5S818: 11,12

ST   D7S820: 11,13

ST   TH01: 6,9

ST   TPOX: 11,12

ST   vWA: 14,16

DI   NCIt; C9154; Adult acute myeloid leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YNK

AC   CVCL_R990

SY   Yamame Normal Kidney

RX   DOI=10.2331/suisan.44.415;

RX   DOI=10.3147/jsfp.28.27;

CC   Group: Fish cell line.

OX   NCBI_TaxID=8020; ! Oncorhynchus masou

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   YO-K

AC   CVCL_6F98

RX   PubMed=15325525;

CC   Group: Fish cell line.

OX   NCBI_TaxID=8255; ! Paralichthys olivaceus

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   YOL1/34

AC   CVCL_J782

DR   ECACC; 85102247

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_4342 ! Y3-Ag 1.2.3

CA   Hybridoma

//

ID   Yoruba68IPSC4

AC   CVCL_9999

SY   TFDF1iPSC10

DR   ISCR; 1481

RX   PubMed=20038950;

CC   From: The Scripps Research Institute; La Jolla; USA.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Induced pluripotent stem cell

//

ID   YOS-B

AC   CVCL_H193

RX   PubMed=1486031;

DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_H194 ! YOS-M

SX   Male

CA   Cancer cell line

//

ID   YOS-M

AC   CVCL_H194

DR   Cosmic; 787509

RX   PubMed=1486031;

DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_H193 ! YOS-B

SX   Male

CA   Cancer cell line

//

ID   Yoshida sarcoma

AC   CVCL_4U54

SY   YS; YOSHIDA; Yoshida ascites sarcoma cell; Ascites sarcoma of Nagasaki strain

DR   BTO; BTO:0001213

DR   TKG; TKG 0088

RX   CelloPub=CLPUB00267;

RX   PubMed=12979052;

RX   PubMed=14906546;

CC   Miscellaneous: This is not a cell line but a xenograft, it is the parent tumor for many cell lines.

CC   Derived from metastatic site: Ascites.

DI   NCIt; C60505; Rat sarcoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

CA   Cancer cell line

//

ID   Yoshizaki

AC   CVCL_W836

DR   Cosmic; 945373

RX   PubMed=8980248;

DI   NCIt; C7550; Ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   YOU

AC   CVCL_N819

DR   Cosmic; 1656047

RX   PubMed=15274292;

RX   PubMed=22426987;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YP-MEL

AC   CVCL_L217

RX   PubMed=7520166;

RX   PubMed=9290701;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   YPBE-1

AC   CVCL_0J55

RX   PubMed=8839795;

CC   Transformant: Ad12-SV40.

CC   Breed/subspecies: Copenhagen.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

CA   Transformed cell line

//

ID   YPEN-1

AC   CVCL_0587

SY   YPEN1

DR   CLO; CLO_0009716

DR   MCCL; MCC:0000493

DR   ATCC; CRL-2222

RX   PubMed=8900918;

CC   Transformant: Ad12-SV40.

CC   Breed/subspecies: Copenhagen.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

SX   Male

CA   Transformed cell line

//

ID   YPEN-2

AC   CVCL_0J52

RX   PubMed=8900918;

CC   Transformant: Ad12-SV40.

CC   Breed/subspecies: Copenhagen.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

SX   Male

CA   Transformed cell line

//

ID   YPK-1

AC   CVCL_CZ89

RX   CelloPub=CLPUB00333;

CC   Doubling time: 49.3 hours (CelloPub=CLPUB00333).

CC   Derived from metastatic site: Ascites.

DI   NCIt; C8294; Pancreatic adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YR-A

AC   CVCL_0C32

DR   Cosmic; 2239094

RX   PubMed=9559344;

RX   PubMed=9815546;

CC   Derived from metastatic site: Subcutaneous.

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   YROS-1

AC   CVCL_W630

RX   PubMed=7479367;

CC   Breed/subspecies: Wistar.

DI   NCIt; C60487; Rat osteosarcoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

SX   Female

CA   Cancer cell line

//

ID   YROS-2

AC   CVCL_W631

RX   PubMed=7479367;

CC   Breed/subspecies: Wistar.

DI   NCIt; C60487; Rat osteosarcoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

SX   Female

CA   Cancer cell line

//

ID   YS-5Fu-R-TC

AC   CVCL_4U62

SY   YS-5Fu-R

DR   TKG; TKG 0094

DR   TKG; TKG 0655

CC   Selected for resistance to: ChEBI; CHEBI:46345; 5-fluorouracil (5-FU).

CC   Derived from metastatic site: Ascites.

DI   NCIt; C60505; Rat sarcoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_4U54 ! Yoshida sarcoma

CA   Cancer cell line

//

ID   YS-6MP-R-TC

AC   CVCL_4U55

SY   YS-6MP-R

DR   TKG; TKG 0098

DR   TKG; TKG 0656

CC   Selected for resistance to: ChEBI; CHEBI:50667; Mercaptopurine (6-MP).

CC   Derived from metastatic site: Ascites.

DI   NCIt; C60505; Rat sarcoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_4U54 ! Yoshida sarcoma

CA   Cancer cell line

//

ID   YS-DM-R-TC

AC   CVCL_4U56

SY   YS-DM-R

DR   TKG; TKG 0092

DR   TKG; TKG 0657

CC   Selected for resistance to: ChEBI; CHEBI:41977; Daunorubicin (Daunomycin).

CC   Derived from metastatic site: Ascites.

DI   NCIt; C60505; Rat sarcoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_4U54 ! Yoshida sarcoma

CA   Cancer cell line

//

ID   YS-EX-R-TC

AC   CVCL_4U57

SY   YS-EX-R

DR   TKG; TKG 0093

DR   TKG; TKG 0658

CC   Selected for resistance to: ChEBI; CHEBI:4027; Cyclophosphamide (CP; Endoxan).

CC   Derived from metastatic site: Ascites.

DI   NCIt; C60505; Rat sarcoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_4U54 ! Yoshida sarcoma

CA   Cancer cell line

//

ID   YS-G-TC

AC   CVCL_4U58

SY   YS-G

DR   TKG; TKG 0089

DR   TKG; TKG 0688

CC   Selected for resistance to: ChEBI; CHEBI:82354; Nitrogen mustard N-oxide.

CC   Derived from metastatic site: Ascites.

DI   NCIt; C60505; Rat sarcoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_4U54 ! Yoshida sarcoma

CA   Cancer cell line

//

ID   YS-MC-R-TC

AC   CVCL_4U59

SY   YS-MC-R

DR   TKG; TKG 0096

DR   TKG; TKG 0659

CC   Selected for resistance to: ChEBI; CHEBI:27504; Mitomycin C (MMC).

CC   Derived from metastatic site: Ascites.

DI   NCIt; C60505; Rat sarcoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_4U54 ! Yoshida sarcoma

CA   Cancer cell line

//

ID   YS-PPB

AC   CVCL_5436

RX   PubMed=9686589;

WW   http://www.cells-talk.com/index.php/page/copelibrary?key=YS-PPB

CC   Breed/subspecies: BALB/c.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Spontaneously immortalized cell line

//

ID   YS-TC

AC   CVCL_G359

DR   ChEMBL-Cells; CHEMBL3308014

DR   ChEMBL-Targets; CHEMBL612816

DR   TKG; TKG 0654

RX   PubMed=7829394;

CC   Derived from metastatic site: Ascites.

DI   NCIt; C60505; Rat sarcoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_4U54 ! Yoshida sarcoma

CA   Cancer cell line

//

ID   YS-TM-R-TC

AC   CVCL_4U60

SY   YS-TM-R

DR   TKG; TKG 0100

DR   TKG; TKG 0660

CC   Selected for resistance to: ChEBI; CHEBI:34638; Chromomycin A3.

CC   Derived from metastatic site: Ascites.

DI   NCIt; C60505; Rat sarcoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_4U54 ! Yoshida sarcoma

CA   Cancer cell line

//

ID   YS001

AC   CVCL_6474

DR   CLO; CLO_0009717

DR   ATCC; CRL-11776

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Embryonic stem cell

//

ID   YS08

AC   CVCL_4J68

RX   Patent=US7476540;

RX   PubMed=15857173;

CC   Registration: International Depositary Authority, Korean Cell Line Research Foundation; KCLRF-BP-000123.

CC   Monoclonal antibody target: Membrane protein antigen of human mesenchymal stem cells.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   YS14

AC   CVCL_4J69

RX   Patent=US7476540;

RX   PubMed=15857173;

CC   Registration: International Depositary Authority, Korean Cell Line Research Foundation; KCLRF-BP-000124.

CC   Monoclonal antibody target: Membrane protein antigen of human mesenchymal stem cells.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   YS18

AC   CVCL_4J70

RX   Patent=US7476540;

RX   PubMed=15857173;

CC   Registration: International Depositary Authority, Korean Cell Line Research Foundation; KCLRF-BP-000125.

CC   Monoclonal antibody target: Membrane protein antigen of human mesenchymal stem cells.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   YS9;22

AC   CVCL_A743

SY   YS9:22; YS9-22; YS 9:22

DR   CGH-DB; 9220-4

DR   Cosmic; 1012129

RX   PubMed=7808006;

RX   PubMed=16408098;

DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   YSCCC

AC   CVCL_3629

DR   CLO; CLO_0050859

DR   BioSample; SAMN03472100

DR   RCB; RCB1549

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 12

ST   D16S539: 10,11

ST   D5S818: 10,12

ST   D7S820: 10,11

ST   TH01: 7,9

ST   TPOX: 11

ST   vWA: 16,17

DI   NCIt; C4436; Cholangiocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   YSK

AC   CVCL_6745

DR   JCRB; JCRB0619

CC   Discontinued: JCRB; JCRB0619; true.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

SX   Sex undetermined

CA   Undefined cell line type

//

ID   YSK-21

AC   CVCL_E942

RX   PubMed=11550287;

DI   NCIt; C9154; Adult acute myeloid leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YST-1

AC   CVCL_5192

DR   CLO; CLO_0050136

DR   BioSample; SAMN03472012

DR   RCB; RCB2136

DR   TKG; TKG 0454

RX   PubMed=1980563;

RX   PubMed=9290701;

RX   PubMed=16510576;

ST   Source(s): RCB; TKG

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 8,12

ST   D16S539: 10,12

ST   D5S818: 10,11

ST   D7S820: 9,10

ST   TH01: 7,9

ST   TPOX: 8,11

ST   vWA: 17,18

DI   NCIt; C3269; Schwannoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   YSWS-SF

AC   CVCL_IJ28

SY   Yunnan Semi-fine Wool Sheep-Skin Fibroblast

RX   PubMed=24448770;

CC   Doubling time: 26 hours (PubMed=24448770).

CC   Miscellaneous: As no cell line name was given in the paper, we assigned the name based on the abbreviation of the cell description.

CC   Breed/subspecies: Yunnan semi-fine wool sheep.

OX   NCBI_TaxID=9940; ! Ovis aries

SX   Male

CA   Finite cell line

//

ID   YT

AC   CVCL_1797

DR   BTO; BTO:0005228

DR   CLO; CLO_0009718

DR   BioSample; SAMN03473541

DR   ChEMBL-Cells; CHEMBL3308146

DR   ChEMBL-Targets; CHEMBL2366114

DR   Cosmic; 850219

DR   Cosmic; 946358

DR   Cosmic; 991546

DR   Cosmic; 1012130

DR   Cosmic; 1524828

DR   Cosmic; 1542072

DR   Cosmic; 2390120

DR   Cosmic-CLP; 946358

DR   DSMZ; ACC-434

DR   GDSC; 946358

DR   GEO; GSM236811

DR   GEO; GSM236847

DR   GEO; GSM472010

DR   GEO; GSM1670588

DR   Lonza; 95

RX   PubMed=10803505;

RX   PubMed=16408098;

RX   PubMed=19194464;

RX   PubMed=21052088;

RX   PubMed=25586472;

RX   PubMed=27397505;

WW   http://www.cells-talk.com/index.php/page/copelibrary?key=YT

CC   Doubling time: ~40-50 hours (DSMZ).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; DSMZ

ST   Amelogenin: X,Y

ST   CSF1PO: 10,11

ST   D13S317: 9,11

ST   D16S539: 10,12

ST   D5S818: 10,11

ST   D7S820: 11,12

ST   TH01: 6,7

ST   TPOX: 8

ST   vWA: 17,20 (Cosmic-CLP)

ST   vWA: 17,18,20 (DSMZ)

DI   NCIt; C82217; Natural killer cell lymphoblastic leukemia/lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YT-1

AC   CVCL_EJ05

SY   YT1

DR   Cosmic; 2024371

RX   PubMed=7911075;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C82217; Natural killer cell lymphoblastic leukemia/lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1797 ! YT

SX   Male

CA   Cancer cell line

//

ID   YT-nu

AC   CVCL_H524

SY   YT-NU

DR   ChEMBL-Cells; CHEMBL3307254

DR   ChEMBL-Targets; CHEMBL612817

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   YT1

AC   CVCL_T024

SY   YT1-hES

RX   PubMed=22287285;

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   YT2

AC   CVCL_T025

SY   YT2-hES

RX   PubMed=22287285;

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   YT3

AC   CVCL_T026

SY   YT3-hES

RX   PubMed=22287285;

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   YTA 3.1.2

AC   CVCL_J783

DR   ECACC; 89040603

CC   Monoclonal antibody target: UniProtKB; P06332; Mouse Cd4.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_4342 ! Y3-Ag 1.2.3

CA   Hybridoma

//

ID   YTA 74.4.4

AC   CVCL_J784

DR   ECACC; 11060804

CC   Monoclonal antibody target: UniProtKB; Q62351; Mouse Tfrc/Cd71.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_4342 ! Y3-Ag 1.2.3

CA   Hybridoma

//

ID   YTF

AC   CVCL_6F99

SY   Yellow Tail Fin

RX   DOI=10.3147/jsfp.29.29;

CC   Group: Fish cell line.

OX   NCBI_TaxID=8161; ! Seriola quinqueradiata

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   YTH 30.15

AC   CVCL_J785

DR   ECACC; 11060807

CC   Monoclonal antibody target: UniProtKB; P09564; Human CD7.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_4342 ! Y3-Ag 1.2.3

CA   Hybridoma

//

ID   YTH 470.5

AC   CVCL_T981

DR   ECACC; 11072206

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_4342 ! Y3-Ag 1.2.3

CA   Hybridoma

//

ID   YTH 53.1

AC   CVCL_J786

DR   ECACC; 11060813

CC   Monoclonal antibody target: UniProtKB; P13987; Human CD59.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_4342 ! Y3-Ag 1.2.3

CA   Hybridoma

//

ID   YTH 71.3

AC   CVCL_T982

DR   ECACC; 11072205

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_4342 ! Y3-Ag 1.2.3

CA   Hybridoma

//

ID   YTH 76.3

AC   CVCL_J787

DR   ECACC; 11060815

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_4342 ! Y3-Ag 1.2.3

CA   Hybridoma

//

ID   YTH 80.103

AC   CVCL_J788

DR   ECACC; 11060811

CC   Monoclonal antibody target: UniProtKB; P08575; Human PTPRC/CD45.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_4342 ! Y3-Ag 1.2.3

CA   Hybridoma

//

ID   YTH 81.5

AC   CVCL_J789

DR   ECACC; 11072203

CC   Monoclonal antibody target: UniProtKB; P20701; Human ITGAL/CD11a.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_4342 ! Y3-Ag 1.2.3

CA   Hybridoma

//

ID   YTH 862.2

AC   CVCL_J790

DR   ECACC; 11060817

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_4342 ! Y3-Ag 1.2.3

CA   Hybridoma

//

ID   YTH 89.1

AC   CVCL_J791

DR   ECACC; 11060814

CC   Monoclonal antibody target: UniProtKB; P02724; Human GYPA.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_4342 ! Y3-Ag 1.2.3

CA   Hybridoma

//

ID   YTH 906.9HL

AC   CVCL_J792

DR   ECACC; 11060809

CC   Monoclonal antibody target: UniProtKB; P01589; Human IL2RA/CD25.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_4342 ! Y3-Ag 1.2.3

CA   Hybridoma

//

ID   YTH 913.12

AC   CVCL_J793

DR   ECACC; 11060810

CC   Monoclonal antibody target: UniProtKB; P10747; Human CD28.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_4342 ! Y3-Ag 1.2.3

CA   Hybridoma

//

ID   YTK

AC   CVCL_R991

SY   Yellow Tail Kidney

RX   DOI=10.3147/jsfp.15.201;

CC   Group: Fish cell line.

OX   NCBI_TaxID=8161; ! Seriola quinqueradiata

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   YTMLC-90

AC   CVCL_6959

SY   YTMLC 90

DR   CCRID; 3153C0001000000061

RX   PubMed=15207095;

DI   NCIt; C3493; Squamous cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YTS

AC   CVCL_D324

DR   Lonza; 96

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C82217; Natural killer cell lymphoblastic leukemia/lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1797 ! YT

SX   Male

CA   Cancer cell line

//

ID   YTS 105.18.10

AC   CVCL_J794

DR   ECACC; 11060802

CC   Monoclonal antibody target: UniProtKB; P01731; Mouse Cd8a.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_4342 ! Y3-Ag 1.2.3

CA   Hybridoma

//

ID   YTS 121.5.2

AC   CVCL_J795

DR   ECACC; 87072283

CC   Monoclonal antibody target: UniProtKB; P13379; Mouse Cd5.

CC   Discontinued: ECACC; 87072283; probable.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_4342 ! Y3-Ag 1.2.3

CA   Hybridoma

//

ID   YTS 154.7.7.10

AC   CVCL_J796

DR   ECACC; 87072285

CC   Monoclonal antibody target: UniProtKB; P01831; Mouse Thy1/Cd90.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_4342 ! Y3-Ag 1.2.3

CA   Hybridoma

//

ID   YTS 156.7.7

AC   CVCL_J797

DR   ECACC; 89040604

CC   Monoclonal antibody target: UniProtKB; P10300; Mouse Cd8b.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_4342 ! Y3-Ag 1.2.3

CA   Hybridoma

//

ID   YTS 169.4.2.1

AC   CVCL_J798

DR   ECACC; 87072284

CC   Monoclonal antibody target: UniProtKB; P01731; Mouse Cd8a.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_4342 ! Y3-Ag 1.2.3

CA   Hybridoma

//

ID   YTS 177.9.6.1

AC   CVCL_J799

DR   ECACC; 11060819

CC   Monoclonal antibody target: UniProtKB; P06332; Mouse Cd4.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_4342 ! Y3-Ag 1.2.3

CA   Hybridoma

//

ID   YTS 191.1.1.2

AC   CVCL_J800

DR   ECACC; 87072282

CC   Monoclonal antibody target: UniProtKB; P06332; Mouse Cd4.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_4342 ! Y3-Ag 1.2.3

CA   Hybridoma

//

ID   YTS 213.1.1

AC   CVCL_J801

DR   ECACC; 11060803

CC   Monoclonal antibody target: UniProtKB; P11835; Mouse Itgb2/Cd18.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_4342 ! Y3-Ag 1.2.3

CA   Hybridoma

//

ID   YTS-1

AC   CVCL_6746

SY   YTS1

DR   BTO; BTO:0003554

RX   PubMed=2733301;

RX   PubMed=3573461;

DI   NCIt; C4912; Bladder carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YTS-Eco

AC   CVCL_EG36

SY   YTS/Eco; YTS/eco; YTS ECO; YTS eco; YTSeco

CC   Transfected with: MGI; MGI:88117; Slc7a1.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C82217; Natural killer cell lymphoblastic leukemia/lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D324 ! YTS

SX   Male

CA   Cancer cell line

//

ID   YUAME

AC   CVCL_EI13

RX   PubMed=26214590;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Deep exome analysis.

CC   Derived from metastatic site: Not specified.

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YUAVEY

AC   CVCL_K001

RX   PubMed=22842228;

RX   PubMed=26214590;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Deep exome analysis.

CC   Derived from metastatic site: Not specified.

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Yub 10F

AC   CVCL_3257

SY   Yub10F

DR   BioSample; SAMN03472454

DR   JCRB; JCRB1116

DR   JCRB; NIHS0420

DR   SKIP; SKIP000333

CC   Discontinued: JCRB; NIHS0420; true.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 8,11

ST   D16S539: 10,13

ST   D5S818: 10

ST   D7S820: 10,11

ST   TH01: 6,7

ST   TPOX: 8

ST   vWA: 13,14

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Adult stem cell

//

ID   Yub621b

AC   CVCL_3258

DR   BioSample; SAMN03472451

DR   JCRB; JCRB1112

DR   JCRB; NIHS0416

DR   SKIP; SKIP000329

CC   Discontinued: JCRB; NIHS0416; true.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 10,14

ST   D13S317: 8,11

ST   D16S539: 11,12

ST   D5S818: 11

ST   D7S820: 11

ST   TH01: 9

ST   TPOX: 8,11

ST   vWA: 17,18

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_3259 ! Yub621BMC

OI   CVCL_3260 ! Yub621c

CA   Adult stem cell

//

ID   Yub621BMC

AC   CVCL_3259

SY   Yub621_BMC

DR   JCRB; JCRB1113

DR   JCRB; NIHS0417

DR   SKIP; SKIP000330

RX   PubMed=21155951;

CC   Discontinued: JCRB; NIHS0417; true.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 10,14

ST   D13S317: 8,11

ST   D16S539: 11,12

ST   D5S818: 11

ST   D7S820: 11

ST   TH01: 9

ST   TPOX: 8,11

ST   vWA: 17,18

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_3258 ! Yub621b

OI   CVCL_3260 ! Yub621c

CA   Adult stem cell

//

ID   Yub621c

AC   CVCL_3260

DR   JCRB; JCRB1111

DR   JCRB; NIHS0415

DR   SKIP; SKIP000328

CC   Discontinued: JCRB; NIHS0415; true.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 10,14

ST   D13S317: 8,11

ST   D16S539: 11,12

ST   D5S818: 11

ST   D7S820: 11

ST   TH01: 9

ST   TPOX: 8,11

ST   vWA: 17,18

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_3258 ! Yub621b

OI   CVCL_3259 ! Yub621BMC

CA   Adult stem cell

//

ID   Yub622

AC   CVCL_3261

DR   BioSample; SAMN03472452

DR   JCRB; JCRB1114

DR   JCRB; NIHS0418

DR   SKIP; SKIP000331

CC   Discontinued: JCRB; NIHS0418; true.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 11,13

ST   D16S539: 9,12

ST   D5S818: 11,13

ST   D7S820: 11

ST   TH01: 6,9.3

ST   TPOX: 8

ST   vWA: 14,18

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Adult stem cell

//

ID   Yub623

AC   CVCL_3262

DR   BioSample; SAMN03472453

DR   JCRB; JCRB1115

DR   JCRB; NIHS0419

DR   SKIP; SKIP000332

CC   Discontinued: JCRB; NIHS0419; true.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 8,12

ST   D16S539: 9,11

ST   D5S818: 11,13

ST   D7S820: 9.1,11

ST   TH01: 9

ST   TPOX: 8

ST   vWA: 18

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Adult stem cell

//

ID   Yub625

AC   CVCL_3263

DR   BioSample; SAMN03472468

DR   JCRB; JCRB1155

DR   JCRB; NIHS0461

CC   Discontinued: JCRB; NIHS0461; true.

ST   Source(s): JCRB

ST   Amelogenin: X,Y

ST   CSF1PO: 9,12

ST   D13S317: 12

ST   D16S539: 9,10

ST   D5S818: 12,13

ST   D7S820: 10,11

ST   TH01: 6,9.3

ST   TPOX: 8,11

ST   vWA: 14,18

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Adult stem cell

//

ID   Yub631

AC   CVCL_3264

DR   BioSample; SAMN03472469

DR   JCRB; JCRB1156

DR   JCRB; NIHS0462

CC   Discontinued: JCRB; NIHS0462; true.

ST   Source(s): JCRB

ST   Amelogenin: X,Y

ST   CSF1PO: 10,11

ST   D13S317: 10,11

ST   D16S539: 9

ST   D5S818: 12,13

ST   D7S820: 8,10

ST   TH01: 6

ST   TPOX: 8,12

ST   vWA: 14,17

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Adult stem cell

//

ID   Yub632

AC   CVCL_3265

DR   BioSample; SAMN03472470

DR   JCRB; JCRB1157

DR   JCRB; NIHS0463

CC   Discontinued: JCRB; NIHS0463; true.

ST   Source(s): JCRB

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 8,10

ST   D16S539: 9,11

ST   D5S818: 10,11

ST   D7S820: 8,10

ST   TH01: 6,9

ST   TPOX: 7,8

ST   vWA: 18,19

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Adult stem cell

//

ID   Yub633

AC   CVCL_3266

DR   BioSample; SAMN03472471

DR   JCRB; JCRB1158

DR   JCRB; NIHS0464

RX   PubMed=21155951;

CC   Discontinued: JCRB; NIHS0464; true.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 8,9

ST   D16S539: 9,12

ST   D5S818: 11

ST   D7S820: 10,12

ST   TH01: 6

ST   TPOX: 8,11

ST   vWA: 14,17

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Adult stem cell

//

ID   Yub634

AC   CVCL_3267

DR   BioSample; SAMN03472473

DR   JCRB; JCRB1161

DR   JCRB; NIHS0465

RX   PubMed=21155951;

CC   Discontinued: JCRB; NIHS0465; true.

ST   Source(s): JCRB

ST   Amelogenin: X,Y

ST   CSF1PO: 9,11

ST   D13S317: 8,12

ST   D16S539: 11,12

ST   D5S818: 12

ST   D7S820: 9,11

ST   TH01: 6,9

ST   TPOX: 8

ST   vWA: 17,18

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Adult stem cell

//

ID   Yub635

AC   CVCL_3268

DR   BioSample; SAMN03472474

DR   JCRB; JCRB1162

DR   JCRB; NIHS0473

RX   PubMed=21155951;

CC   Discontinued: JCRB; NIHS0473; true.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 9,12

ST   D13S317: 9,11

ST   D16S539: 9,11

ST   D5S818: 10,11

ST   D7S820: 8,9

ST   TH01: 6

ST   TPOX: 8,11

ST   vWA: 16,19

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Adult stem cell

//

ID   Yub636

AC   CVCL_3269

DR   BioSample; SAMN03472420

DR   JCRB; JCRB1169

DR   JCRB; NIHS0475

CC   Discontinued: JCRB; NIHS0475; true.

ST   Source(s): JCRB

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 8,13

ST   D16S539: 9,10

ST   D5S818: 9,11

ST   D7S820: 9,12

ST   TH01: 9

ST   TPOX: 8

ST   vWA: 14,16

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Adult stem cell

//

ID   Yub637b

AC   CVCL_3270

SY   Yub637B

DR   BioSample; SAMN03472475

DR   JCRB; JCRB1163

DR   JCRB; NIHS0474

RX   PubMed=21155951;

CC   Discontinued: JCRB; NIHS0474; true.

ST   Source(s): JCRB

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 8,12

ST   D16S539: 10

ST   D5S818: 10,11

ST   D7S820: 9,12

ST   TH01: 9

ST   TPOX: 9

ST   vWA: 16,18

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_3240 ! Yub637s

SX   Male

CA   Adult stem cell

//

ID   Yub637s

AC   CVCL_3240

DR   JCRB; JCRB1173

DR   JCRB; NIHS0476

CC   Discontinued: JCRB; NIHS0476; true.

ST   Source(s): JCRB

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 8,12

ST   D16S539: 10

ST   D5S818: 10,11

ST   D7S820: 9,12

ST   TH01: 9

ST   TPOX: 9

ST   vWA: 16,18

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_3270 ! Yub637b

SX   Male

CA   Adult stem cell

//

ID   Yub642

AC   CVCL_2954

DR   BioSample; SAMN03472421

DR   JCRB; JCRB1172

DR   JCRB; NIHS0477

CC   Discontinued: JCRB; NIHS0477; true.

ST   Source(s): JCRB

ST   Amelogenin: X,Y

ST   CSF1PO: 10

ST   D13S317: 8,10

ST   D16S539: 9,10

ST   D5S818: 10,13

ST   D7S820: 8,11

ST   TH01: 6

ST   TPOX: 10,11

ST   vWA: 16,18

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_2824 ! Yub642b

OI   CVCL_2823 ! Yub642p

SX   Male

CA   Adult stem cell

//

ID   Yub642b

AC   CVCL_2824

DR   JCRB; JCRB1174

DR   JCRB; NIHS0479

CC   Discontinued: JCRB; NIHS0479; true.

ST   Source(s): JCRB

ST   Amelogenin: X,Y

ST   CSF1PO: 10

ST   D13S317: 8,10

ST   D16S539: 9,10

ST   D5S818: 10,13

ST   D7S820: 8,11

ST   TH01: 6

ST   TPOX: 10,11

ST   vWA: 16,18

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_2954 ! Yub642

OI   CVCL_2823 ! Yub642p

SX   Male

CA   Adult stem cell

//

ID   Yub642p

AC   CVCL_2823

SY   Yub642P

DR   JCRB; JCRB1171

DR   JCRB; NIHS0478

RX   PubMed=21155951;

CC   Discontinued: JCRB; NIHS0478; true.

ST   Source(s): JCRB

ST   Amelogenin: X,Y

ST   CSF1PO: 10

ST   D13S317: 8,10

ST   D16S539: 9,10

ST   D5S818: 10,13

ST   D7S820: 8,11

ST   TH01: 6

ST   TPOX: 10,11

ST   vWA: 16,18

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_2954 ! Yub642

OI   CVCL_2824 ! Yub642b

SX   Male

CA   Adult stem cell

//

ID   YUBEL

AC   CVCL_J515

DR   Cosmic; 1548846

RX   PubMed=21543894;

RX   PubMed=26214590;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Deep exome analysis.

CC   Derived from metastatic site: Not specified.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   YUBRUSE

AC   CVCL_K002

RX   PubMed=22842228;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Deep exome analysis.

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C4022; Acral lentiginous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YUBUNE

AC   CVCL_J516

DR   Cosmic; 1548847

RX   PubMed=21543894;

RX   PubMed=26214590;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Deep exome analysis.

CC   Derived from metastatic site: Not specified.

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   YUCAL

AC   CVCL_J532

RX   PubMed=21569352;

RX   PubMed=26214590;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Deep exome analysis.

CC   Derived from metastatic site: Not specified.

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   YUCAS

AC   CVCL_J065

DR   Cosmic; 1548848

RX   PubMed=21521745;

RX   PubMed=21543894;

RX   PubMed=21569352;

RX   PubMed=26214590;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Deep exome analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Not specified.

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YUCHER

AC   CVCL_J517

DR   Cosmic; 1548849

RX   PubMed=21543894;

RX   PubMed=21569352;

RX   PubMed=26214590;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Deep exome analysis.

CC   Derived from metastatic site: Not specified.

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YUCHIME

AC   CVCL_EI14

RX   PubMed=26214590;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Deep exome analysis.

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YUCHUFA

AC   CVCL_K003

RX   PubMed=22842228;

RX   PubMed=26214590;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Deep exome analysis.

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   YUCINJ

AC   CVCL_K004

RX   PubMed=22842228;

RX   PubMed=26214590;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Deep exome analysis.

CC   Derived from metastatic site: Not specified.

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   YUCLAT

AC   CVCL_J518

DR   Cosmic; 1548850

RX   PubMed=21543894;

RX   PubMed=22842228;

RX   PubMed=26214590;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Deep exome analysis.

CC   Derived from metastatic site: Not specified.

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YUCLIR

AC   CVCL_J533

RX   PubMed=21569352;

CC   Part of: Yale University (YU) melanoma cell collection.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   YUCOT

AC   CVCL_J066

DR   Cosmic; 1548851

RX   PubMed=21521745;

RX   PubMed=21543894;

RX   PubMed=22842228;

RX   PubMed=26214590;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Deep exome analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Not specified.

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   YUCRENA

AC   CVCL_K005

RX   PubMed=22842228;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Deep exome analysis.

DI   NCIt; C7712; Uveal melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YUCYLO

AC   CVCL_EI15

RX   PubMed=26214590;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Deep exome analysis.

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   YUDAN3

AC   CVCL_J541

SY   YUDAN-3; YUDAN 3

DR   Cosmic; 1020271

CC   Part of: Yale University (YU) melanoma cell collection.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   YUDATE

AC   CVCL_K006

RX   PubMed=22842228;

RX   PubMed=26214590;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Deep exome analysis.

CC   Derived from metastatic site: Not specified.

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YUDEDE

AC   CVCL_G322

RX   PubMed=20149136;

RX   PubMed=22842228;

RX   PubMed=26214590;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Deep exome analysis.

CC   Derived from metastatic site: Not specified.

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YUDEW

AC   CVCL_J519

DR   Cosmic; 1548880

DR   Cosmic; 2439309

RX   PubMed=21543894;

RX   PubMed=26214590;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Deep exome analysis.

CC   Derived from metastatic site: Not specified.

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   YUDOSO

AC   CVCL_G323

DR   Cosmic; 1548852

DR   Cosmic; 2439312

RX   PubMed=20149136;

RX   PubMed=21521745;

RX   PubMed=21543894;

RX   PubMed=21569352;

RX   PubMed=26214590;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Deep exome analysis.

CC   Omics: Transcriptome analysis.

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YUDUTY

AC   CVCL_K007

RX   PubMed=22842228;

RX   PubMed=26214590;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Deep exome analysis.

CC   Derived from metastatic site: Not specified.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   YUFIC

AC   CVCL_G324

DR   Cosmic; 1548853

DR   Cosmic; 2439314

RX   PubMed=20149136;

RX   PubMed=21543894;

RX   PubMed=26214590;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Deep exome analysis.

CC   Derived from metastatic site: Not specified.

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YUFULO

AC   CVCL_G325

RX   PubMed=20149136;

RX   PubMed=21569352;

CC   Part of: Yale University (YU) melanoma cell collection.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YUGAFFE

AC   CVCL_K008

RX   PubMed=22842228;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Deep exome analysis.

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YUGANK

AC   CVCL_K009

RX   PubMed=22842228;

RX   PubMed=26214590;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Deep exome analysis.

CC   Derived from metastatic site: Brain.

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YUGASP

AC   CVCL_J520

DR   Cosmic; 1548854

RX   PubMed=21543894;

RX   PubMed=26214590;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Deep exome analysis.

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   YUGATOR

AC   CVCL_EI17

DR   Cosmic; 2439318

RX   PubMed=26214590;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Deep exome analysis.

CC   Derived from metastatic site: Not specified.

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YUGEK

AC   CVCL_J540

DR   Cosmic; 1548886

RX   PubMed=21543894;

CC   Part of: Yale University (YU) melanoma cell collection.

DI   NCIt; C4022; Acral lentiginous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   YUGEN8

AC   CVCL_A744

SY   YUGEN-8; YUGEN 8

DR   Cosmic; 1197387

DR   Cosmic; 1548855

DR   Cosmic; 2439320

RX   PubMed=9177196;

RX   PubMed=20149136;

RX   PubMed=21543894;

RX   PubMed=21569352;

RX   PubMed=26214590;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Deep exome analysis.

CC   Derived from metastatic site: Not specified.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   YUGLIDE

AC   CVCL_K010

RX   PubMed=22842228;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Deep exome analysis.

DI   NCIt; C7712; Uveal melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   YUGOE

AC   CVCL_J067

DR   Cosmic; 1548856

RX   PubMed=21521745;

RX   PubMed=21543894;

RX   PubMed=21569352;

RX   PubMed=22842228;

RX   PubMed=26214590;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Deep exome analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Not specified.

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YUHEF

AC   CVCL_G326

DR   Cosmic; 1548857

RX   PubMed=20149136;

RX   PubMed=21521745;

RX   PubMed=21543894;

RX   PubMed=22842228;

RX   PubMed=26214590;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Deep exome analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Not specified.

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YUHEIK

AC   CVCL_J073

DR   Cosmic; 1548858

RX   PubMed=21521745;

RX   PubMed=21543894;

RX   PubMed=21569352;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Transcriptome analysis.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   YUHOIN

AC   CVCL_J521

DR   Cosmic; 1548859

RX   PubMed=21543894;

RX   PubMed=21569352;

RX   PubMed=22842228;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Deep exome analysis.

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C114828; Mucosal melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   YUHUY

AC   CVCL_G327

DR   Cosmic; 1548860

RX   PubMed=20149136;

RX   PubMed=21521745;

RX   PubMed=21543894;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Not specified.

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YUKADI

AC   CVCL_K011

RX   PubMed=22842228;

RX   PubMed=26214590;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Deep exome analysis.

CC   Derived from metastatic site: Not specified.

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YUKARN

AC   CVCL_K012

RX   PubMed=22842228;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Deep exome analysis.

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   YUKIM

AC   CVCL_G328

DR   Cosmic; 1548861

DR   Cosmic; 2439332

RX   PubMed=20149136;

RX   PubMed=21521745;

RX   PubMed=21543894;

RX   PubMed=21569352;

RX   PubMed=26214590;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Deep exome analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Not specified.

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   YUKOLI

AC   CVCL_G329

DR   Cosmic; 1548862

RX   PubMed=20149136;

RX   PubMed=21543894;

RX   PubMed=22842228;

RX   PubMed=26214590;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Deep exome analysis.

CC   Derived from metastatic site: Not specified.

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YUKSI

AC   CVCL_J068

DR   Cosmic; 1548863

DR   Cosmic; 2439333

RX   PubMed=21521745;

RX   PubMed=21543894;

RX   PubMed=21569352;

RX   PubMed=26214590;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Deep exome analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Not specified.

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YULAC

AC   CVCL_B483

DR   Cosmic; 1197390

DR   Cosmic; 1548864

RX   PubMed=20149136;

RX   PubMed=21521745;

RX   PubMed=21543894;

RX   PubMed=21569352;

RX   PubMed=22842228;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Deep exome analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Not specified.

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   YULAPE

AC   CVCL_K013

RX   PubMed=22842228;

RX   PubMed=26214590;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Deep exome analysis.

CC   Derived from metastatic site: Not specified.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YULAXER

AC   CVCL_K014

RX   PubMed=22842228;

RX   PubMed=26214590;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Deep exome analysis.

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   YULIN

AC   CVCL_J522

DR   Cosmic; 1548879

RX   PubMed=21543894;

CC   Part of: Yale University (YU) melanoma cell collection.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YULOCUS

AC   CVCL_EI19

DR   Cosmic; 2439338

RX   PubMed=26214590;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Deep exome analysis.

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YULOMA

AC   CVCL_K015

RX   PubMed=22842228;

RX   PubMed=26214590;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Deep exome analysis.

CC   Derived from metastatic site: Not specified.

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YULONE

AC   CVCL_J523

DR   Cosmic; 1548865

DR   Cosmic; 2439339

RX   PubMed=21543894;

RX   PubMed=26214590;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Deep exome analysis.

CC   Derived from metastatic site: Not specified.

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   YULOVY

AC   CVCL_G330

RX   PubMed=20149136;

RX   PubMed=21569352;

RX   PubMed=22842228;

RX   PubMed=26214590;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Deep exome analysis.

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   YUMAC

AC   CVCL_A745

DR   Cosmic; 1197386

DR   Cosmic; 1548866

RX   PubMed=20149136;

RX   PubMed=21543894;

RX   PubMed=21569352;

RX   PubMed=22842228;

RX   PubMed=26214590;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Deep exome analysis.

CC   Derived from metastatic site: Not specified.

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YUMAG

AC   CVCL_J534

RX   PubMed=21569352;

CC   Part of: Yale University (YU) melanoma cell collection.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YUMINE

AC   CVCL_K016

RX   PubMed=22842228;

RX   PubMed=26214590;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Deep exome analysis.

CC   Derived from metastatic site: Not specified.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   YUMOBER

AC   CVCL_EI20

DR   Cosmic; 2439344

RX   PubMed=26214590;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Deep exome analysis.

CC   Derived from metastatic site: Not specified.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Yumoto

AC   CVCL_B484

SY   YUMOTO

DR   Cosmic; 877464

DR   Cosmic; 1152542

RX   PubMed=9790785;

DI   NCIt; C4028; Cervical squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   YUMUT

AC   CVCL_G331

DR   Cosmic; 1548867

RX   PubMed=20149136;

RX   PubMed=21543894;

RX   PubMed=22842228;

RX   PubMed=26214590;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Deep exome analysis.

CC   Derived from metastatic site: Not specified.

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YUNACK

AC   CVCL_EI21

RX   PubMed=26214590;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Deep exome analysis.

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   YUNIBO

AC   CVCL_J535

DR   Cosmic; 2439350

RX   PubMed=21569352;

RX   PubMed=26214590;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Deep exome analysis.

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YUNIGE

AC   CVCL_J524

DR   Cosmic; 1548868

RX   PubMed=21543894;

CC   Part of: Yale University (YU) melanoma cell collection.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YUNUFF

AC   CVCL_K017

RX   PubMed=22842228;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Deep exome analysis.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   YUNUVO

AC   CVCL_J525

DR   Cosmic; 1548885

RX   PubMed=21543894;

CC   Part of: Yale University (YU) melanoma cell collection.

DI   NCIt; C4022; Acral lentiginous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YUPAC7

AC   CVCL_EI22

DR   Cosmic; 2439353

RX   PubMed=26214590;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Deep exome analysis.

CC   Derived from metastatic site: Not specified.

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   YUPAO

AC   CVCL_J536

RX   PubMed=21569352;

CC   Part of: Yale University (YU) melanoma cell collection.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   YUPEET

AC   CVCL_K018

RX   PubMed=22842228;

RX   PubMed=26214590;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Deep exome analysis.

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YUPLA

AC   CVCL_J069

DR   Cosmic; 1548869

DR   Cosmic; 2439355

RX   PubMed=21521745;

RX   PubMed=21543894;

RX   PubMed=21569352;

RX   PubMed=26214590;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Deep exome analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Not specified.

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YUPOM

AC   CVCL_EI23

DR   Cosmic; 2439356

RX   PubMed=26214590;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Deep exome analysis.

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YURDE

AC   CVCL_K019

RX   PubMed=22842228;

RX   PubMed=26214590;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Deep exome analysis.

CC   Derived from metastatic site: Not specified.

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YURED

AC   CVCL_K020

RX   PubMed=22842228;

RX   PubMed=26214590;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Deep exome analysis.

CC   Derived from metastatic site: Not specified.

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   YURIF

AC   CVCL_B485

DR   Cosmic; 1197391

DR   Cosmic; 1548870

DR   Cosmic; 2013572

RX   PubMed=20149136;

RX   PubMed=21543894;

RX   PubMed=21569352;

RX   PubMed=22842228;

RX   PubMed=26214590;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Deep exome analysis.

CC   Derived from metastatic site: Not specified.

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YURKEN

AC   CVCL_K021

RX   PubMed=22842228;

RX   PubMed=26214590;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Deep exome analysis.

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   YUROB

AC   CVCL_B486

DR   Cosmic; 1548871

DR   Cosmic; 2439361

RX   PubMed=20149136;

RX   PubMed=21521745;

RX   PubMed=21543894;

RX   PubMed=21569352;

RX   PubMed=26214590;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Deep exome analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Not specified.

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   YUROL

AC   CVCL_J070

DR   Cosmic; 1548872

DR   Cosmic; 2439364

RX   PubMed=21521745;

RX   PubMed=21543894;

RX   PubMed=21569352;

RX   PubMed=26214590;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Deep exome analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Not specified.

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YUSAC2

AC   CVCL_A746

SY   YUSAC-2; YUSAC 2; YUSAC

DR   Cosmic; 1197388

RX   PubMed=9177196;

RX   PubMed=20149136;

RX   PubMed=21569352;

CC   Part of: Yale University (YU) melanoma cell collection.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YUSAN

AC   CVCL_J526

DR   Cosmic; 1548873

RX   PubMed=21543894;

RX   PubMed=22842228;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Deep exome analysis.

CC   Derived from metastatic site: Not specified.

DI   NCIt; C114828; Mucosal melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   YUSARI

AC   CVCL_K022

RX   PubMed=22842228;

RX   PubMed=26214590;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Deep exome analysis.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YUSIK

AC   CVCL_B487

DR   Cosmic; 1548874

RX   PubMed=20149136;

RX   PubMed=21543894;

RX   PubMed=21569352;

RX   PubMed=22842228;

RX   PubMed=26214590;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Deep exome analysis.

CC   Derived from metastatic site: Not specified.

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   YUSIPU

AC   CVCL_EI16

DR   Cosmic; 2439372

RX   PubMed=26214590;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Deep exome analysis.

CC   Derived from metastatic site: Not specified.

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YUSIT1

AC   CVCL_A747

SY   YUSIT-1; YUSIT 1; Yusit-1; YUSITI; Yusiti; YUSIT

DR   Cosmic; 1197389

DR   Cosmic; 1921229

DR   Cosmic; 2439373

RX   PubMed=9177196;

RX   PubMed=20149136;

RX   PubMed=26214590;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Deep exome analysis.

CC   Derived from metastatic site: Not specified.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YUSIT1-B11

AC   CVCL_R736

DR   Cosmic; 1921231

RX   Patent=US20130231347;

RX   PubMed=22389471;

CC   Selected for resistance to: ChEBI; CHEBI:75045; Dabrafenib (Tafinlar; GSK2118436).

CC   Derived from metastatic site: Not specified.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_A747 ! YUSIT1

SX   Male

CA   Cancer cell line

//

ID   YUSIT1-B31

AC   CVCL_R737

DR   Cosmic; 1921232

RX   Patent=US20130231347;

RX   PubMed=22389471;

CC   Selected for resistance to: ChEBI; CHEBI:75045; Dabrafenib (Tafinlar; GSK2118436).

CC   Derived from metastatic site: Not specified.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_A747 ! YUSIT1

SX   Male

CA   Cancer cell line

//

ID   YUSIT1-B5

AC   CVCL_R738

DR   Cosmic; 1921230

RX   Patent=US20130231347;

RX   PubMed=22389471;

CC   Selected for resistance to: ChEBI; CHEBI:75045; Dabrafenib (Tafinlar; GSK2118436).

CC   Derived from metastatic site: Not specified.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_A747 ! YUSIT1

SX   Male

CA   Cancer cell line

//

ID   YUSIV

AC   CVCL_G332

DR   Cosmic; 1548875

DR   Cosmic; 2439374

RX   PubMed=20149136;

RX   PubMed=21521745;

RX   PubMed=21543894;

RX   PubMed=21569352;

RX   PubMed=26214590;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Deep exome analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Not specified.

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   YUSTE

AC   CVCL_J527

DR   Cosmic; 1548876

RX   PubMed=21543894;

RX   PubMed=21569352;

RX   PubMed=22842228;

RX   PubMed=26214590;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Deep exome analysis.

CC   Derived from metastatic site: Not specified.

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   YUSUBA

AC   CVCL_K023

RX   PubMed=22842228;

RX   PubMed=26214590;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Deep exome analysis.

CC   Derived from metastatic site: Not specified.

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   YUSWI

AC   CVCL_K024

RX   PubMed=22842228;

RX   PubMed=26214590;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Deep exome analysis.

CC   Derived from metastatic site: Small intestine.

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YUTER

AC   CVCL_K025

RX   PubMed=22842228;

RX   PubMed=26214590;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Deep exome analysis.

CC   Derived from metastatic site: Not specified.

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YUTHO

AC   CVCL_J528

DR   Cosmic; 1548881

RX   PubMed=21543894;

CC   Part of: Yale University (YU) melanoma cell collection.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YUTICA

AC   CVCL_J071

DR   Cosmic; 1548877

DR   Cosmic; 2439381

RX   PubMed=21521745;

RX   PubMed=21543894;

RX   PubMed=26214590;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Deep exome analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Not specified.

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YUTUR

AC   CVCL_J539

RX   PubMed=21569352;

CC   Part of: Yale University (YU) melanoma cell collection.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YUVON3

AC   CVCL_G333

SY   YUVON

DR   Cosmic; 1548882

RX   PubMed=20149136;

RX   PubMed=21543894;

CC   Part of: Yale University (YU) melanoma cell collection.

DI   NCIt; C4022; Acral lentiginous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YUWAGE

AC   CVCL_K026

RX   PubMed=22842228;

RX   PubMed=26214590;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Deep exome analysis.

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YUWALI

AC   CVCL_K027

RX   PubMed=22842228;

RX   PubMed=26214590;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Deep exome analysis.

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YUWERA

AC   CVCL_J530

DR   Cosmic; 1548883

RX   PubMed=21543894;

RX   PubMed=21569352;

CC   Part of: Yale University (YU) melanoma cell collection.

DI   NCIt; C4022; Acral lentiginous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   YUWHIM

AC   CVCL_K028

RX   PubMed=22842228;

RX   PubMed=26214590;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Deep exome analysis.

CC   Derived from metastatic site: Not specified.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YUWIM

AC   CVCL_J531

DR   Cosmic; 1548878

RX   PubMed=21543894;

CC   Part of: Yale University (YU) melanoma cell collection.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YUZAZ

AC   CVCL_EI18

DR   Cosmic; 2439392

RX   PubMed=26214590;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Deep exome analysis.

CC   Derived from metastatic site: Not specified.

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YUZEAL

AC   CVCL_K029

RX   PubMed=22842228;

RX   PubMed=26214590;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Deep exome analysis.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YUZEST

AC   CVCL_EI24

RX   PubMed=26214590;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Deep exome analysis.

CC   Derived from metastatic site: Not specified.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YUZOR

AC   CVCL_J072

DR   Cosmic; 1548884

RX   PubMed=21521745;

RX   PubMed=21543894;

RX   PubMed=21569352;

CC   Part of: Yale University (YU) melanoma cell collection.

CC   Omics: Transcriptome analysis.

DI   NCIt; C4022; Acral lentiginous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   YW 62.3.20

AC   CVCL_J091

SY   YW62.3.20

DR   ECACC; 11072202

RX   PubMed=3330997;

CC   Monoclonal antibody target: UniProtKB; P06800; Mouse Ptprc/Cd45.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_4342 ! Y3-Ag 1.2.3

CA   Hybridoma

//

ID   Z-119

AC   CVCL_IU88

SY   Z119

DR   Cosmic; 2491094

RX   PubMed=8600166;

RX   PubMed=9067587;

CC   Doubling time: 20-30 hours (PubMed=8600166).

DI   NCIt; C36312; B acute lymphoblastic leukemia with t(9;22)(q34;q11.2) BCR-ABL1

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Z-138

AC   CVCL_B077

SY   Z138

DR   EFO; EFO_0005479

DR   ATCC; CRL-3001

DR   BioSample; SAMN03471023

DR   Cosmic; 2078183

DR   Cosmic; 2088021

DR   Cosmic; 2296992

DR   GEO; GSM115807

DR   Lonza; 1605

RX   PubMed=9669839;

RX   PubMed=16183118;

RX   PubMed=16203034;

RX   PubMed=16960149;

RX   PubMed=25315077;

CC   Part of: Lymphoma Research Foundation Mantle Cell Lymphoma cell bank (LRF MCL cell bank).

CC   Doubling time: 24 hours (PubMed=25315077).

ST   Source(s): ATCC; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 10,11

ST   D13S317: 9,12

ST   D16S539: 11

ST   D18S51: 14,18

ST   D21S11: 30,32.2

ST   D3S1358: 16

ST   D5S818: 11,13

ST   D7S820: 8

ST   D8S1179: 8,13

ST   FGA: 20,22

ST   Penta D: 13,15

ST   Penta E: 7,18

ST   TH01: 6

ST   TPOX: 8

ST   vWA: 15,18

DI   NCIt; C4337; Mantle cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Z-181

AC   CVCL_IU89

SY   Z181

DR   Cosmic; 2491095

RX   PubMed=8600166;

RX   PubMed=9067587;

CC   Doubling time: 30-40 hours (PubMed=8600166).

DI   NCIt; C36312; B acute lymphoblastic leukemia with t(9;22)(q34;q11.2) BCR-ABL1

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Z-33

AC   CVCL_4796

SY   Z33

RX   PubMed=8751477;

WW   http://www.cells-talk.com/index.php/page/copelibrary?key=Z-33

DI   NCIt; C36312; B acute lymphoblastic leukemia with t(9;22)(q34;q11.2) BCR-ABL1

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Z2

AC   CVCL_J056

DR   ECACC; 93022522

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   Z24

AC   CVCL_HB35

RX   PubMed=1430210;

RX   PubMed=1689731;

RX   PubMed=1750930;

RX   PubMed=11330042;

RX   PubMed=17045664;

CC   Transformant: ChEBI; CHEBI:23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_0214 ! CHO-K1

SX   Female

CA   Transformed cell line

//

ID   Z26

AC   CVCL_J057

DR   ECACC; 93022519

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   Z310

AC   CVCL_F753

RX   PubMed=12470873;

RX   PubMed=17825520;

RX   PubMed=18162136;

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV3-neo].

CC   Breed/subspecies: Sprague-Dawley.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

CA   Transformed cell line

//

ID   Z34

AC   CVCL_J058

DR   ECACC; 93022521

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   Z41

AC   CVCL_J059

DR   ECACC; 93022520

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   Z65

AC   CVCL_HB89

RX   PubMed=1430210;

RX   PubMed=1689731;

RX   PubMed=1750930;

RX   PubMed=9184070;

RX   PubMed=11330042;

RX   PubMed=17045664;

CC   Transformant: ChEBI; CHEBI:23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_0214 ! CHO-K1

SX   Female

CA   Transformed cell line

//

ID   ZA

AC   CVCL_D596

DR   CGH-DB; 361-2

DR   Cosmic; 930337

DR   Cosmic; 1046039

DR   Cosmic; 1123029

RX   PubMed=2228902;

RX   PubMed=2654810;

RX   PubMed=12632084;

RX   PubMed=17052259;

RX   PubMed=17599052;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Zajdela-Hepatoma

AC   CVCL_1D00

SY   ZH-CLS

DR   CLS; 500306/p652_Zajdela-Hepatoma

CC   Breed/subspecies: Sprague-Dawley.

DI   NCIt; C60416; Rat hepatocellular carcinoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

CA   Cancer cell line

//

ID   ZC-7901

AC   CVCL_R992

DR   KCB; KCB 93047YJ

RX   CelloPub=CLPUB00036;

CC   Group: Fish cell line.

CC   Misspelling: 'ZC-79001' in KCB 93047YJ.

OX   NCBI_TaxID=7959; ! Ctenopharyngodon idella

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ZC-7901S1

AC   CVCL_R993

RX   CelloPub=CLPUB00036;

CC   Group: Fish cell line.

OX   NCBI_TaxID=7959; ! Ctenopharyngodon idella

HI   CVCL_R992 ! ZC-7901

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ZC15.K

AC   CVCL_S366

DR   ATCC; CRL-6537

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-6537; true.

OX   NCBI_TaxID=9704; ! Zalophus californianus

OI   CVCL_S331 ! ZC15.Lu

SX   Sex undetermined

CA   Finite cell line

//

ID   ZC15.Lu

AC   CVCL_S331

DR   ATCC; CRL-6606

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-6606; true.

OX   NCBI_TaxID=9704; ! Zalophus californianus

OI   CVCL_S366 ! ZC15.K

SX   Sex undetermined

CA   Finite cell line

//

ID   ZC2.Sk/Mu

AC   CVCL_S367

DR   ATCC; CRL-6536

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Characteristics: Possibly infected by seal poxvirus.

CC   Discontinued: ATCC; CRL-6536; true.

OX   NCBI_TaxID=9704; ! Zalophus californianus

SX   Sex undetermined

CA   Finite cell line

//

ID   ZEB2

AC   CVCL_6E09

RX   PubMed=15602876;

RX   PubMed=17141029;

RX   PubMed=18399791;

CC   Group: Fish cell line.

CC   Characteristics: Requires feeder cells. Maintenance of ZEB2 depends on the presence of cell line RTS34st (CVCL_L016).

CC   Transfected with: UniProtKB; P42212; GFP.

OX   NCBI_TaxID=7955; ! Danio rerio

SX   Sex undetermined

CA   Embryonic stem cell

//

ID   ZEB2J

AC   CVCL_6E10

RX   PubMed=18399791;

RX   PubMed=19116758;

CC   Group: Fish cell line.

CC   Characteristics: Does not require feeder cells.

CC   Transfected with: UniProtKB; P42212; GFP.

OX   NCBI_TaxID=7955; ! Danio rerio

HI   CVCL_6E09 ! ZEB2

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ZEM

AC   CVCL_R818

RX   PubMed=1591622;

CC   Group: Fish cell line.

OX   NCBI_TaxID=7955; ! Danio rerio

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ZEM-2

AC   CVCL_5678

SY   ZEM2

RX   PubMed=7765109;

CC   Group: Fish cell line.

OX   NCBI_TaxID=7955; ! Danio rerio

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ZEM-2A

AC   CVCL_J060

RX   PubMed=7765109;

CC   Group: Fish cell line.

OX   NCBI_TaxID=7955; ! Danio rerio

HI   CVCL_5678 ! ZEM-2

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ZEM2S

AC   CVCL_3274

SY   ZEM-2S

DR   CLO; CLO_0009723

DR   ATCC; CRL-2147

DR   BCRC; 60253

CC   Group: Fish cell line.

OX   NCBI_TaxID=7955; ! Danio rerio

HI   CVCL_5678 ! ZEM-2

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ZEMH

AC   CVCL_R819

RX   PubMed=1591622;

CC   Group: Fish cell line.

OX   NCBI_TaxID=7955; ! Danio rerio

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ZEN

AC   CVCL_5417

SY   7-1-144

DR   JCRB; JCRB1311

RX   DOI=10.1021/jf00097a040;

CC   Monoclonal antibody target: ChEBI; CHEBI:10106; Zearalenone.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   Zeng01i-iPSH9

AC   CVCL_AS49

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/zeng01i-ipsh9.cmsx

ST   Source(s): WiCell

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 9

ST   D16S539: 12,13

ST   D18S51: 13

ST   D21S11: 30

ST   D3S1358: 13,16

ST   D5S818: 11,12

ST   D7S820: 9,11

ST   D8S1179: 8,14

ST   FGA: 26,28

ST   Penta D: 11,13

ST   Penta E: 11,14

ST   TH01: 9.3

ST   TPOX: 10,11

ST   vWA: 17

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_9773 ! WA09

SX   Female

CA   Induced pluripotent stem cell

//

ID   Zeng02i-iPSH14

AC   CVCL_AS50

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/zeng02i-ipsh14.cmsx

ST   Source(s): WiCell

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 11

ST   D16S539: 11,13

ST   D18S51: 12,14

ST   D21S11: 30,31

ST   D3S1358: 15,16

ST   D5S818: 11,13

ST   D7S820: 10,11

ST   D8S1179: 13,14

ST   FGA: 21

ST   Penta D: 12,13

ST   Penta E: 13,20

ST   TH01: 6,7

ST   TPOX: 8

ST   vWA: 15,16

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_9775 ! WA14

SX   Male

CA   Induced pluripotent stem cell

//

ID   ZES1

AC   CVCL_6E11

SY   Zebrafish ES-like 1

RX   PubMed=24967707;

CC   Group: Fish cell line.

OX   NCBI_TaxID=7955; ! Danio rerio

SX   Sex undetermined

CA   Embryonic stem cell

//

ID   ZF13

AC   CVCL_6G00

SY   ZF-13; ZF 13

RX   PubMed=7737359;

CC   Group: Fish cell line.

OX   NCBI_TaxID=7955; ! Danio rerio

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ZF29

AC   CVCL_6G01

SY   ZF-29; ZF 29

RX   PubMed=7737359;

CC   Group: Fish cell line.

OX   NCBI_TaxID=7955; ! Danio rerio

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ZF4

AC   CVCL_3275

DR   CLO; CLO_0009724

DR   EFO; EFO_0001261

DR   ATCC; CRL-2050

DR   BCRC; 60246

DR   KCB; KCB 2014059YJ

DR   Lonza; 1135

RX   PubMed=18377224;

CC   Group: Fish cell line.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=7955; ! Danio rerio

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ZFB1

AC   CVCL_6E12

SY   ZebraFish Bone 1

RX   DOI=10.1111/j.1439-0426.2010.01411.x;

RX   PubMed=23909483;

CC   Group: Fish cell line.

OX   NCBI_TaxID=7955; ! Danio rerio

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ZFL

AC   CVCL_3276

SY   ZF-L; ZebraFish Liver

DR   CLO; CLO_0009725

DR   ATCC; CRL-2643

DR   BCRC; 60454

DR   BCRJ; 0256

RX   PubMed=7994634;

RX   PubMed=24355757;

CC   Group: Fish cell line.

OX   NCBI_TaxID=7955; ! Danio rerio

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   Zfp57+/- clone 6909

AC   CVCL_DR00

RX   PubMed=27345984;

CC   Knockout cell: Method=Homologous recombination (1 of 2 alleles); MGI; MGI:99204; Zfp57.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Embryonic stem cell

//

ID   Zfp57+/- clone 6911

AC   CVCL_DR01

RX   PubMed=27345984;

CC   Knockout cell: Method=Homologous recombination (1 of 2 alleles); MGI; MGI:99204; Zfp57.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Embryonic stem cell

//

ID   Zfp57-/- clone 406

AC   CVCL_DR02

RX   PubMed=27345984;

CC   Knockout cell: Method=Homologous recombination; MGI; MGI:99204; Zfp57.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Embryonic stem cell

//

ID   Zfp57-/- clone 631

AC   CVCL_DR03

RX   PubMed=27345984;

CC   Knockout cell: Method=Homologous recombination; MGI; MGI:99204; Zfp57.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Embryonic stem cell

//

ID   Zfp57-/- clone 634

AC   CVCL_DR04

RX   PubMed=27345984;

CC   Knockout cell: Method=Homologous recombination; MGI; MGI:99204; Zfp57.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Embryonic stem cell

//

ID   ZFTMA

AC   CVCL_4Z52

RX   PubMed=21359817;

RX   PubMed=22922019;

CC   Group: Bird cell line.

CC   Omics: Deep RNAseq analysis.

OX   NCBI_TaxID=59729; ! Taeniopygia guttata

SX   Female

CA   Cancer cell line

//

ID   ZG

AC   CVCL_R820

SY   Zebrafish Gill

RX   PubMed=1591622;

CC   Group: Fish cell line.

OX   NCBI_TaxID=7955; ! Danio rerio

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   Zh1

AC   CVCL_V187

SY   ZZU-hESC-1

DR   ISCR; 2258

RX   PubMed=22711576;

CC   From: Reproductive Medical Center, the First Affiliated Hospital; ZhengZhou University; ZhengZhou; China.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   Zh21

AC   CVCL_V188

SY   ZZU-hESC-21

DR   ISCR; 2259

RX   PubMed=22711576;

CC   From: Reproductive Medical Center, the First Affiliated Hospital; ZhengZhou University; ZhengZhou; China.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   ZHBTc4

AC   CVCL_C715

SY   ZHBTc4-mESC; ZHBTc4 ES

DR   EFO; EFO_0005914

DR   ENCODE; ENCBS071NKO

DR   ENCODE; ENCBS173ENC

DR   ENCODE; ENCBS174ENC

DR   ENCODE; ENCBS175ENC

DR   ENCODE; ENCBS809MFF

DR   ENCODE; ENCBS898AKA

DR   GEO; GSM137761

DR   GEO; GSM137763

DR   GEO; GSM137765

DR   GEO; GSM137767

DR   GEO; GSM137769

DR   GEO; GSM138138

DR   GEO; GSM137786

DR   GEO; GSM137787

DR   GEO; GSM137788

DR   GEO; GSM137789

DR   GEO; GSM137790

DR   GEO; GSM138139

DR   GEO; GSM137791

DR   GEO; GSM137792

DR   GEO; GSM137793

DR   GEO; GSM137794

DR   GEO; GSM137795

DR   GEO; GSM138140

DR   GEO; GSM137770

DR   GEO; GSM137775

DR   GEO; GSM137780

DR   GEO; GSM137762

DR   GEO; GSM137771

DR   GEO; GSM137776

DR   GEO; GSM137764

DR   GEO; GSM137772

DR   GEO; GSM137777

DR   GEO; GSM137766

DR   GEO; GSM137773

DR   GEO; GSM137778

DR   GEO; GSM137768

DR   GEO; GSM137774

DR   GEO; GSM137779

DR   GEO; GSM1014150

DR   GEO; GSM1014152

DR   GEO; GSM1014169

DR   GEO; GSM1385517

DR   RCB; AES0136

RX   PubMed=10742100;

WW   http://genome.ucsc.edu/ENCODE/protocols/cell/mouse/ZhBTc4_Stam_protocol.pdf

CC   Part of: ENCODE project mouse cell lines.

CC   Discontinued: RCB; AES0136; probable.

CC   Breed/subspecies: 129/Ola.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_C714 ! ZHTc6

SX   Male

CA   Embryonic stem cell

//

ID   ZHTc6

AC   CVCL_C714

DR   GEO; GSM137796

DR   GEO; GSM137797

DR   GEO; GSM137798

DR   GEO; GSM137799

DR   GEO; GSM137800

DR   GEO; GSM138141

DR   GEO; GSM137806

DR   GEO; GSM137807

DR   GEO; GSM137808

DR   GEO; GSM137809

DR   GEO; GSM137810

DR   GEO; GSM138142

DR   GEO; GSM137816

DR   GEO; GSM137817

DR   GEO; GSM137818

DR   GEO; GSM137819

DR   GEO; GSM137820

DR   GEO; GSM138143

DR   GEO; GSM137785

DR   GEO; GSM137805

DR   GEO; GSM137815

DR   GEO; GSM137781

DR   GEO; GSM137801

DR   GEO; GSM137811

DR   GEO; GSM137782

DR   GEO; GSM137802

DR   GEO; GSM137812

DR   GEO; GSM137783

DR   GEO; GSM137803

DR   GEO; GSM137813

DR   GEO; GSM137784

DR   GEO; GSM137804

DR   GEO; GSM137814

DR   RCB; AES0137

RX   PubMed=10742100;

CC   Discontinued: RCB; AES0137; probable.

CC   Breed/subspecies: 129/Ola.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3987 ! CGR8

SX   Male

CA   Embryonic stem cell

//

ID   ZIZ-LD-1

AC   CVCL_Z243

DR   ECACC; 93022523

RX   DOI=10.1016/0022-1910(92)90116-U;

CC   Group: Insect cell line.

CC   Discontinued: ECACC; 93022523; probable.

OX   NCBI_TaxID=7539; ! Leptinotarsa decemlineata

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ZIZ-LD-1-15

AC   CVCL_Z244

RX   DOI=10.1016/0022-1910(92)90116-U;

CC   Group: Insect cell line.

OX   NCBI_TaxID=7539; ! Leptinotarsa decemlineata

HI   CVCL_Z243 ! ZIZ-LD-1

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ZIZ-LD-1-3

AC   CVCL_Z245

RX   DOI=10.1016/0022-1910(92)90116-U;

CC   Group: Insect cell line.

OX   NCBI_TaxID=7539; ! Leptinotarsa decemlineata

HI   CVCL_Z243 ! ZIZ-LD-1

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ZIZ-LD-1-4

AC   CVCL_Z246

RX   DOI=10.1016/0022-1910(92)90116-U;

CC   Group: Insect cell line.

OX   NCBI_TaxID=7539; ! Leptinotarsa decemlineata

HI   CVCL_Z243 ! ZIZ-LD-1

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ZK-58

AC   CVCL_9920

SY   ZK58

DR   Cosmic; 1529906

DR   GEO; GSM879224

RX   PubMed=12645653;

RX   PubMed=15150091;

RX   PubMed=19787792;

RX   PubMed=21519327;

DI   NCIt; C9145; Osteosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   ZK-H

AC   CVCL_W465

RX   CelloPub=CLPUB00011;

DI   NCIt; C7402; Hairy cell leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_W466 ! ZK-N

SX   Male

CA   Cancer cell line

//

ID   ZK-N

AC   CVCL_W466

RX   CelloPub=CLPUB00011;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_W465 ! ZK-H

SX   Male

CA   Transformed cell line

//

ID   ZKOP

AC   CVCL_6756

DR   CLO; CLO_0050526

DR   RCB; RCB2151

RX   PubMed=16198317;

CC   Knockout cell: Method=KO mouse; MGI; MGI:1346865; Mapk14.

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_6753 ! KOP

SX   Female

CA   Spontaneously immortalized cell line

//

ID   ZKS

AC   CVCL_5905

SY   Zebrafish Kidney Stromal

RX   PubMed=19433857;

CC   Group: Fish cell line.

CC   Breed/subspecies: AB.

OX   NCBI_TaxID=7955; ! Danio rerio

SX   Sex undetermined

CA   Stromal cell line

//

ID   ZL34

AC   CVCL_5906

SY   ZL-34

DR   BTO; BTO:0003992

DR   ECACC; 11120713

RX   PubMed=1373705;

RX   PubMed=21729925;

CC   From: University Hospital; Zurich; Switzerland.

CC   Doubling time: 29 hours (PubMed=1373705).

ST   Source(s): ECACC

ST   Amelogenin: X

ST   CSF1PO: 11,13

ST   D13S317: 11,12

ST   D16S539: 11

ST   D5S818: 11

ST   D7S820: 9

ST   TH01: 6

ST   TPOX: 8

ST   vWA: 18,20

DI   NCIt; C9351; Pleural mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   ZL5

AC   CVCL_5907

DR   ECACC; 11120715

RX   PubMed=1373705;

CC   From: University Hospital; Zurich; Switzerland.

CC   Doubling time: 31 hours (PubMed=1373705).

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): ECACC

ST   Amelogenin: X,Y

ST   CSF1PO: 10,11

ST   D13S317: 9,13

ST   D16S539: 12

ST   D5S818: 12

ST   D7S820: 10,11

ST   TH01: 6,9.3

ST   TPOX: 8,11

ST   vWA: 16,17

DI   NCIt; C9351; Pleural mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   ZL55

AC   CVCL_5908

DR   ECACC; 12050301

DR   PRIDE; PXD000589

RX   PubMed=1373705;

RX   PubMed=21729925;

RX   PubMed=24207061;

RX   PubMed=25894527;

CC   From: University Hospital; Zurich; Switzerland.

CC   Doubling time: 38 hours (PubMed=1373705).

CC   Omics: Cell surface proteome.

ST   Source(s): ECACC

ST   Amelogenin: X

ST   CSF1PO: 9,11

ST   D13S317: 8

ST   D16S539: 12

ST   D5S818: 10,13

ST   D7S820: 7,11

ST   TH01: 6

ST   TPOX: 8

ST   vWA: 15,19

DI   NCIt; C9351; Pleural mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   ZL92

AC   CVCL_T735

RX   PubMed=1373705;

CC   From: University Hospital; Zurich; Switzerland.

CC   Doubling time: 87 hours (PubMed=1373705).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C9351; Pleural mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   ZM

AC   CVCL_E896

DR   dbMHC; 49088

DR   IHW; IHW9246

DR   IMGT/HLA; 11609

WW   http://bioinformatics.hsanmartino.it/ecbr/cl246.html

CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Transformed cell line

//

ID   ZM-FC

AC   CVCL_E897

DR   dbMHC; 49089

DR   ECACC; 94071440

DR   IHW; IHW9349

DR   IMGT/HLA; 11610

WW   http://bioinformatics.hsanmartino.it/ecbr/cl349.html

CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Transformed cell line

//

ID   ZMAC-1

AC   CVCL_X750

SY   UIMAC FBAL-A; FBAL-A

DR   ATCC; PTA-8764

RX   Patent=US8202717;

WW   http://www.pork.org/filelibrary/researchdocuments/05-200-zuckerman-uofill.pdf

OX   NCBI_TaxID=9823; ! Sus scrofa

CA   Finite cell line

//

ID   ZN-R

AC   CVCL_0I67

SY   ZN-R1

DR   CCLV; CCLV-RIE 0122

RX   PubMed=19941903;

OX   NCBI_TaxID=9925; ! Capra hircus

CA   Finite cell line

//

ID   ZO

AC   CVCL_M694

RX   PubMed=2557656;

DI   NCIt; C9357; Hodgkin lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Zos

AC   CVCL_R779

RX   PubMed=18298897;

DI   NCIt; C9145; Osteosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_R780 ! Zos-M

SX   Male

CA   Cancer cell line

//

ID   Zos-M

AC   CVCL_R780

RX   PubMed=18298897;

CC   Derived from metastatic site: Bone skip lesion.

DI   NCIt; C9145; Osteosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_R779 ! Zos

SX   Male

CA   Cancer cell line

//

ID   ZP101

AC   CVCL_HA98

RX   PubMed=9016792;

CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.

CC   Transfected with: RGD; 61814; Pex2.

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB34 ! CHOTKa

SX   Female

CA   Transformed cell line

//

ID   ZP102

AC   CVCL_HA99

RX   PubMed=9016792;

CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.

CC   Transfected with: RGD; 61814; Pex2.

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB34 ! CHOTKa

SX   Female

CA   Transformed cell line

//

ID   ZP103

AC   CVCL_HB00

RX   PubMed=9016792;

CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.

CC   Transfected with: RGD; 61814; Pex2.

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB34 ! CHOTKa

SX   Female

CA   Transformed cell line

//

ID   ZP104

AC   CVCL_HB01

RX   PubMed=9184070;

CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.

CC   Transfected with: RGD; 61814; Pex2.

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB34 ! CHOTKa

SX   Female

CA   Transformed cell line

//

ID   ZP105

AC   CVCL_HB02

RX   PubMed=9184070;

RX   PubMed=9418886;

RX   PubMed=11330042;

RX   PubMed=17045664;

RX   PubMed=23009329;

CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.

CC   Characteristics: Has a mutation in PEX5.

CC   Transfected with: RGD; 61814; Pex2.

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB34 ! CHOTKa

SX   Female

CA   Transformed cell line

//

ID   ZP106

AC   CVCL_HB03

RX   PubMed=9184070;

CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.

CC   Transfected with: RGD; 61814; Pex2.

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB34 ! CHOTKa

SX   Female

CA   Transformed cell line

//

ID   ZP107

AC   CVCL_HB04

RX   PubMed=9184070;

RX   PubMed=11330042;

RX   PubMed=17045664;

CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.

CC   Transfected with: RGD; 61814; Pex2.

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB34 ! CHOTKa

SX   Female

CA   Transformed cell line

//

ID   ZP108

AC   CVCL_HB05

RX   PubMed=9184070;

CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.

CC   Transfected with: RGD; 61814; Pex2.

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB34 ! CHOTKa

SX   Female

CA   Transformed cell line

//

ID   ZP109

AC   CVCL_HB06

RX   PubMed=9184070;

RX   PubMed=11330042;

RX   PubMed=17045664;

CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.

CC   Transfected with: RGD; 61814; Pex2.

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB34 ! CHOTKa

SX   Female

CA   Transformed cell line

//

ID   ZP110

AC   CVCL_HB07

RX   PubMed=9270878;

RX   PubMed=11330042;

RX   PubMed=17045664;

CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.

CC   Transfected with: RGD; 61814; Pex2.

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB34 ! CHOTKa

SX   Female

CA   Transformed cell line

//

ID   ZP111

AC   CVCL_HB08

RX   PubMed=9270878;

CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.

CC   Transfected with: RGD; 61814; Pex2.

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB34 ! CHOTKa

SX   Female

CA   Transformed cell line

//

ID   ZP112

AC   CVCL_HB09

RX   PubMed=9270878;

CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.

CC   Transfected with: RGD; 61814; Pex2.

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB34 ! CHOTKa

SX   Female

CA   Transformed cell line

//

ID   ZP113

AC   CVCL_HB10

RX   PubMed=9270878;

CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.

CC   Transfected with: RGD; 61814; Pex2.

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB34 ! CHOTKa

SX   Female

CA   Transformed cell line

//

ID   ZP114

AC   CVCL_HB11

RX   PubMed=9270878;

RX   PubMed=11330042;

RX   PubMed=17045664;

CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.

CC   Transfected with: RGD; 61814; Pex2.

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB34 ! CHOTKa

SX   Female

CA   Transformed cell line

//

ID   ZP115

AC   CVCL_HB12

RX   PubMed=9270878;

CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.

CC   Transfected with: RGD; 61814; Pex2.

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB34 ! CHOTKa

SX   Female

CA   Transformed cell line

//

ID   ZP116

AC   CVCL_HB13

RX   PubMed=9727033;

CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.

CC   Transfected with: RGD; 61814; Pex2.

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB34 ! CHOTKa

SX   Female

CA   Transformed cell line

//

ID   ZP117

AC   CVCL_HB14

RX   PubMed=9727033;

CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.

CC   Transfected with: RGD; 61814; Pex2.

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB34 ! CHOTKa

SX   Female

CA   Transformed cell line

//

ID   ZP118

AC   CVCL_HB15

RX   PubMed=9727033;

CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.

CC   Transfected with: RGD; 61814; Pex2.

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB34 ! CHOTKa

SX   Female

CA   Transformed cell line

//

ID   ZP119

AC   CVCL_HB16

RX   PubMed=9727033;

RX   PubMed=17045664;

CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.

CC   Transfected with: RGD; 61814; Pex2.

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB34 ! CHOTKa

SX   Female

CA   Transformed cell line

//

ID   ZP120

AC   CVCL_HB17

RX   PubMed=9727033;

CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.

CC   Transfected with: RGD; 61814; Pex2.

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB34 ! CHOTKa

SX   Female

CA   Transformed cell line

//

ID   ZP121

AC   CVCL_U980

SY   ZP-121

DR   BTO; BTO:0003993

RX   PubMed=10222139;

RX   PubMed=16529741;

CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.

CC   Transfected with: RGD; 61814; Pex2.

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB34 ! CHOTKa

SX   Female

CA   Transformed cell line

//

ID   ZP122

AC   CVCL_HA95

RX   PubMed=10222139;

CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.

CC   Transfected with: RGD; 61814; Pex2.

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB34 ! CHOTKa

SX   Female

CA   Transformed cell line

//

ID   ZP123

AC   CVCL_HA96

RX   PubMed=10222139;

CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.

CC   Transfected with: RGD; 61814; Pex2.

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB34 ! CHOTKa

SX   Female

CA   Transformed cell line

//

ID   ZP124

AC   CVCL_U981

RX   PubMed=10222139;

RX   PubMed=17045664;

CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.

CC   Transfected with: RGD; 61814; Pex2.

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB34 ! CHOTKa

SX   Female

CA   Transformed cell line

//

ID   ZP125

AC   CVCL_HB33

RX   PubMed=10222139;

CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.

CC   Transfected with: RGD; 61814; Pex2.

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB34 ! CHOTKa

SX   Female

CA   Transformed cell line

//

ID   ZP126

AC   CVCL_U982

RX   PubMed=10222139;

RX   PubMed=17045664;

CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.

CC   Transfected with: RGD; 61814; Pex2.

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB34 ! CHOTKa

SX   Female

CA   Transformed cell line

//

ID   ZP127

AC   CVCL_U983

RX   PubMed=10222139;

CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.

CC   Transfected with: RGD; 61814; Pex2.

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB34 ! CHOTKa

SX   Female

CA   Transformed cell line

//

ID   ZP128

AC   CVCL_HB18

RX   PubMed=10441330;

RX   PubMed=17045664;

CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.

CC   Transfected with: RGD; 61814; Pex2.

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB34 ! CHOTKa

SX   Female

CA   Transformed cell line

//

ID   ZP137

AC   CVCL_HA97

RX   PubMed=10222139;

CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.

CC   Transfected with: RGD; 61814; Pex2.

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB34 ! CHOTKa

SX   Female

CA   Transformed cell line

//

ID   ZP139

AC   CVCL_HB19

RX   PubMed=9418886;

RX   PubMed=11330042;

RX   PubMed=17045664;

RX   PubMed=23009329;

CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.

CC   Characteristics: Has a mutation in PEX5.

CC   Transfected with: RGD; 61814; Pex2.

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB34 ! CHOTKa

SX   Female

CA   Transformed cell line

//

ID   ZP150

AC   CVCL_HB20

RX   PubMed=10441330;

CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.

CC   Characteristics: Has mutations in both alleles of PEX13.

CC   Transfected with: RGD; 61814; Pex2.

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB34 ! CHOTKa

SX   Female

CA   Transformed cell line

//

ID   ZP151

AC   CVCL_HB21

RX   PubMed=10222139;

CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.

CC   Transfected with: RGD; 61814; Pex2.

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB34 ! CHOTKa

SX   Female

CA   Transformed cell line

//

ID   ZP158

AC   CVCL_HB22

RX   PubMed=10222139;

CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.

CC   Transfected with: RGD; 61814; Pex2.

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB34 ! CHOTKa

SX   Female

CA   Transformed cell line

//

ID   ZP159

AC   CVCL_HB23

RX   PubMed=10222139;

CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.

CC   Transfected with: RGD; 61814; Pex2.

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB34 ! CHOTKa

SX   Female

CA   Transformed cell line

//

ID   ZP160

AC   CVCL_HB24

RX   PubMed=9727033;

CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.

CC   Transfected with: RGD; 61814; Pex2.

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB34 ! CHOTKa

SX   Female

CA   Transformed cell line

//

ID   ZP161

AC   CVCL_HB25

RX   PubMed=9727033;

CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.

CC   Transfected with: RGD; 61814; Pex2.

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB34 ! CHOTKa

SX   Female

CA   Transformed cell line

//

ID   ZP162

AC   CVCL_HB26

RX   PubMed=9727033;

CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.

CC   Transfected with: RGD; 61814; Pex2.

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB34 ! CHOTKa

SX   Female

CA   Transformed cell line

//

ID   ZP163

AC   CVCL_HB27

RX   PubMed=9727033;

CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.

CC   Transfected with: RGD; 61814; Pex2.

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB34 ! CHOTKa

SX   Female

CA   Transformed cell line

//

ID   ZP164

AC   CVCL_HB28

RX   PubMed=9727033;

CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.

CC   Transfected with: RGD; 61814; Pex2.

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB34 ! CHOTKa

SX   Female

CA   Transformed cell line

//

ID   ZP165

AC   CVCL_HB29

RX   PubMed=9727033;

CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.

CC   Transfected with: RGD; 61814; Pex2.

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB34 ! CHOTKa

SX   Female

CA   Transformed cell line

//

ID   ZP166

AC   CVCL_HB30

RX   PubMed=10222139;

CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.

CC   Transfected with: RGD; 61814; Pex2.

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB34 ! CHOTKa

SX   Female

CA   Transformed cell line

//

ID   ZP167

AC   CVCL_HB31

RX   PubMed=10222139;

RX   PubMed=17045664;

CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.

CC   Transfected with: RGD; 61814; Pex2.

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB34 ! CHOTKa

SX   Female

CA   Transformed cell line

//

ID   ZP92

AC   CVCL_HB32

RX   PubMed=1430210;

RX   PubMed=9184070;

RX   PubMed=11330042;

RX   PubMed=17045664;

CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.

CC   Transformant: ChEBI; CHEBI:23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_0214 ! CHO-K1

SX   Female

CA   Transformed cell line

//

ID   ZPEG101

AC   CVCL_HB38

RX   PubMed=23009329;

CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.

CC   Characteristics: Has mutations in both alleles of PEX5.

CC   Transfected with: RGD; 61814; Pex2.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Transformant: ChEBI; CHEBI:132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB36 ! CHOTKaEG1

SX   Female

CA   Transformed cell line

//

ID   ZPEG224

AC   CVCL_HB40

RX   PubMed=12054588;

CC   Transfected with: RGD; 61814; Pex2.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB37 ! CHOTKaEG2

SX   Female

CA   Transformed cell line

//

ID   ZPEG227

AC   CVCL_HB41

RX   PubMed=12054588;

CC   Characteristics: Has mutations in both alleles of PEX7.

CC   Transfected with: RGD; 61814; Pex2.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB37 ! CHOTKaEG2

SX   Female

CA   Transformed cell line

//

ID   ZPEG228

AC   CVCL_HB42

RX   PubMed=12054588;

CC   Transfected with: RGD; 61814; Pex2.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB37 ! CHOTKaEG2

SX   Female

CA   Transformed cell line

//

ID   ZPEG229

AC   CVCL_HB43

RX   PubMed=12054588;

CC   Transfected with: RGD; 61814; Pex2.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB37 ! CHOTKaEG2

SX   Female

CA   Transformed cell line

//

ID   ZPEG230

AC   CVCL_HB44

RX   PubMed=12054588;

CC   Transfected with: RGD; 61814; Pex2.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB37 ! CHOTKaEG2

SX   Female

CA   Transformed cell line

//

ID   ZPEG231

AC   CVCL_HB45

RX   PubMed=12054588;

CC   Characteristics: Does not express PEX7 mRNA.

CC   Transfected with: RGD; 61814; Pex2.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB37 ! CHOTKaEG2

SX   Female

CA   Transformed cell line

//

ID   ZPEG232

AC   CVCL_HB46

RX   PubMed=18543353;

CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.

CC   Transfected with: RGD; 61814; Pex2.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Transformant: ChEBI; CHEBI:132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB37 ! CHOTKaEG2

SX   Female

CA   Transformed cell line

//

ID   ZPEG233

AC   CVCL_HB47

RX   PubMed=18543353;

CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.

CC   Transfected with: RGD; 61814; Pex2.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Transformant: ChEBI; CHEBI:132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB37 ! CHOTKaEG2

SX   Female

CA   Transformed cell line

//

ID   ZPEG234

AC   CVCL_HB48

RX   PubMed=18543353;

CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.

CC   Transfected with: RGD; 61814; Pex2.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Transformant: ChEBI; CHEBI:132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB37 ! CHOTKaEG2

SX   Female

CA   Transformed cell line

//

ID   ZPEG235

AC   CVCL_HB49

RX   PubMed=18543353;

CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.

CC   Transfected with: RGD; 61814; Pex2.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Transformant: ChEBI; CHEBI:132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB37 ! CHOTKaEG2

SX   Female

CA   Transformed cell line

//

ID   ZPEG236

AC   CVCL_HB50

RX   PubMed=18543353;

CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.

CC   Transfected with: RGD; 61814; Pex2.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Transformant: ChEBI; CHEBI:132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB37 ! CHOTKaEG2

SX   Female

CA   Transformed cell line

//

ID   ZPEG237

AC   CVCL_HB51

RX   PubMed=18543353;

CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.

CC   Transfected with: RGD; 61814; Pex2.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Transformant: ChEBI; CHEBI:132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB37 ! CHOTKaEG2

SX   Female

CA   Transformed cell line

//

ID   ZPEG238

AC   CVCL_HB52

RX   PubMed=18543353;

CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.

CC   Characteristics: Has a mutation in both alleles of PEX3.

CC   Transfected with: RGD; 61814; Pex2.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Transformant: ChEBI; CHEBI:132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB37 ! CHOTKaEG2

SX   Female

CA   Transformed cell line

//

ID   ZPEG239

AC   CVCL_HB53

RX   PubMed=18543353;

CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.

CC   Characteristics: Has a mutation in both alleles of PEX2.

CC   Transfected with: RGD; 61814; Pex2.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Transformant: ChEBI; CHEBI:132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB37 ! CHOTKaEG2

SX   Female

CA   Transformed cell line

//

ID   ZPEG240

AC   CVCL_HB54

RX   PubMed=18543353;

CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.

CC   Transfected with: RGD; 61814; Pex2.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Transformant: ChEBI; CHEBI:132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB37 ! CHOTKaEG2

SX   Female

CA   Transformed cell line

//

ID   ZPEG241

AC   CVCL_HB55

RX   PubMed=18543353;

CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.

CC   Transfected with: RGD; 61814; Pex2.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Transformant: ChEBI; CHEBI:132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB37 ! CHOTKaEG2

SX   Female

CA   Transformed cell line

//

ID   ZPEG242

AC   CVCL_HB56

RX   PubMed=18543353;

CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.

CC   Transfected with: RGD; 61814; Pex2.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Transformant: ChEBI; CHEBI:132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB37 ! CHOTKaEG2

SX   Female

CA   Transformed cell line

//

ID   ZPEG243

AC   CVCL_HB57

RX   PubMed=18543353;

CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.

CC   Transfected with: RGD; 61814; Pex2.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Transformant: ChEBI; CHEBI:132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB37 ! CHOTKaEG2

SX   Female

CA   Transformed cell line

//

ID   ZPEG244

AC   CVCL_HB58

RX   PubMed=18543353;

CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.

CC   Transfected with: RGD; 61814; Pex2.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Transformant: ChEBI; CHEBI:132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB37 ! CHOTKaEG2

SX   Female

CA   Transformed cell line

//

ID   ZPEG245

AC   CVCL_HB59

RX   PubMed=18543353;

CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.

CC   Transfected with: RGD; 61814; Pex2.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Transformant: ChEBI; CHEBI:132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB37 ! CHOTKaEG2

SX   Female

CA   Transformed cell line

//

ID   ZPEG246

AC   CVCL_HB60

RX   PubMed=18543353;

CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.

CC   Transfected with: RGD; 61814; Pex2.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Transformant: ChEBI; CHEBI:132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB37 ! CHOTKaEG2

SX   Female

CA   Transformed cell line

//

ID   ZPEG247

AC   CVCL_HB61

RX   PubMed=18543353;

CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.

CC   Transfected with: RGD; 61814; Pex2.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Transformant: ChEBI; CHEBI:132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB37 ! CHOTKaEG2

SX   Female

CA   Transformed cell line

//

ID   ZPEG252

AC   CVCL_HB39

RX   PubMed=16723118;

CC   Characteristics: Has a mutation in both alleles of PEX1.

CC   Transfected with: RGD; 61814; Pex2.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB37 ! CHOTKaEG2

SX   Female

CA   Transformed cell line

//

ID   ZPG101

AC   CVCL_HB64

RX   PubMed=10222140;

CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.

CC   Transfected with: RGD; 61814; Pex2.

CC   Transfected with: UniProtKB; P42212; GFP.

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB62 ! CHOTKaG1

SX   Female

CA   Spontaneously immortalized cell line

//

ID   ZPG102

AC   CVCL_HB65

RX   PubMed=10222140;

CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.

CC   Transfected with: RGD; 61814; Pex2.

CC   Transfected with: UniProtKB; P42212; GFP.

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB62 ! CHOTKaG1

SX   Female

CA   Spontaneously immortalized cell line

//

ID   ZPG103

AC   CVCL_HB66

RX   PubMed=10222140;

CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.

CC   Transfected with: RGD; 61814; Pex2.

CC   Transfected with: UniProtKB; P42212; GFP.

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB62 ! CHOTKaG1

SX   Female

CA   Spontaneously immortalized cell line

//

ID   ZPG113

AC   CVCL_HB67

RX   PubMed=10222140;

CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.

CC   Transfected with: RGD; 61814; Pex2.

CC   Transfected with: UniProtKB; P42212; GFP.

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB62 ! CHOTKaG1

SX   Female

CA   Spontaneously immortalized cell line

//

ID   ZPG115

AC   CVCL_HB68

RX   PubMed=10222140;

CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.

CC   Transfected with: RGD; 61814; Pex2.

CC   Transfected with: UniProtKB; P42212; GFP.

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB62 ! CHOTKaG1

SX   Female

CA   Spontaneously immortalized cell line

//

ID   ZPG117

AC   CVCL_HB69

RX   PubMed=10222140;

CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.

CC   Transfected with: RGD; 61814; Pex2.

CC   Transfected with: UniProtKB; P42212; GFP.

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB62 ! CHOTKaG1

SX   Female

CA   Spontaneously immortalized cell line

//

ID   ZPG118

AC   CVCL_HB70

RX   PubMed=10222140;

CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.

CC   Transfected with: RGD; 61814; Pex2.

CC   Transfected with: UniProtKB; P42212; GFP.

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB62 ! CHOTKaG1

SX   Female

CA   Spontaneously immortalized cell line

//

ID   ZPG203

AC   CVCL_HB71

RX   PubMed=10222140;

CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.

CC   Transfected with: RGD; 61814; Pex2.

CC   Transfected with: UniProtKB; P42212; GFP.

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB63 ! CHOTKaG2

SX   Female

CA   Spontaneously immortalized cell line

//

ID   ZPG205

AC   CVCL_HB72

RX   PubMed=10222140;

CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.

CC   Transfected with: RGD; 61814; Pex2.

CC   Transfected with: UniProtKB; P42212; GFP.

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB63 ! CHOTKaG2

SX   Female

CA   Spontaneously immortalized cell line

//

ID   ZPG206

AC   CVCL_HB73

RX   PubMed=10222140;

CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.

CC   Transfected with: RGD; 61814; Pex2.

CC   Transfected with: UniProtKB; P42212; GFP.

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB63 ! CHOTKaG2

SX   Female

CA   Spontaneously immortalized cell line

//

ID   ZPG207

AC   CVCL_HB74

RX   PubMed=10222140;

RX   PubMed=17045664;

CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.

CC   Transfected with: RGD; 61814; Pex2.

CC   Transfected with: UniProtKB; P42212; GFP.

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB63 ! CHOTKaG2

SX   Female

CA   Spontaneously immortalized cell line

//

ID   ZPG208

AC   CVCL_HB75

RX   PubMed=10222140;

RX   PubMed=17045664;

CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.

CC   Transfected with: RGD; 61814; Pex2.

CC   Transfected with: UniProtKB; P42212; GFP.

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB63 ! CHOTKaG2

SX   Female

CA   Spontaneously immortalized cell line

//

ID   ZPG209

AC   CVCL_HB76

RX   PubMed=10222140;

CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.

CC   Transfected with: RGD; 61814; Pex2.

CC   Transfected with: UniProtKB; P42212; GFP.

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB63 ! CHOTKaG2

SX   Female

CA   Spontaneously immortalized cell line

//

ID   ZPG210

AC   CVCL_HB77

RX   PubMed=10222140;

CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.

CC   Transfected with: RGD; 61814; Pex2.

CC   Transfected with: UniProtKB; P42212; GFP.

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_HB63 ! CHOTKaG2

SX   Female

CA   Spontaneously immortalized cell line

//

ID   ZQNK-29

AC   CVCL_4U93

RX   Patent=CN102876632A;

RX   PubMed=26299072;

CC   Registration: International Depositary Authority, China Center for Type Culture Collection (CCTCC); C201278.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C4684; Nasal type extranodal NK/T-cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   ZR-75-1

AC   CVCL_0588

SY   ZR751; ZR75-1; ZR75_1

DR   BTO; BTO:0003136

DR   CLO; CLO_0009727

DR   EFO; EFO_0001262

DR   MCCL; MCC:0000494

DR   CLDB; cl4817

DR   CLDB; cl4818

DR   CLDB; cl4819

DR   CLDB; cl4820

DR   CLDB; cl4821

DR   CLDB; cl4946

DR   ATCC; CRL-1500

DR   BCRC; 60055

DR   BioSample; SAMN01821608

DR   BioSample; SAMN03471337

DR   CCLE; ZR751_BREAST

DR   CCRID; 3111C0001CCC000090

DR   CCRID; 3131C0001000700126

DR   ChEMBL-Cells; CHEMBL3307615

DR   ChEMBL-Targets; CHEMBL614393

DR   CLS; 300163/p689_ZR-75-1

DR   Cosmic; 687503

DR   Cosmic; 755295

DR   Cosmic; 871152

DR   Cosmic; 877452

DR   Cosmic; 894094

DR   Cosmic; 904398

DR   Cosmic; 934532

DR   Cosmic; 944296

DR   Cosmic; 979717

DR   Cosmic; 991333

DR   Cosmic; 997927

DR   Cosmic; 1010919

DR   Cosmic; 1044205

DR   Cosmic; 1046930

DR   Cosmic; 1047720

DR   Cosmic; 1136344

DR   Cosmic; 1152530

DR   Cosmic; 1175836

DR   Cosmic; 1287904

DR   Cosmic; 1289421

DR   Cosmic; 1309006

DR   Cosmic; 1326279

DR   Cosmic; 1571792

DR   Cosmic; 1523772

DR   Cosmic; 1524343

DR   Cosmic; 1603229

DR   Cosmic; 1609464

DR   Cosmic; 2165028

DR   Cosmic; 2301536

DR   Cosmic; 2318372

DR   Cosmic; 2361354

DR   ECACC; 87012601

DR   GEO; GSM73744

DR   GEO; GSM115120

DR   GEO; GSM155214

DR   GEO; GSM217613

DR   GEO; GSM344360

DR   GEO; GSM344410

DR   GEO; GSM350508

DR   GEO; GSM378142

DR   GEO; GSM388216

DR   GEO; GSM481332

DR   GEO; GSM783956

DR   GEO; GSM845400

DR   GEO; GSM847449

DR   GEO; GSM847509

DR   GEO; GSM844725

DR   GEO; GSM887750

DR   GEO; GSM888845

DR   GEO; GSM1008921

DR   GEO; GSM1215256

DR   GEO; GSM1374993

DR   GEO; GSM1374994

DR   GEO; GSM1374995

DR   GEO; GSM1401648

DR   GEO; GSM1556182

DR   GEO; GSM1556183

DR   GEO; GSM1556184

DR   GEO; GSM1556185

DR   GEO; GSM1556186

DR   GEO; GSM1664567

DR   ICLC; HTL99006

DR   IZSLER; BS TCL 75

DR   KCB; KCB 2010136YJ

DR   KCLB; 21500

DR   LINCS; 50574

DR   PRIDE; PXD001327

DR   RCB; RCB1906

RX   PubMed=688225;

RX   PubMed=1911442;

RX   PubMed=6582512;

RX   PubMed=10862037;

RX   PubMed=11044355;

RX   PubMed=12353263;

RX   PubMed=12800145;

RX   PubMed=15677628;

RX   PubMed=15767549;

RX   PubMed=17157791;

RX   PubMed=19582160;

RX   PubMed=19727395;

RX   PubMed=20070913;

RX   PubMed=21378333;

RX   PubMed=22460905;

RX   PubMed=24162158;

RX   PubMed=25238572;

RX   PubMed=23601657;

RX   PubMed=25485619;

RX   PubMed=28196595;

WW   http://www.pawefish.path.cam.ac.uk/BreastCellLineDescriptions/zr-75-1.htm

WW   http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=ZR-75-1

WW   http://lincs.hms.harvard.edu/resources/reagents/icbp43/

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: ICBP43 breast cancer cell line panel.

CC   Part of: JFCR45 cancer cell line panel.

CC   Part of: KuDOS 95 cell line panel.

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Array-based CGH.

CC   Omics: CNV analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: miRNA expression profiling.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Discontinued: RCB; RCB1906; true.

CC   Derived from metastatic site: Ascites.

ST   Source(s): ATCC; CLS; ECACC; KCLB; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 9

ST   D16S539: 11

ST   D18S51: 13,14

ST   D21S11: 31

ST   D3S1358: 15,16

ST   D5S818: 13

ST   D7S820: 10,11 (ATCC; CLS; ECACC; PubMed=25877200)

ST   D7S820: 10 (KCLB)

ST   D8S1179: 11,13

ST   FGA: 20,22

ST   Penta D: 14

ST   Penta E: 7,14

ST   TH01: 7,9.3

ST   TPOX: 8

ST   vWA: 16,18

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   ZR-75-27

AC   CVCL_5612

RX   PubMed=688225;

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_1661 ! ZR-75-30

SX   Female

CA   Cancer cell line

//

ID   ZR-75-30

AC   CVCL_1661

SY   ZR7530; ZR75-30

DR   BTO; BTO:0004915

DR   CLO; CLO_0009728

DR   EFO; EFO_0001263

DR   CLDB; cl4822

DR   CLDB; cl4823

DR   CLDB; cl4824

DR   ATCC; CRL-1504

DR   BCRC; 60056

DR   BioSample; SAMN03471856

DR   CCLE; ZR7530_BREAST

DR   CCRID; 3111C0001CCC000240

DR   CCRID; 3131C0001000700060

DR   CCRID; 3131C0001001200003

DR   CCRID; 3142C0001000000053

DR   ChEMBL-Cells; CHEMBL3308094

DR   ChEMBL-Targets; CHEMBL1075613

DR   Cosmic; 687504

DR   Cosmic; 871160

DR   Cosmic; 877444

DR   Cosmic; 894095

DR   Cosmic; 904399

DR   Cosmic; 909907

DR   Cosmic; 921977

DR   Cosmic; 949194

DR   Cosmic; 979716

DR   Cosmic; 1046953

DR   Cosmic; 1047719

DR   Cosmic; 1136346

DR   Cosmic; 1152523

DR   Cosmic; 1287913

DR   Cosmic; 1289422

DR   Cosmic; 1571790

DR   Cosmic; 1603230

DR   Cosmic; 2165016

DR   Cosmic-CLP; 909907

DR   ECACC; 88113004

DR   GDSC; 909907

DR   GEO; GSM69200

DR   GEO; GSM73747

DR   GEO; GSM115121

DR   GEO; GSM217611

DR   GEO; GSM344379

DR   GEO; GSM344429

DR   GEO; GSM350533

DR   GEO; GSM783957

DR   GEO; GSM847450

DR   GEO; GSM847510

DR   GEO; GSM844727

DR   GEO; GSM844726

DR   GEO; GSM887751

DR   GEO; GSM888846

DR   GEO; GSM1401666

DR   GEO; GSM1661991

DR   GEO; GSM1670589

DR   LINCS; 50575

RX   PubMed=688225;

RX   PubMed=11044355;

RX   PubMed=11414198;

RX   PubMed=17157791;

RX   PubMed=19582160;

RX   PubMed=20070913;

RX   PubMed=22460905;

RX   PubMed=23601657;

RX   PubMed=25485619;

RX   PubMed=25984343;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://www.pawefish.path.cam.ac.uk/BreastCellLineDescriptions/ZR-75-30.html

WW   http://lincs.hms.harvard.edu/resources/reagents/icbp43/

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: ICBP43 breast cancer cell line panel.

CC   Part of: MD Anderson Cell Lines Project.

CC   Doubling time: 60 hours (PubMed=25984343).

CC   Microsatellite instability: Instable (MSI-low) (Sanger).

CC   Omics: Array-based CGH.

CC   Omics: CNV analysis.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: miRNA expression profiling.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: shRNA library screening.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Ascites.

ST   Source(s): ATCC; Cosmic-CLP; ECACC; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 10,11

ST   D16S539: 9

ST   D18S51: 17

ST   D21S11: 31

ST   D3S1358: 15,18

ST   D5S818: 12,13

ST   D7S820: 11,12

ST   D8S1179: 13,14

ST   FGA: 22

ST   Penta D: 2.2,10

ST   Penta E: 5,7

ST   TH01: 8,9

ST   TPOX: 10,11

ST   vWA: 18,19

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_5612 ! ZR-75-27

SX   Female

CA   Cancer cell line

//

ID   ZR-75-9a1

AC   CVCL_5613

RX   PubMed=2713239;

CC   Selected for resistance to: ChEBI; CHEBI:41774; Tamoxifen.

CC   Derived from metastatic site: Ascites.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0588 ! ZR-75-1

SX   Female

CA   Cancer cell line

//

ID   ZR-75-B

AC   CVCL_5614

SY   ZR75-B; ZR-75B; ZR-75b; ZR75B

DR   EFO; EFO_0001264

DR   Cosmic; 1136345

DR   Cosmic; 1176641

DR   GEO; GSM1215271

DR   LINCS; 51096

RX   PubMed=6178756;

RX   PubMed=17157791;

RX   PubMed=18516279;

RX   PubMed=24162158;

CC   Misspelling: Occasionally 'ZRB75'.

CC   Derived from metastatic site: Ascites.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0588 ! ZR-75-1

SX   Female

CA   Cancer cell line

//

ID   ZR-78

AC   CVCL_8025

SY   ZR78

DR   BTO; BTO:0004916

RX   PubMed=3460088;

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_0214 ! CHO-K1

SX   Female

CA   Spontaneously immortalized cell line

//

ID   ZR-78.1

AC   CVCL_8026

DR   BTO; BTO:0004917

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_8025 ! ZR-78

SX   Female

CA   Spontaneously immortalized cell line

//

ID   ZR-82

AC   CVCL_8027

DR   BTO; BTO:0004918

RX   PubMed=3460088;

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_0214 ! CHO-K1

SX   Female

CA   Spontaneously immortalized cell line

//

ID   ZR-87

AC   CVCL_8028

RX   PubMed=3460088;

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_0214 ! CHO-K1

SX   Female

CA   Spontaneously immortalized cell line

//

ID   ZR75-1 25DOCR

AC   CVCL_4Y42

RX   PubMed=25312014;

CC   Selected for resistance to: ChEBI; CHEBI:4672; Docetaxel anhydrous (Taxotere).

CC   Derived from metastatic site: Ascites.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0588 ! ZR-75-1

SX   Female

CA   Cancer cell line

//

ID   ZR75-1 25PACR

AC   CVCL_4Y44

RX   PubMed=25312014;

CC   Selected for resistance to: ChEBI; CHEBI:45863; Paclitaxel (Taxol).

CC   Derived from metastatic site: Ascites.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0588 ! ZR-75-1

SX   Female

CA   Cancer cell line

//

ID   ZR75-1 50DOCR

AC   CVCL_4Y43

RX   PubMed=25312014;

CC   Selected for resistance to: ChEBI; CHEBI:4672; Docetaxel anhydrous (Taxotere).

CC   Derived from metastatic site: Ascites.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0588 ! ZR-75-1

SX   Female

CA   Cancer cell line

//

ID   ZR75-1 50PACR

AC   CVCL_4Y45

RX   PubMed=25312014;

CC   Selected for resistance to: ChEBI; CHEBI:45863; Paclitaxel (Taxol).

CC   Derived from metastatic site: Ascites.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0588 ! ZR-75-1

SX   Female

CA   Cancer cell line

//

ID   ZR75T

AC   CVCL_IW49

RX   PubMed=8430082;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Derived from metastatic site: Ascites.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0588 ! ZR-75-1

SX   Female

CA   Cancer cell line

//

ID   ZS-1

AC   CVCL_9R46

RX   Patent=US9340815;

CC   Group: Bird cell line.

CC   Breed/subspecies: East Lansing Line 0.TVB*S1.

OX   NCBI_TaxID=9031; ! Gallus gallus

CA   Spontaneously immortalized cell line

//

ID   ZSM

AC   CVCL_F481

DR   CLO; CLO_0051136

DR   RCB; HSC0001

RX   PubMed=21383383;

CC   Part of: Sonoda-Tajima cell collection.

CC   Population: China.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   ZSSJ

AC   CVCL_6E22

RX   PubMed=19116758;

CC   Group: Fish cell line.

OX   NCBI_TaxID=7955; ! Danio rerio

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ZZ-R 127

AC   CVCL_5418

SY   ZZ-R

DR   CCLV; CCLV-RIE 0127

RX   PubMed=19656987;

RX   PubMed=19941903;

OX   NCBI_TaxID=9925; ! Capra hircus

CA   Spontaneously immortalized cell line

//

ID   __Parent_cell_line_of_DLD-1/HCT 8/HCT 15/HRT-18

AC   CVCL_3449

RX   PubMed=9809040;

DI   NCIt; C4349; Colon adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line


您正在向 biovector.net  发送关于产品 细胞株Cell Lines 96及完全培养基-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心http://www.biovector.net 的询问

点击“立即发送”后,我们将在1个工作日内与您取得联系。